

  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-3-fluoro-2-nitrobenzene
C6H3BrFNO2
886762-70-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 2 O 0.0000 1.3338 0.0 0
M  V30 3 O 0.0000 4.0012 0.0 0
M  V30 4 Br 2.3101 5.3350 0.0 0
M  V30 5 F 2.3101 0.0000 0.0 0
M  V30 6 C 2.3101 2.6675 0.0 0
M  V30 7 C 3.0801 4.0012 0.0 0
M  V30 8 C 3.0801 1.3338 0.0 0
M  V30 9 C 4.6201 4.0012 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 8
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
1150617-53-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0 VAL=5
M  V30 2 O 1.3338 5.3901 0.0 0
M  V30 3 O 4.0012 5.3901 0.0 0
M  V30 4 N 5.3348 3.0801 0.0 0
M  V30 5 C 6.6687 2.3101 0.0 0
M  V30 6 Br 0.0000 3.0801 0.0 0
M  V30 7 C 2.6675 3.0801 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 1.3338 2.3101 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 886762-70-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1150617-53-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19493123
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fragment Based Optimization of Metabotropic Glutamate Receptor 2 (mGluR2)
Positive Allosteric Modulators in the Absence of Structural Information
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Szabo, Gyorgy; Turos, Gyorgy I.; Kolok, Sandor; Vastag, Monika; Santa,
Zsuzsanna; Dekany, Miklos; Levay, Gyorgy I.; Greiner, Istvan; Natsumi,
Minami; Tatsuya, Watanabe; Keseru, Gyorgy M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2019), 62(1), 234-246

$RFMT $RIREG SCHEME2 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Salicylaldehyde
C7H6O2
90-02-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 O 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Methylimino)methyl]phenol
C8H9NO
3117-65-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 O 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90-02-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3117-65-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6201545
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, spectra, redox properties and catalytic activity of
ruthenium(III) Schiff base complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Venkatachalam, G.; Maheswaran, S.; Ramesh, R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Indian Journal of Chemistry, Section A: Inorganic, Bio-inorganic,
Physical, Theoretical & Analytical Chemistry (2005), 44A(4), 705-709

$RFMT $RIREG SCHEME3 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-(bromomethyl)-3-nitro-, methyl ester
C9H8BrNO4
98475-07-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.6201 0.0 0
M  V30 2 Br 2.6675 5.3901 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 O 8.0023 2.3101 0.0 0
M  V30 5 O 6.6685 4.6201 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 15 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-2-methyl-4-nitro-1H-isoindol-1-one
C9H8N2O3
682757-52-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6519 3.0012 0.0 0 VAL=5
M  V30 2 O 6.6519 1.4612 0.0 0
M  V30 3 O 7.9855 3.7712 0.0 0
M  V30 4 O 0.0000 3.0608 0.0 0
M  V30 5 C 1.3627 0.0000 0.0 0
M  V30 6 C 3.9844 3.0012 0.0 0
M  V30 7 C 2.6508 3.7712 0.0 0
M  V30 8 C 5.3181 3.7712 0.0 0
M  V30 9 C 3.6643 1.4947 0.0 0
M  V30 10 C 1.5064 2.7406 0.0 0
M  V30 11 C 2.6508 5.3112 0.0 0
M  V30 12 C 5.3181 5.3112 0.0 0
M  V30 13 N 2.1327 1.3338 0.0 0
M  V30 14 C 3.9844 6.0812 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 4 10
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98475-07-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 682757-52-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37362864
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a Bromodomain and Extra Terminal Domain (BET) Inhibitor with
the Selectivity for the Second Bromodomain (BD2) and the Capacity for the
Treatment of Inflammatory Diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Zhijie; Yin, Li; Xiong, Zhenghan; Huang, Fei; Yang, Na; Jiang, Fei;
Li, Huili; Cui, Yong; Ren, Jiwei; Cheng, Zitian; Jia, Kun; Lu, Tao; Zhu,
Jiapeng; Hu, Qinghua; Chen, Yadong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(15), 10824-10848

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzenesulfonyl chloride
C6H4ClNO4S
98-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 1.5400 0.0 0 VAL=6
M  V30 2 Cl 8.4700 1.5400 0.0 0
M  V30 3 O 6.9300 3.0800 0.0 0
M  V30 4 O 6.9300 0.0000 0.0 0
M  V30 5 N 0.7700 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 0.2064 0.0 0
M  V30 7 O 0.0000 2.8736 0.0 0
M  V30 8 C 5.3900 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 3.0800 0.2064 0.0 0
M  V30 12 C 3.0800 2.8736 0.0 0
M  V30 13 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitrobenzenesulfonamide
C7H8N2O4S
6319-45-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 4.6201 0.0 0 VAL=6
M  V30 2 N 8.0023 5.3901 0.0 0
M  V30 3 O 5.8985 5.9538 0.0 0
M  V30 4 O 7.4385 3.2864 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-74-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6319-45-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-15592369
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Studies on the Synthesis of the Alkaloid (-)-Gilbertine via Indolidene
Chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Feldman, Ken S.; Folda, Tamara S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2016), 81(11), 4566-4575

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzenesulfonyl chloride
C6H4ClNO4S
98-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 1.5400 0.0 0 VAL=6
M  V30 2 Cl 8.4700 1.5400 0.0 0
M  V30 3 O 6.9300 3.0800 0.0 0
M  V30 4 O 6.9300 0.0000 0.0 0
M  V30 5 N 0.7700 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 0.2064 0.0 0
M  V30 7 O 0.0000 2.8736 0.0 0
M  V30 8 C 5.3900 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 3.0800 0.2064 0.0 0
M  V30 12 C 3.0800 2.8736 0.0 0
M  V30 13 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitrobenzenesulfonamide
C7H8N2O4S
6319-45-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 4.6201 0.0 0 VAL=6
M  V30 2 N 8.0023 5.3901 0.0 0
M  V30 3 O 5.8985 5.9538 0.0 0
M  V30 4 O 7.4385 3.2864 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-74-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6319-45-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-14162638
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM unspecified alcohol used as solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compounds inducing chondrogenesis and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schultz, Peter G.; Chatterjee, Arnab K.; Zhu, Shoutian; Payette, Joshua;
Yoon, Hongchul; Yang, Baiyuan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20140271955 A1 2014-09-18

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
4-Nitrobenzenesulfonyl chloride
C6H4ClNO4S
98-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 1.5400 0.0 0 VAL=6
M  V30 2 Cl 8.4700 1.5400 0.0 0
M  V30 3 O 6.9300 3.0800 0.0 0
M  V30 4 O 6.9300 0.0000 0.0 0
M  V30 5 N 0.7700 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 0.2064 0.0 0
M  V30 7 O 0.0000 2.8736 0.0 0
M  V30 8 C 5.3900 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 3.0800 0.2064 0.0 0
M  V30 12 C 3.0800 2.8736 0.0 0
M  V30 13 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitrobenzenesulfonamide
C7H8N2O4S
6319-45-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 4.6201 0.0 0 VAL=6
M  V30 2 N 8.0023 5.3901 0.0 0
M  V30 3 O 5.8985 5.9538 0.0 0
M  V30 4 O 7.4385 3.2864 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 98-74-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6319-45-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-2418029
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a solution of 1.326 g (6.0 mmol) of
3-nitrobenzenesulfonyl chloride or 4-nitrobenzenesulfonyl chloride in 30
mL of dry THF was added 1.37 g (13.5 mmol) of triethylamine and then 4.0
mL (8.0 mmol) of methylamine as a solution in THF at 0°C. with stirring.
The resulting cloudy solution was stirred overnight at ambient
temperature. After this time period, the reaction mixture was diluted
with 100 mL of saturated sodium chloride solution and 50 mL of ethyl
acetate, then transferred to a 500 mL separatory funnel, mixed
thoroughly, and the organic phase was separated. The aqueous phase was
extracted twice with 50 mL of ethyl acetate. The combined organic layers
were dried over anhydrous Na2SO4, filtered, and concentrated under
reduced pressure, and the resulting residue purified by recrystallization
from EtOH. N-methyl-4-nitrobenzenesulfonamide, yield 1.17 g, 90%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of hydrazonodiaminopyrazoles with antiproliferative activity.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Zaihui; Daynard, Timothy Scott; Sviridov, Serguei V.; Chafeev,
Mikhail A.; Wang, Shisen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20030060453 A1 2003-03-27

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-2-nitrobenzene
C6H4ClNO2
88-73-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitrobenzenamine
C7H8N2O2
612-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 88-73-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 612-28-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14962171
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 6674-22-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for Nucleophilic
Substitution A mixture of 2-chloronitrobenzene (0.1 mol), the
amine/aniline (0.1 mol) and DBU (0.1 mol) are heated at 80°C for 1 h. The
reaction mixture was allowed to cool to room temperature and partitioned
between dichloromethane and water. The organic layer was dried over
anhydrous sodium sulphate and the residue was chromatographed on silica
gel (60-120 mesh), eluting with petroleum ether (b.p. 60-80°C).
2-Chloronitrobenzene was eluted first, followed by the highly colored
(orange to red) product 3. 3l, yield 90%. M.p.a (Lit. M.p.) °C: 37-38
(37)[10]
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An improved synthesis of N-substituted-2-nitroanilines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chauhan, S. M. S.; Singh, Ram; Geetanjali
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2003), 33(16), 2899-2906

$RFMT $RIREG SCHEME6 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Dimethoxybenzaldehyde
C9H10O3
93-02-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3338 0.0 0
M  V30 2 O 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 O 6.9300 4.0011 0.0 0
M  V30 6 C 7.7000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2,5-Dimethoxyphenyl)methylene]methanamine
C10H13NO2
114943-72-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 N 6.9300 5.3347 0.0 0
M  V30 3 C 8.4700 5.3347 0.0 0
M  V30 4 O 4.6200 1.3338 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 O 1.5400 6.6685 0.0 0
M  V30 7 C 0.0000 6.6685 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 3.8500 5.3347 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 93-02-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 114943-72-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-4900269
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cholinesterase inhibitors: SAR and enzyme inhibitory activity of
3-[ω-(benzylmethylamino)alkoxy]xanthen-9-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Piazzi, Lorna; Belluti, Federica; Bisi, Alessandra; Gobbi, Silvia; Rizzo,
Stefano; Bartolini, Manuela; Andrisano, Vincenza; Recanatini, Maurizio;
Rampa, Angela
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2007), 15(1), 575-585

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5,7-dichloropyrazolo[1,5-a]pyrimidine-3-carboxylate
C9H7Cl2N3O2
940284-55-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 4.5602 0.0 0
M  V30 2 O 7.6823 5.7048 0.0 0
M  V30 3 O 7.1277 3.0957 0.0 0
M  V30 4 C 9.1887 5.3846 0.0 0
M  V30 5 C 10.2191 6.5290 0.0 0
M  V30 6 Cl 0.0000 4.6200 0.0 0
M  V30 7 Cl 2.6674 0.0000 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 N 2.6674 4.6200 0.0 0
M  V30 10 C 5.1454 4.8804 0.0 0
M  V30 11 N 4.0011 2.3100 0.0 0
M  V30 12 N 2.9876 6.1263 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 14 C 4.5191 6.2874 0.0 0
M  V30 15 C 2.6674 1.5400 0.0 0
M  V30 16 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 14
M  V30 16 2 13 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-chloro-7-(methylamino)pyrazolo[1,5-a]pyrimidine-3-carboxylate
C10H11ClN4O2
2271470-64-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 C 0.0000 3.8500 0.0 0
M  V30 3 C 7.9856 4.5603 0.0 0
M  V30 4 O 9.0160 5.7048 0.0 0
M  V30 5 O 8.4614 3.0957 0.0 0
M  V30 6 C 10.5224 5.3846 0.0 0
M  V30 7 C 11.5529 6.5290 0.0 0
M  V30 8 Cl 4.0011 0.0000 0.0 0
M  V30 9 N 4.0011 4.6200 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 11 C 2.6673 3.8500 0.0 0
M  V30 12 N 4.3213 6.1263 0.0 0
M  V30 13 C 6.4791 4.8804 0.0 0
M  V30 14 N 5.3348 2.3100 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 16 C 5.8528 6.2874 0.0 0
M  V30 17 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 16
M  V30 17 2 14 17
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 940284-55-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2271470-64-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24222206
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted 7-(methylamino)pyrazolo[1,5-a]pyrimidine-3-carboxamide
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bleisch, Thomas John; Gernert, Douglas Linn; Stevens, Freddie Craig
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021162944 A1 2021-08-19

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5,7-dichloropyrazolo[1,5-a]pyrimidine-3-carboxylate
C9H7Cl2N3O2
940284-55-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 4.5602 0.0 0
M  V30 2 O 7.6823 5.7048 0.0 0
M  V30 3 O 7.1277 3.0957 0.0 0
M  V30 4 C 9.1887 5.3846 0.0 0
M  V30 5 C 10.2191 6.5290 0.0 0
M  V30 6 Cl 0.0000 4.6200 0.0 0
M  V30 7 Cl 2.6674 0.0000 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 N 2.6674 4.6200 0.0 0
M  V30 10 C 5.1454 4.8804 0.0 0
M  V30 11 N 4.0011 2.3100 0.0 0
M  V30 12 N 2.9876 6.1263 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 14 C 4.5191 6.2874 0.0 0
M  V30 15 C 2.6674 1.5400 0.0 0
M  V30 16 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 14
M  V30 16 2 13 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-chloro-7-(methylamino)pyrazolo[1,5-a]pyrimidine-3-carboxylate
C10H11ClN4O2
2271470-64-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 C 0.0000 3.8500 0.0 0
M  V30 3 C 7.9856 4.5603 0.0 0
M  V30 4 O 9.0160 5.7048 0.0 0
M  V30 5 O 8.4614 3.0957 0.0 0
M  V30 6 C 10.5224 5.3846 0.0 0
M  V30 7 C 11.5529 6.5290 0.0 0
M  V30 8 Cl 4.0011 0.0000 0.0 0
M  V30 9 N 4.0011 4.6200 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 11 C 2.6673 3.8500 0.0 0
M  V30 12 N 4.3213 6.1263 0.0 0
M  V30 13 C 6.4791 4.8804 0.0 0
M  V30 14 N 5.3348 2.3100 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 16 C 5.8528 6.2874 0.0 0
M  V30 17 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 16
M  V30 17 2 14 17
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 940284-55-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2271470-64-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24308378
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 7-(Methylamino)pyrazolo[1,5-a]pyrimidine-3-carboxamide compounds as
TYK2-JH2 inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bleisch, Thomas John; Chen, Zhaogen; Jessop, Theodore Curtis
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021162942 A1 2021-08-19

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5,7-dichloropyrazolo[1,5-a]pyrimidine-3-carboxylate
C9H7Cl2N3O2
940284-55-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 4.5602 0.0 0
M  V30 2 O 7.6823 5.7048 0.0 0
M  V30 3 O 7.1277 3.0957 0.0 0
M  V30 4 C 9.1887 5.3846 0.0 0
M  V30 5 C 10.2191 6.5290 0.0 0
M  V30 6 Cl 0.0000 4.6200 0.0 0
M  V30 7 Cl 2.6674 0.0000 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 N 2.6674 4.6200 0.0 0
M  V30 10 C 5.1454 4.8804 0.0 0
M  V30 11 N 4.0011 2.3100 0.0 0
M  V30 12 N 2.9876 6.1263 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 14 C 4.5191 6.2874 0.0 0
M  V30 15 C 2.6674 1.5400 0.0 0
M  V30 16 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 14
M  V30 16 2 13 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-chloro-7-(methylamino)pyrazolo[1,5-a]pyrimidine-3-carboxylate
C10H11ClN4O2
2271470-64-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 C 0.0000 3.8500 0.0 0
M  V30 3 C 7.9856 4.5603 0.0 0
M  V30 4 O 9.0160 5.7048 0.0 0
M  V30 5 O 8.4614 3.0957 0.0 0
M  V30 6 C 10.5224 5.3846 0.0 0
M  V30 7 C 11.5529 6.5290 0.0 0
M  V30 8 Cl 4.0011 0.0000 0.0 0
M  V30 9 N 4.0011 4.6200 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 11 C 2.6673 3.8500 0.0 0
M  V30 12 N 4.3213 6.1263 0.0 0
M  V30 13 C 6.4791 4.8804 0.0 0
M  V30 14 N 5.3348 2.3100 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 16 C 5.8528 6.2874 0.0 0
M  V30 17 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 16
M  V30 17 2 14 17
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 940284-55-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2271470-64-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22657282
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 7-(methylamino)pyrazolo[1,5-a]pyrimidine-3-carboxamide
derivatives for treating psoriasis or systemic lupus erythematosus
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhaogen; Jessop, Theodore Curtis
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020123225 A1 2020-06-18

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5,7-dichloropyrazolo[1,5-a]pyrimidine-3-carboxylate
C9H7Cl2N3O2
940284-55-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 4.5602 0.0 0
M  V30 2 O 7.6823 5.7048 0.0 0
M  V30 3 O 7.1277 3.0957 0.0 0
M  V30 4 C 9.1887 5.3846 0.0 0
M  V30 5 C 10.2191 6.5290 0.0 0
M  V30 6 Cl 0.0000 4.6200 0.0 0
M  V30 7 Cl 2.6674 0.0000 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 N 2.6674 4.6200 0.0 0
M  V30 10 C 5.1454 4.8804 0.0 0
M  V30 11 N 4.0011 2.3100 0.0 0
M  V30 12 N 2.9876 6.1263 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 14 C 4.5191 6.2874 0.0 0
M  V30 15 C 2.6674 1.5400 0.0 0
M  V30 16 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 14
M  V30 16 2 13 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-chloro-7-(methylamino)pyrazolo[1,5-a]pyrimidine-3-carboxylate
C10H11ClN4O2
2271470-64-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 C 0.0000 3.8500 0.0 0
M  V30 3 C 7.9856 4.5603 0.0 0
M  V30 4 O 9.0160 5.7048 0.0 0
M  V30 5 O 8.4614 3.0957 0.0 0
M  V30 6 C 10.5224 5.3846 0.0 0
M  V30 7 C 11.5529 6.5290 0.0 0
M  V30 8 Cl 4.0011 0.0000 0.0 0
M  V30 9 N 4.0011 4.6200 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 11 C 2.6673 3.8500 0.0 0
M  V30 12 N 4.3213 6.1263 0.0 0
M  V30 13 C 6.4791 4.8804 0.0 0
M  V30 14 N 5.3348 2.3100 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 16 C 5.8528 6.2874 0.0 0
M  V30 17 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 16
M  V30 17 2 14 17
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 940284-55-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2271470-64-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-21732949
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolo[1,5-a]pyrimidine-3-carboxamide derivatives useful
in the treatment of psoriasis and systemic lupus erythematosus
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhaogen; Erickson, Jon Andre; Zhao, Gaiying
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020055636 A1 2020-03-19

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
2-Iodobenzoic acid
C7H5IO2
88-67-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 I 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodo-N-methylbenzamide
C8H8INO
58084-22-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 O 5.3901 1.3337 0.0 0
M  V30 4 C 6.9302 4.0010 0.0 0
M  V30 5 I 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 88-67-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 58084-22-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34300374
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diversity-oriented enantioselective construction of atropisomeric
heterobiaryls and N-aryl indoles via vinylidene ortho-quinone methides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Da; Huang, Shengli; Hu, Fangli; Peng, Lei; Jia, Shiqi; Mao, Hui;
Gong, Xiangnan; Li, Fenglan; Qin, Wenling; Yan, Hailong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM CCS Chemistry (2022), 4(8), 2686-2697

$RFMT $RIREG SCHEME9 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Nitrobenzaldehyde
C7H5NO3
99-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 C 6.6687 1.5400 0.0 0
M  V30 5 O 8.0023 2.3101 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-nitrobenzenemethanamine
C8H10N2O2
19499-61-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 5 O 1.3337 0.0000 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-61-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 19499-61-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39627296
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Installation of Pargyline, a LSD1 Inhibitor, in the HDAC Inhibitory
Template Culminated in the Identification of a Tractable Antiprostate
Cancer Agent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ojha, Ritu; Chen, I-Chung; Hsieh, Chien-Ming; Nepali, Kunal; Lai,
Row-Wen; Hsu, Kai-Cheng; Lin, Tony Eight; Pan, Shiow-Lin; Chen,
Mei-Chuan; Liou, Jing-Ping
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(24), 17824-17845

$RFMT $RIREG SCHEME10 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chlorobenzaldehyde
C7H5ClO
89-98-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 Cl 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2-Chlorophenyl)methylene]methanamine
C8H8ClN
17972-08-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 Cl 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 89-98-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 17972-08-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-7637404
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cholinesterase inhibitors: SAR and enzyme inhibitory activity of
3-[ω-(benzylmethylamino)alkoxy]xanthen-9-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Piazzi, Lorna; Belluti, Federica; Bisi, Alessandra; Gobbi, Silvia; Rizzo,
Stefano; Bartolini, Manuela; Andrisano, Vincenza; Recanatini, Maurizio;
Rampa, Angela
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2007), 15(1), 575-585

$RFMT $RIREG SCHEME11 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[Bis(methylthio)methylene]-3-methyl-2-thioxo-4-thiazolidinone
C7H9NOS4
874500-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 2.3101 0.0 0
M  V30 2 S 1.3337 3.0801 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 O 3.0175 5.6422 0.0 0
M  V30 7 C 6.2949 6.3388 0.0 0
M  V30 8 S 7.9700 3.4372 0.0 0
M  V30 9 C 4.0010 3.0801 0.0 0
M  V30 10 C 4.1621 4.6116 0.0 0
M  V30 11 S 5.4080 2.4537 0.0 0
M  V30 12 N 5.6684 4.9318 0.0 0
M  V30 13 C 6.4384 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 9
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 6 10
M  V30 7 1 7 12
M  V30 8 2 8 13
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5Z)-3-Methyl-5-[(methylamino)(methylthio)methylene]-2-thioxo-4-thiazolidinone
C7H10N2OS3
2098933-66-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 2.3101 0.0 0
M  V30 2 N 1.3337 3.0801 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 O 3.0175 5.6422 0.0 0
M  V30 7 C 6.2949 6.3388 0.0 0
M  V30 8 S 7.9700 3.4372 0.0 0
M  V30 9 C 4.0010 3.0801 0.0 0
M  V30 10 C 4.1621 4.6116 0.0 0
M  V30 11 S 5.4080 2.4537 0.0 0
M  V30 12 N 5.6684 4.9318 0.0 0
M  V30 13 C 6.4384 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 9
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 6 10
M  V30 7 1 7 12
M  V30 8 2 8 13
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 874500-18-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2098933-66-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-17300008
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-solvent, stereoselective, optimization study, optimized
on solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of rhodanine-derived enaminones in aqueous medium
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Devi, N. S.; Devi, Nirada
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2017), 47(13), 1209-1213

$RFMT $RIREG SCHEME12 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzonitrile
C8H7NO
874-90-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9301 1.3337 0.0 0
M  V30 2 N 8.4701 1.3337 0.0 0
M  V30 3 O 0.7700 1.3337 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 C 5.3901 1.3337 0.0 0
M  V30 6 C 4.6201 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 3.0800 0.0000 0.0 0
M  V30 9 C 3.0800 2.6673 0.0 0
M  V30 10 C 2.3100 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-methoxybenzylamine
C9H13NO
702-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 874-90-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 702-24-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32794894
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 22031-12-5
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 60871-84-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-89-8
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nickel-catalyzed hydrogenative coupling of nitriles and amines for
general amine synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chandrashekhar, Vishwas G.; Baumann, Wolfgang; Beller, Matthias;
Jagadeesh, Rajenahally V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Science (Washington, DC, United States) (2022), 376(6600), 1433-1441

$RFMT $RIREG SCHEME13 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl N-[1-(4-chlorophenyl)-2-cyano-1H-naphtho[2,1-b]pyran-3-yl]methanimidate
C23H17ClN2O2
875132-87-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 6.6685 0.0000 0.0 0
M  V30 3 N 9.3358 3.0801 0.0 0
M  V30 4 C 10.6697 3.8501 0.0 0
M  V30 5 O 12.0033 3.0801 0.0 0
M  V30 6 C 13.3370 3.8501 0.0 0
M  V30 7 C 14.6707 3.0801 0.0 0
M  V30 8 Cl 0.0000 0.7700 0.0 0
M  V30 9 C 5.3348 5.3901 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 4.0010 6.1601 0.0 0
M  V30 12 C 6.6685 6.1601 0.0 0
M  V30 13 C 6.6685 3.0801 0.0 0
M  V30 14 C 4.0010 7.7002 0.0 0
M  V30 15 C 2.6673 5.3901 0.0 0
M  V30 16 O 8.0022 5.3901 0.0 0
M  V30 17 C 6.6685 7.7002 0.0 0
M  V30 18 C 8.0022 3.8501 0.0 0
M  V30 19 C 5.3348 8.4702 0.0 0
M  V30 20 C 2.6673 8.4702 0.0 0
M  V30 21 C 1.3337 6.1601 0.0 0
M  V30 22 C 1.3337 7.7002 0.0 0
M  V30 23 C 4.0010 3.0801 0.0 0
M  V30 24 C 2.6673 3.8501 0.0 0
M  V30 25 C 4.0010 1.5400 0.0 0
M  V30 26 C 1.3337 3.0801 0.0 0
M  V30 27 C 2.6673 0.7700 0.0 0
M  V30 28 C 1.3337 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 13
M  V30 3 2 3 4 CFG=2
M  V30 4 1 3 18
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 28
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 23
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 12 17
M  V30 18 2 13 18
M  V30 19 2 14 19
M  V30 20 1 14 20
M  V30 21 2 15 21
M  V30 22 1 16 18
M  V30 23 1 17 19
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
12-(4-Chlorophenyl)-10,12-dihydro-10-methyl-11H-naphtho[1′,2′:5,6]pyrano[2,3-...
C22H16ClN3O
2170401-64-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0023 4.6201 0.0 0
M  V30 2 C 10.6697 6.1601 0.0 0
M  V30 3 Cl 5.3348 0.0000 0.0 0
M  V30 4 C 5.3348 6.1601 0.0 0
M  V30 5 C 4.0012 6.9302 0.0 0
M  V30 6 C 6.6685 6.9302 0.0 0
M  V30 7 C 2.6673 6.1601 0.0 0
M  V30 8 C 4.0012 8.4702 0.0 0
M  V30 9 C 6.6685 8.4702 0.0 0
M  V30 10 C 8.0023 6.1601 0.0 0
M  V30 11 C 1.3337 6.9302 0.0 0
M  V30 12 C 2.6673 4.6201 0.0 0
M  V30 13 O 5.3348 9.2402 0.0 0
M  V30 14 C 2.6673 9.2402 0.0 0
M  V30 15 N 8.0023 9.2402 0.0 0
M  V30 16 N 9.3360 6.9302 0.0 0
M  V30 17 C 1.3337 8.4702 0.0 0
M  V30 18 C 0.0000 6.1601 0.0 0
M  V30 19 C 1.3337 3.8501 0.0 0
M  V30 20 C 9.3360 8.4702 0.0 0
M  V30 21 C 0.0000 4.6201 0.0 0
M  V30 22 C 5.3348 4.6201 0.0 0
M  V30 23 C 6.6685 3.8501 0.0 0
M  V30 24 C 4.0012 3.8501 0.0 0
M  V30 25 C 6.6685 2.3101 0.0 0
M  V30 26 C 4.0012 2.3101 0.0 0
M  V30 27 C 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 16
M  V30 3 1 3 27
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 22
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 2 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 2 7 12
M  V30 13 1 8 13
M  V30 14 1 8 14
M  V30 15 1 9 13
M  V30 16 1 9 15
M  V30 17 1 10 16
M  V30 18 1 11 17
M  V30 19 2 11 18
M  V30 20 1 12 19
M  V30 21 2 14 17
M  V30 22 2 15 20
M  V30 23 1 16 20
M  V30 24 1 18 21
M  V30 25 2 19 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 875132-87-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2170401-64-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-22119678
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and antibacterial activity of some new
benzo[5,6]chromeno[2,3-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ameli, Shohreh; Pordel, Mehdi; Davoodnia, Abolghasem; Jajarmi, Maryam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Bioorganic Chemistry (2017), 43(4), 429-434

$RFMT $RIREG SCHEME14 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-5-thiazoleacetate
C14H12F3N3O3S
875798-48-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3358 1.3337 0.0 0
M  V30 2 C 8.0022 2.1037 0.0 0
M  V30 3 N 6.6685 1.3337 0.0 0
M  V30 4 O 8.0022 3.6437 0.0 0
M  V30 5 C 14.6386 2.4608 0.0 0
M  V30 6 C 15.5437 3.7067 0.0 0
M  V30 7 O 17.0754 3.5458 0.0 0
M  V30 8 O 14.9174 5.1135 0.0 0
M  V30 9 C 17.9805 4.7917 0.0 0
M  V30 10 C 1.3337 1.3337 0.0 0
M  V30 11 F 2.1037 0.0000 0.0 0
M  V30 12 F 0.0000 0.5637 0.0 0
M  V30 13 F 0.5637 2.6673 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 S 12.0765 1.4774 0.0 0
M  V30 16 N 10.8306 3.6352 0.0 0
M  V30 17 C 13.1069 2.6218 0.0 0
M  V30 18 C 12.3369 3.9554 0.0 0
M  V30 19 C 5.3348 2.1037 0.0 0
M  V30 20 C 4.0010 1.3337 0.0 0
M  V30 21 C 5.3348 3.6437 0.0 0
M  V30 22 C 2.6673 2.1037 0.0 0
M  V30 23 C 4.0010 4.4137 0.0 0
M  V30 24 C 2.6673 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 19
M  V30 6 1 5 6
M  V30 7 1 5 17
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 22
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-5-thiazoleacet...
C14H13F3N4O2S
875798-50-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3358 1.3337 0.0 0
M  V30 2 C 8.0022 2.1037 0.0 0
M  V30 3 N 6.6685 1.3337 0.0 0
M  V30 4 O 8.0022 3.6437 0.0 0
M  V30 5 C 14.6386 2.4608 0.0 0
M  V30 6 C 15.5437 3.7067 0.0 0
M  V30 7 N 17.0754 3.5458 0.0 0
M  V30 8 O 14.9174 5.1135 0.0 0
M  V30 9 C 17.9805 4.7917 0.0 0
M  V30 10 C 1.3337 1.3337 0.0 0
M  V30 11 F 0.5637 2.6673 0.0 0
M  V30 12 F 0.0000 0.5637 0.0 0
M  V30 13 F 2.1037 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 S 12.0765 1.4774 0.0 0
M  V30 16 N 10.8306 3.6352 0.0 0
M  V30 17 C 13.1069 2.6218 0.0 0
M  V30 18 C 12.3369 3.9554 0.0 0
M  V30 19 C 5.3348 2.1037 0.0 0
M  V30 20 C 4.0010 1.3337 0.0 0
M  V30 21 C 5.3348 3.6437 0.0 0
M  V30 22 C 2.6673 2.1037 0.0 0
M  V30 23 C 4.0010 4.4137 0.0 0
M  V30 24 C 2.6673 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 19
M  V30 6 1 5 6
M  V30 7 1 5 17
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 22
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 875798-48-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 875798-50-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15005040
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7786-30-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 45 This example describes the synthesis of Step 1: A mixture of
compound 44.2 (2.0 mmol) and anhydrous MgCl2, (2.0 mmol) in methylamine
(10 mL of a 2.0 M solution in THF) was stirred at room temperature for
several hours. The mixture was concentrated, diluted with EtOAC and
filtered. The filtrate was washed with brine, dried, concentrated and
purified by flash column chromatography on silica gel to provide the
intermediate amide in 90% yield. EIMS (m/z): calcd. for
C14H13F3N4O2S(M+)+H 359.07, found 359.10.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thienopyrimidines useful as Aurora kinase inhibitors and their
preparation, pharmaceutical compositions, and their use for treatment of
Aurora kinase-mediated diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lew, Willard; Baskaran, Subramanian; Oslob, Johan D.; Yoburn, Joshua C.;
Zhong, Min
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060035908 A1 2006-02-16

$RFMT $RIREG SCHEME15 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-[[(ethylamino)carbonyl]amino]-7-(3-pyridinyl)[1,2,4]triazolo[1,5-a]p...
C16H16N6O3
882519-97-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 2.3100 0.0 0
M  V30 2 O 4.0011 1.5400 0.0 0
M  V30 3 O 6.6684 1.5400 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 N 10.5783 5.3900 0.0 0
M  V30 6 C 11.3483 6.7236 0.0 0
M  V30 7 N 12.8883 6.7236 0.0 0
M  V30 8 O 10.5783 8.0574 0.0 0
M  V30 9 C 13.6583 8.0574 0.0 0
M  V30 10 C 15.1983 8.0574 0.0 0
M  V30 11 N 6.6684 4.6200 0.0 0
M  V30 12 C 6.6684 6.1600 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 14 N 8.1330 4.1441 0.0 0
M  V30 15 C 5.3347 6.9300 0.0 0
M  V30 16 N 8.1330 6.6359 0.0 0
M  V30 17 C 4.0011 4.6200 0.0 0
M  V30 18 C 9.0383 5.3900 0.0 0
M  V30 19 C 4.0011 6.1600 0.0 0
M  V30 20 C 2.6674 6.9300 0.0 0
M  V30 21 C 1.3336 6.1600 0.0 0
M  V30 22 C 2.6674 8.4700 0.0 0
M  V30 23 C 0.0000 6.9300 0.0 0
M  V30 24 N 1.3336 9.2400 0.0 0
M  V30 25 C 0.0000 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 18
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 19 20
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[(Ethylamino)carbonyl]amino]-N-methyl-7-(3-pyridinyl)[1,2,4]triazolo[1,5-a...
C16H17N7O2
882519-98-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 2.3100 0.0 0
M  V30 2 N 4.0011 1.5400 0.0 0
M  V30 3 O 6.6684 1.5400 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 N 10.5783 5.3900 0.0 0
M  V30 6 C 11.3483 6.7236 0.0 0
M  V30 7 N 12.8883 6.7236 0.0 0
M  V30 8 O 10.5783 8.0574 0.0 0
M  V30 9 C 13.6583 8.0574 0.0 0
M  V30 10 C 15.1983 8.0574 0.0 0
M  V30 11 N 6.6684 4.6200 0.0 0
M  V30 12 C 6.6684 6.1600 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 14 N 8.1330 4.1441 0.0 0
M  V30 15 C 5.3347 6.9300 0.0 0
M  V30 16 N 8.1330 6.6359 0.0 0
M  V30 17 C 4.0011 4.6200 0.0 0
M  V30 18 C 9.0383 5.3900 0.0 0
M  V30 19 C 4.0011 6.1600 0.0 0
M  V30 20 C 2.6674 6.9300 0.0 0
M  V30 21 C 2.6674 8.4700 0.0 0
M  V30 22 C 1.3336 6.1600 0.0 0
M  V30 23 C 1.3336 9.2400 0.0 0
M  V30 24 N 0.0000 6.9300 0.0 0
M  V30 25 C 0.0000 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 18
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 19 20
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 882519-97-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 882519-98-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12073736
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-24-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM DNA gyrase (GyrB)/topoisomerase IV (ParE) inhibitors: Synthesis and
antibacterial activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM East, Stephen P.; White, Clara Bantry; Barker, Oliver; Barker, Stephanie;
Bennett, James; Brown, David; Boyd, E. Andrew; Brennan, Christopher;
Chowdhury, Chandana; Collins, Ian; Convers-Reignier, Emmanuelle; Dymock,
Brian W.; Fletcher, Rowena; Haydon, David J.; Gardiner, Mihaly; Hatcher,
Stuart; Ingram, Peter; Lancett, Paul; Mortenson, Paul; Papadopoulos,
Konstantinos; Smee, Carol; Thomaides-Brears, Helena B.; Tye, Heather;
Workman, James; Czaplewski, Lloyd G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(3), 894-899

$RFMT $RIREG SCHEME16 STEP1
$RXN



  2  1
$MOL
1-Cyclopropyl-1,4-dihydro-6-methyl-4-oxo-3-(phenylmethoxy)-2-pyridinecarboxyl...
C17H17NO4
887774-72-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.2074 4.6201 0.0 0
M  V30 2 O 2.8737 5.3901 0.0 0
M  V30 3 O 5.5412 5.3901 0.0 0
M  V30 4 O 6.8749 3.0801 0.0 0
M  V30 5 C 8.2085 2.3101 0.0 0
M  V30 6 C 1.5400 0.0000 0.0 0
M  V30 7 O 6.8749 0.0000 0.0 0
M  V30 8 C 4.2074 3.0801 0.0 0
M  V30 9 N 2.8737 2.3101 0.0 0
M  V30 10 C 5.5412 2.3101 0.0 0
M  V30 11 C 2.8737 0.7700 0.0 0
M  V30 12 C 5.5412 0.7700 0.0 0
M  V30 13 C 4.2074 0.0000 0.0 0
M  V30 14 C 1.5400 3.0801 0.0 0
M  V30 15 C 0.7700 4.4137 0.0 0
M  V30 16 C 0.0000 3.0801 0.0 0
M  V30 17 C 9.5424 3.0801 0.0 0
M  V30 18 C 9.5424 4.6201 0.0 0
M  V30 19 C 10.8760 2.3101 0.0 0
M  V30 20 C 10.8760 5.3901 0.0 0
M  V30 21 C 12.2097 3.0801 0.0 0
M  V30 22 C 12.2097 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 5 17
M  V30 7 1 6 11
M  V30 8 2 7 12
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 9 14
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Cyclopropyl-1,4-dihydro-N,6-dimethyl-4-oxo-3-(phenylmethoxy)-2-pyridinecarb...
C18H20N2O3
887774-86-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.2074 2.3101 0.0 0
M  V30 2 N 2.8737 1.5400 0.0 0
M  V30 3 O 5.5412 1.5400 0.0 0
M  V30 4 C 2.8737 0.0000 0.0 0
M  V30 5 O 6.8749 3.8501 0.0 0
M  V30 6 C 8.2085 4.6201 0.0 0
M  V30 7 C 1.5400 6.9302 0.0 0
M  V30 8 O 6.8749 6.9302 0.0 0
M  V30 9 C 4.2074 3.8501 0.0 0
M  V30 10 N 2.8737 4.6201 0.0 0
M  V30 11 C 5.5412 4.6201 0.0 0
M  V30 12 C 2.8737 6.1601 0.0 0
M  V30 13 C 5.5412 6.1601 0.0 0
M  V30 14 C 4.2074 6.9302 0.0 0
M  V30 15 C 1.5400 3.8501 0.0 0
M  V30 16 C 0.0000 3.8501 0.0 0
M  V30 17 C 0.7700 2.5164 0.0 0
M  V30 18 C 9.5424 3.8501 0.0 0
M  V30 19 C 9.5424 2.3101 0.0 0
M  V30 20 C 10.8760 4.6201 0.0 0
M  V30 21 C 10.8760 1.5400 0.0 0
M  V30 22 C 12.2097 3.8501 0.0 0
M  V30 23 C 12.2097 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 6 18
M  V30 8 1 7 12
M  V30 9 2 8 13
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 10 15
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 887774-72-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 887774-86-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4667862
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE 3: Preparation of
3-benzyloxy-1-cyclopropyl-6-methyl-4-oxo-1,4-dihydro-pyridine-2-carboxylic
acid methylamide. Procedure I: To a cold suspension (ice-salt bath,
internal temp. = 4°C) of
3-benzyloxy-1-cyclopropyl-6-methyl-4-oxo-1,4-dihydro-pyridine-2-carboxylic
acid (150.49 g, 0.50 mol), dichloromethane (750 mL) and dimethylformamide
(3.9 mL, 0.05 mol) in a 3N-RBF fitted with a mechanical stirrer was added
oxalyl chloride (58.0 mL, 0.66 mol) dropwise over a period of 1h. The
internal temperature was kept at below 10°C during the addition. After
addition of about 30 mL of oxalyl chloride, a dark red solution resulted.
The reaction was monitored by thin layer chromatrography (TLC, eluent:
CH2Cl2/MeOH, 9/1 ratio). The complete consumption of starting material
was observed within 15 min after the addition of oxalyl chloride. In
another 5L 3N-RBF fitted with a mechanical stirrer was placed
dichloromethane (1250 mL), triethylamine (180.0 mL, 1.291 mol) and a
solution of 2M methylamine in tetrahydrofuran (325 mL, 0.65 mol). The
mixture was cooled in an ice-salt bath and the internal temperature was
4°C. The acid chloride generated in situ above was transferred to an
addition funnel, and slowly added to the amine solution over a period of
2.5h. An exothermic reaction was noticed, but the internal temperature
was kept at below 8°C. After 10 min, monitoring of the reaction by TLC
(CH2Cl2/MeOH, 9/1 ratio, v/v) indicated complete consumption of acid
chloride, and formation of
3-benzyloxy-1-cyclopropyl-6-methyl-4-oxo-1,4-dihydro-pyridine-2-carboxylic
acid methylamide. The reaction mixture was quenched with brine (500 mL),
and the mixture was stirred for 5 min. The organic fraction was collected
and washed twice more with brine (2×300mL), dried over sodium sulfate,
filtered and concentrated in vacuo to afford a brown solid. The solid was
suspended in 600 mL of a mixture of ethanol and ethyl acetate (1/9 ratio,
v/v) and the slurry was stirred for 60 h. The solid was collected by
suction filtration, washed with ethyl acetate (50 mL), and was then
air-dried. Finally, the solid was dried at 40°C for 12h under vacuum to
constant weight. The title compound was thus obtained as an off-white,
slightly brownish solid (141.1 g, 90 %). M.p. 132-135 °C; 1H-NMR (CDCl3,
400 MHz) δ 1.05 (m, 4H, cyclopropyl-H), 2.38 (s, 3H, CH3), 2.70 (d,
J=1.8Hz, 3H, NCH3), 3.35 (m, 1H, CH), 5.07 (s, 2H, CH2), 6.14(s, 1H, CH),
7.15 (br, 1H), 7.35 (m, 5H, ArH); 13C (CDCl3) δ 9.48, 20.30, 25.86,
34.15, 74.01, 118.16, 127.79, 128.06(2C), 128.22(2C), 137.35, 142.05,
143.98, 149.91, 162.01, 173.89; MS (m/z): 313 (M+ +1).
$DTYPE RXN:VAR(1):NOTES
$DATUM exothermic, optimization study, optimized on temperature, reaction time
and stoichiometry
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for the preparation of
3-hydroxy-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamides
by treatment of the corresponding acids with acid chloride formation
reagents and amines.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Yingsheng; Agostino, Sandra Vittoria; Tam, Tim Fat; Zhao, Yanqing;
Li, Wanren; Shah, Birenkumar Hasmukhbhai; Leung-Toung, Regis
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA2488034 A1 2006-05-19

$RFMT $RIREG SCHEME17 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S)-1-[(1S)-1-(Dimethylamino)ethyl]-2-(ethylthio)ferrocene
C16H23FeNS
888954-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8320 6.3454 0.0 0
M  V30 2 N 3.8320 7.0167 0.0 0
M  V30 3 C 4.4127 6.0106 0.0 0
M  V30 4 C 4.4127 7.3514 0.0 0
M  V30 5 C 3.0719 7.4550 0.0 0
M  V30 6 S 1.6312 7.7158 0.0 0
M  V30 7 C 1.0505 8.0505 0.0 0
M  V30 8 C 0.4698 7.7158 0.0 0
M  V30 9 Fe 1.6312 3.5083 0.0 0 CHG=2 VAL=10
M  V30 10 C 3.2513 6.0106 0.0 0 CHG=-1 VAL=4
M  V30 11 C 1.6312 7.0444 0.0 0 VAL=5
M  V30 12 C 2.2341 5.4206 0.0 0 VAL=5
M  V30 13 C 0.0370 6.0106 0.0 0 VAL=5
M  V30 14 C 1.0542 5.4206 0.0 0 VAL=5
M  V30 15 C 0.0000 1.0375 0.0 0 CHG=-1 VAL=4
M  V30 16 C 3.2161 1.0375 0.0 0 VAL=5
M  V30 17 C 2.1953 1.6275 0.0 0 VAL=5
M  V30 18 C 1.0172 1.6275 0.0 0 VAL=5
M  V30 19 C 1.5942 0.0000 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 11
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 9 14
M  V30 14 1 9 15
M  V30 15 1 9 16
M  V30 16 1 9 17
M  V30 17 1 9 18
M  V30 18 1 9 19
M  V30 19 1 10 11
M  V30 20 1 10 12
M  V30 21 2 11 13
M  V30 22 2 12 14
M  V30 23 1 13 14
M  V30 24 1 15 18
M  V30 25 1 15 19
M  V30 26 1 16 17
M  V30 27 2 16 19
M  V30 28 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-(ethylthio)-2-[(1S)-1-(methylamino)ethyl]-, (1S)-
C15H21FeNS
888954-48-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.2686 1.7281 0.0 0
M  V30 2 N 2.2686 2.2731 0.0 0
M  V30 3 C 2.7401 1.4564 0.0 0
M  V30 4 C 2.8046 2.5839 0.0 0
M  V30 5 S 3.0779 0.5675 0.0 0
M  V30 6 C 3.5493 0.8408 0.0 0
M  V30 7 C 4.0207 0.5675 0.0 0
M  V30 8 Fe 1.3212 2.8421 0.0 0 CHG=2 VAL=10
M  V30 9 C 1.7792 1.3182 0.0 0 VAL=5
M  V30 10 C 2.6064 0.8408 0.0 0 CHG=-1 VAL=4
M  V30 11 C 0.8243 1.3182 0.0 0 VAL=5
M  V30 12 C 1.2927 0.0000 0.0 0 VAL=5
M  V30 13 C 0.0000 0.8408 0.0 0 VAL=5
M  V30 14 C 0.8543 4.3931 0.0 0 CHG=-1 VAL=4
M  V30 15 C 1.3212 5.7113 0.0 0 VAL=5
M  V30 16 C 2.6365 4.8720 0.0 0 VAL=5
M  V30 17 C 1.8092 4.3931 0.0 0 VAL=5
M  V30 18 C 0.0300 4.8720 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 8 13
M  V30 13 1 8 14
M  V30 14 1 8 15
M  V30 15 1 8 16
M  V30 16 1 8 17
M  V30 17 1 8 18
M  V30 18 1 9 10
M  V30 19 2 9 11
M  V30 20 1 10 12
M  V30 21 1 11 13
M  V30 22 2 12 13
M  V30 23 1 14 17
M  V30 24 1 14 18
M  V30 25 1 15 16
M  V30 26 2 15 18
M  V30 27 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 888954-46-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 888954-48-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28976335
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Easily accessible ferrocenyl N-P/S type ligands and their applications in
asymmetric allylic substitutions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lam, Fuk Loi; Au-Yeung, Terry T. L.; Cheung, Hong Yee; Kok, Stanton H.
L.; Lam, Wing Sze; Wong, Kwok Yin; Chan, Albert S. C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron: Asymmetry (2006), 17(4), 497-499

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S)-1-[(1S)-1-(Dimethylamino)ethyl]-2-[(1,1-dimethylethyl)thio]ferrocene
C18H27FeNS
888954-47-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.9271 3.4580 0.0 0
M  V30 2 C 4.6865 3.0203 0.0 0
M  V30 3 C 5.4458 3.4580 0.0 0
M  V30 4 C 5.1121 2.2538 0.0 0
M  V30 5 C 4.2342 2.2683 0.0 0
M  V30 6 C 4.9597 1.3590 0.0 0
M  V30 7 N 4.9597 0.4836 0.0 0
M  V30 8 C 5.7190 1.7991 0.0 0
M  V30 9 C 5.7190 0.0435 0.0 0
M  V30 10 C 4.1254 0.0000 0.0 0
M  V30 11 Fe 2.1304 5.0226 0.0 0 CHG=2 VAL=10
M  V30 12 C 2.8680 2.5681 0.0 0 VAL=5
M  V30 13 C 4.2004 1.7991 0.0 0 CHG=-1 VAL=4
M  V30 14 C 2.0845 0.4449 0.0 0 VAL=5
M  V30 15 C 1.3276 2.5681 0.0 0 VAL=5
M  V30 16 C 0.0000 1.7991 0.0 0 VAL=5
M  V30 17 C 1.3759 7.5206 0.0 0 CHG=-1 VAL=4
M  V30 18 C 2.1304 9.6437 0.0 0 VAL=5
M  V30 19 C 4.2463 8.2920 0.0 0 VAL=5
M  V30 20 C 2.9139 7.5206 0.0 0 VAL=5
M  V30 21 C 0.0484 8.2920 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 13
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 11 16
M  V30 16 1 11 17
M  V30 17 1 11 18
M  V30 18 1 11 19
M  V30 19 1 11 20
M  V30 20 1 11 21
M  V30 21 1 12 13
M  V30 22 2 12 15
M  V30 23 1 13 14
M  V30 24 2 14 16
M  V30 25 1 15 16
M  V30 26 1 17 20
M  V30 27 1 17 21
M  V30 28 1 18 19
M  V30 29 2 18 21
M  V30 30 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(1,1-dimethylethyl)thio]-2-[(1S)-1-(methylamino)ethyl]-, (1S)-
C17H25FeNS
888954-50-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.1261 10.0719 0.0 0
M  V30 2 C 1.3666 10.5097 0.0 0
M  V30 3 C 0.6071 10.0719 0.0 0
M  V30 4 C 0.9288 11.2692 0.0 0
M  V30 5 C 1.8068 11.2692 0.0 0
M  V30 6 C 5.0021 8.2820 0.0 0
M  V30 7 N 5.0021 9.1600 0.0 0
M  V30 8 C 5.7616 7.8442 0.0 0
M  V30 9 C 5.8366 9.6413 0.0 0
M  V30 10 Fe 2.1261 4.5764 0.0 0 CHG=2 VAL=10
M  V30 11 C 2.1261 9.1938 0.0 0 CHG=-1 VAL=4
M  V30 12 C 4.2426 7.8442 0.0 0 VAL=5
M  V30 13 C 2.9122 7.0726 0.0 0 VAL=5
M  V30 14 C 0.0484 7.8442 0.0 0 VAL=5
M  V30 15 C 1.3763 7.0726 0.0 0 VAL=5
M  V30 16 C 4.1966 1.3521 0.0 0 CHG=-1 VAL=4
M  V30 17 C 0.0000 1.3521 0.0 0 VAL=5
M  V30 18 C 1.3279 2.1237 0.0 0 VAL=5
M  V30 19 C 2.8639 2.1237 0.0 0 VAL=5
M  V30 20 C 2.0802 0.0000 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 10 15
M  V30 15 1 10 16
M  V30 16 1 10 17
M  V30 17 1 10 18
M  V30 18 1 10 19
M  V30 19 1 10 20
M  V30 20 1 11 12
M  V30 21 1 11 14
M  V30 22 2 12 13
M  V30 23 1 13 15
M  V30 24 2 14 15
M  V30 25 1 16 19
M  V30 26 1 16 20
M  V30 27 1 17 18
M  V30 28 2 17 20
M  V30 29 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 888954-47-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 888954-50-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29776441
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Easily accessible ferrocenyl N-P/S type ligands and their applications in
asymmetric allylic substitutions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lam, Fuk Loi; Au-Yeung, Terry T. L.; Cheung, Hong Yee; Kok, Stanton H.
L.; Lam, Wing Sze; Wong, Kwok Yin; Chan, Albert S. C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron: Asymmetry (2006), 17(4), 497-499

$RFMT $RIREG SCHEME19 STEP1
$RXN



  2  1
$MOL
6-[2-[(3,4,5-Trimethoxyphenyl)amino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]-2-pyrid...
C21H19N5O5
888969-43-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9302 4.0010 0.0 0
M  V30 2 C 16.7348 5.8795 0.0 0
M  V30 3 O 17.0549 7.3858 0.0 0
M  V30 4 O 17.8792 4.8490 0.0 0
M  V30 5 O 2.3101 6.6685 0.0 0
M  V30 6 C 0.7700 6.6685 0.0 0
M  V30 7 O 2.3101 1.3337 0.0 0
M  V30 8 C 3.0801 0.0000 0.0 0
M  V30 9 O 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 N 11.5165 6.9887 0.0 0
M  V30 12 C 10.0102 6.6685 0.0 0
M  V30 13 C 11.6775 8.5202 0.0 0
M  V30 14 C 9.2402 8.0022 0.0 0
M  V30 15 N 9.2402 5.3348 0.0 0
M  V30 16 C 10.2706 9.1466 0.0 0
M  V30 17 C 7.7002 8.0022 0.0 0
M  V30 18 C 7.7002 5.3348 0.0 0
M  V30 19 N 6.9302 6.6685 0.0 0
M  V30 20 C 12.6609 5.9582 0.0 0
M  V30 21 N 14.1257 6.4341 0.0 0
M  V30 22 C 12.3408 4.4518 0.0 0
M  V30 23 C 15.2701 5.4035 0.0 0
M  V30 24 C 13.4853 3.4213 0.0 0
M  V30 25 C 14.9499 3.8972 0.0 0
M  V30 26 C 5.3901 4.0010 0.0 0
M  V30 27 C 4.6201 5.3348 0.0 0
M  V30 28 C 4.6201 2.6673 0.0 0
M  V30 29 C 3.0801 5.3348 0.0 0
M  V30 30 C 3.0801 2.6673 0.0 0
M  V30 31 C 2.3101 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 1 26
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 23
M  V30 6 1 5 6
M  V30 7 1 5 29
M  V30 8 1 7 8
M  V30 9 1 7 30
M  V30 10 1 9 10
M  V30 11 1 9 31
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 20
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 2 13 16
M  V30 18 1 14 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-6-[2-[(3,4,5-trimethoxyphenyl)amino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl...
C22H22N6O4
863599-22-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 4.0009 0.0 0
M  V30 2 C 16.7346 5.8794 0.0 0
M  V30 3 N 17.8789 4.8488 0.0 0
M  V30 4 O 17.0547 7.3857 0.0 0
M  V30 5 C 19.3436 5.3249 0.0 0
M  V30 6 O 2.3100 1.3336 0.0 0
M  V30 7 C 3.0800 0.0000 0.0 0
M  V30 8 O 2.3100 6.6684 0.0 0
M  V30 9 C 0.7700 6.6684 0.0 0
M  V30 10 O 0.7700 4.0009 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 12 C 10.0100 6.6684 0.0 0
M  V30 13 N 11.5164 6.9885 0.0 0
M  V30 14 C 9.2400 8.0020 0.0 0
M  V30 15 N 9.2400 5.3347 0.0 0
M  V30 16 C 11.6774 8.5201 0.0 0
M  V30 17 C 10.2706 9.1464 0.0 0
M  V30 18 C 7.7000 8.0020 0.0 0
M  V30 19 C 7.7000 5.3347 0.0 0
M  V30 20 N 6.9300 6.6684 0.0 0
M  V30 21 C 12.6608 5.9581 0.0 0
M  V30 22 N 14.1255 6.4340 0.0 0
M  V30 23 C 12.3406 4.4517 0.0 0
M  V30 24 C 15.2699 5.4034 0.0 0
M  V30 25 C 13.4852 3.4213 0.0 0
M  V30 26 C 14.9497 3.8971 0.0 0
M  V30 27 C 5.3900 4.0009 0.0 0
M  V30 28 C 4.6200 2.6673 0.0 0
M  V30 29 C 4.6200 5.3347 0.0 0
M  V30 30 C 3.0800 2.6673 0.0 0
M  V30 31 C 3.0800 5.3347 0.0 0
M  V30 32 C 2.3100 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 19
M  V30 2 1 1 27
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 24
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 1 6 30
M  V30 9 1 8 9
M  V30 10 1 8 31
M  V30 11 1 10 11
M  V30 12 1 10 32
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 1 13 21
M  V30 18 1 14 17
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 2 16 17
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 1 21 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 888969-43-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 863599-22-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2817413
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM 75-90% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of 7H-pyrrolo[2,3-d]pyrimidines as focal adhesion
kinase inhibitors. Part 2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Choi, Ha-Soon; Wang, Zhicheng; Richmond, Wendy; He, Xiaohui; Yang,
Kunyong; Jiang, Tao; Karanewsky, Donald; Gu, Xiang-Ju; Zhou, Vicki; Liu,
Yi; Che, Jianwei; Lee, Christian C.; Caldwell, Jeremy; Kanazawa,
Takanori; Umemura, Ichiro; Matsuura, Naoko; Ohmori, Osamu; Honda,
Toshiyuki; Gray, Nathanael; He, Yun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2006), 16(10), 2689-2692

$RFMT $RIREG SCHEME20 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-9-(2,5-di-O-acetyl-3-azido-3-deoxy-β-D-ribofuranosyl)-9H-purine
C14H14ClN7O5
889126-06-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3934 9.0261 0.0 0
M  V30 2 C 4.1475 9.9314 0.0 0
M  V30 3 C 4.3085 11.4629 0.0 0
M  V30 4 O 2.7406 9.3049 0.0 0
M  V30 5 N 2.4919 7.3509 0.0 0
M  V30 6 N 1.2460 6.4457 0.0 0 CHG=1 VAL=4
M  V30 7 N 0.0000 5.5405 0.0 0 CHG=-1
M  V30 8 C 3.1884 4.0738 0.0 0
M  V30 9 O 3.6643 2.6091 0.0 0
M  V30 10 C 2.6339 1.4647 0.0 0
M  V30 11 C 1.1274 1.7849 0.0 0
M  V30 12 O 3.1097 0.0000 0.0 0
M  V30 13 Cl 13.0288 6.5238 0.0 0
M  V30 14 C 6.3769 6.4640 0.0 0 CFG=2
M  V30 15 C 5.2323 7.4946 0.0 0 CFG=2
M  V30 16 O 5.7505 5.0572 0.0 0
M  V30 17 C 3.8987 6.7246 0.0 0 CFG=2
M  V30 18 C 4.2189 5.2182 0.0 0 CFG=2
M  V30 19 N 7.8831 6.7842 0.0 0
M  V30 20 C 9.0277 5.7538 0.0 0
M  V30 21 C 8.5096 8.1911 0.0 0
M  V30 22 C 10.3613 6.5238 0.0 0
M  V30 23 N 9.0277 4.2138 0.0 0
M  V30 24 N 10.0412 8.0302 0.0 0
M  V30 25 C 11.6950 5.7538 0.0 0
M  V30 26 C 10.3613 3.4438 0.0 0
M  V30 27 N 11.6950 4.2138 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 6
M  V30 6 1 17 5 CFG=1
M  V30 7 2 6 7
M  V30 8 1 8 9
M  V30 9 1 18 8 CFG=3
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 25
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 19 CFG=3
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 20 23
M  V30 24 2 21 24
M  V30 25 1 22 24
M  V30 26 2 22 25
M  V30 27 1 23 26
M  V30 28 1 25 27
M  V30 29 2 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 14 15 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Adenosine, 3′-azido-3′-deoxy-N-methyl-
C11H14N8O3
889126-08-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3935 6.4170 0.0 0
M  V30 2 N 13.0288 3.9148 0.0 0
M  V30 3 C 14.3626 3.1447 0.0 0
M  V30 4 N 2.4919 4.7417 0.0 0
M  V30 5 N 1.2459 3.8367 0.0 0 CHG=1 VAL=4
M  V30 6 N 0.0000 2.9314 0.0 0 CHG=-1
M  V30 7 C 3.1885 1.4646 0.0 0
M  V30 8 O 3.6643 0.0000 0.0 0
M  V30 9 N 7.8833 4.1752 0.0 0
M  V30 10 C 9.0278 3.1447 0.0 0
M  V30 11 C 8.5097 5.5820 0.0 0
M  V30 12 C 10.3615 3.9148 0.0 0
M  V30 13 N 9.0278 1.6047 0.0 0
M  V30 14 N 10.0413 5.4211 0.0 0
M  V30 15 C 11.6951 3.1447 0.0 0
M  V30 16 C 10.3615 0.8347 0.0 0
M  V30 17 N 11.6951 1.6047 0.0 0
M  V30 18 C 6.3770 3.8550 0.0 0 CFG=2
M  V30 19 C 5.2324 4.8854 0.0 0 CFG=2
M  V30 20 O 5.7505 2.4480 0.0 0
M  V30 21 C 3.8987 4.1154 0.0 0 CFG=2
M  V30 22 C 4.2189 2.6091 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 19 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 15
M  V30 4 2 4 5
M  V30 5 1 21 4 CFG=1
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 1 22 7 CFG=3
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 18 9 CFG=3
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 18 19 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 889126-06-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 889126-08-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1556671
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of N6-Substituted 3'-Ureidoadenosine Derivatives as Highly
Potent Agonists at the Mutant A3 Adenosine Receptor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jeong, Lak Shin; Choe, Seung Ah; Kim, Ae Yil; Kim, Hea Ok; Gao, Zhan-Guo;
Jacobson, Kenneth A.; Chun, Moon Woo; Moon, Hyung Ryong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nucleosides, Nucleotides & Nucleic Acids (2007), 26(6-7), 717-719

$RFMT $RIREG SCHEME20 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-9-(2,5-di-O-acetyl-3-azido-3-deoxy-β-D-ribofuranosyl)-9H-purine
C14H14ClN7O5
889126-06-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3934 9.0261 0.0 0
M  V30 2 C 4.1475 9.9314 0.0 0
M  V30 3 C 4.3085 11.4629 0.0 0
M  V30 4 O 2.7406 9.3049 0.0 0
M  V30 5 N 2.4919 7.3509 0.0 0
M  V30 6 N 1.2460 6.4457 0.0 0 CHG=1 VAL=4
M  V30 7 N 0.0000 5.5405 0.0 0 CHG=-1
M  V30 8 C 3.1884 4.0738 0.0 0
M  V30 9 O 3.6643 2.6091 0.0 0
M  V30 10 C 2.6339 1.4647 0.0 0
M  V30 11 C 1.1274 1.7849 0.0 0
M  V30 12 O 3.1097 0.0000 0.0 0
M  V30 13 Cl 13.0288 6.5238 0.0 0
M  V30 14 C 6.3769 6.4640 0.0 0 CFG=2
M  V30 15 C 5.2323 7.4946 0.0 0 CFG=2
M  V30 16 O 5.7505 5.0572 0.0 0
M  V30 17 C 3.8987 6.7246 0.0 0 CFG=2
M  V30 18 C 4.2189 5.2182 0.0 0 CFG=2
M  V30 19 N 7.8831 6.7842 0.0 0
M  V30 20 C 9.0277 5.7538 0.0 0
M  V30 21 C 8.5096 8.1911 0.0 0
M  V30 22 C 10.3613 6.5238 0.0 0
M  V30 23 N 9.0277 4.2138 0.0 0
M  V30 24 N 10.0412 8.0302 0.0 0
M  V30 25 C 11.6950 5.7538 0.0 0
M  V30 26 C 10.3613 3.4438 0.0 0
M  V30 27 N 11.6950 4.2138 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 6
M  V30 6 1 17 5 CFG=1
M  V30 7 2 6 7
M  V30 8 1 8 9
M  V30 9 1 18 8 CFG=3
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 25
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 19 CFG=3
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 20 23
M  V30 24 2 21 24
M  V30 25 1 22 24
M  V30 26 2 22 25
M  V30 27 1 23 26
M  V30 28 1 25 27
M  V30 29 2 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 14 15 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Adenosine, 3′-azido-3′-deoxy-N-methyl-
C11H14N8O3
889126-08-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3935 6.4170 0.0 0
M  V30 2 N 13.0288 3.9148 0.0 0
M  V30 3 C 14.3626 3.1447 0.0 0
M  V30 4 N 2.4919 4.7417 0.0 0
M  V30 5 N 1.2459 3.8367 0.0 0 CHG=1 VAL=4
M  V30 6 N 0.0000 2.9314 0.0 0 CHG=-1
M  V30 7 C 3.1885 1.4646 0.0 0
M  V30 8 O 3.6643 0.0000 0.0 0
M  V30 9 N 7.8833 4.1752 0.0 0
M  V30 10 C 9.0278 3.1447 0.0 0
M  V30 11 C 8.5097 5.5820 0.0 0
M  V30 12 C 10.3615 3.9148 0.0 0
M  V30 13 N 9.0278 1.6047 0.0 0
M  V30 14 N 10.0413 5.4211 0.0 0
M  V30 15 C 11.6951 3.1447 0.0 0
M  V30 16 C 10.3615 0.8347 0.0 0
M  V30 17 N 11.6951 1.6047 0.0 0
M  V30 18 C 6.3770 3.8550 0.0 0 CFG=2
M  V30 19 C 5.2324 4.8854 0.0 0 CFG=2
M  V30 20 O 5.7505 2.4480 0.0 0
M  V30 21 C 3.8987 4.1154 0.0 0 CFG=2
M  V30 22 C 4.2189 2.6091 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 19 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 15
M  V30 4 2 4 5
M  V30 5 1 21 4 CFG=1
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 1 22 7 CFG=3
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 18 9 CFG=3
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 18 19 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 889126-06-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 889126-08-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3043118
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of 13, 10,
11, 14, and 12. To a stirred solution of 30a-c and 40a,b in THF (10 mL)
was added 1 M TBAF in THF (4 equiv) at room temperature. The reaction
mixture was stirred for 4 h at room temperature and evaporated. The
residue was purified by silica gel column chromatography to give 13, 10,
11, 14, and 12. N6-Methyl- 9-(3-azido-3-deoxy-β-D-ribofuranosyl)adenine
(26a). 90% yield; white solid; 1H NMR (DMSO-d6) δ 8.31 (s, 1 H), 8.20 (s,
1 H), 7.83 (brs, 1 H), 6.18 (d, 1 H, J = 5.7 Hz), 5.86 (d, 1 H, J = 6.1
Hz), 5.56 (dd, 1 H, J = 4.5, 7.6 Hz), 4.95 (dd, 1 H, J = 5.7, 11.4 Hz),
4.27 (dd, 1 H, J = 3.5, 5.4 Hz), 3.93 (dd, 1 H, J = 3.3, 6.8 Hz),
3.50-3.69 (m, 2 H), 2.92 (s, 3 H); IR (KBr): 3430 (OH), 2104 (N3), 1634
(C=O) cm-1; FAB-MS m/z 307 [M + H]+. Anal. (C11H14N8O3) C, H, N.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Orthogonal Activation of the Reengineered A3 Adenosine Receptor
(Neoceptor) Using Tailored Nucleoside Agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gao, Zhan-Guo; Duong, Heng T.; Sonina, Tatiana; Kim, Soo-Kyung; Van
Rompaey, Philippe; Van Calenbergh, Serge; Mamedova, Liaman; Kim, Hea Ok;
Kim, Myong Jung; Kim, Ae Yil; Liang, Bruce T.; Jeong, Lak Shin; Jacobson,
Kenneth A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2006), 49(9), 2689-2702

$RFMT $RIREG SCHEME21 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-[2-(4-morpholinyl)ethyl]-5-phenyl-2-propyl-1H-pyrrole-3-carboxylate
C22H30N2O3
898221-80-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.6398 0.0 0
M  V30 2 C 4.6200 6.9734 0.0 0
M  V30 3 C 7.3594 8.3502 0.0 0
M  V30 4 C 8.3898 9.4947 0.0 0
M  V30 5 C 7.9139 10.9593 0.0 0
M  V30 6 C 10.5458 7.3148 0.0 0
M  V30 7 O 11.9526 6.6885 0.0 0
M  V30 8 O 10.3847 8.8465 0.0 0
M  V30 9 C 13.1984 7.5937 0.0 0
M  V30 10 C 14.6054 6.9674 0.0 0
M  V30 11 N 6.9300 5.6398 0.0 0
M  V30 12 C 7.8352 4.3938 0.0 0
M  V30 13 C 7.8352 6.8856 0.0 0
M  V30 14 C 9.2999 4.8698 0.0 0
M  V30 15 C 9.2999 6.4098 0.0 0
M  V30 16 C 7.3594 2.9292 0.0 0
M  V30 17 C 5.8529 2.6091 0.0 0
M  V30 18 C 8.3898 1.7847 0.0 0
M  V30 19 C 5.3771 1.1444 0.0 0
M  V30 20 C 7.9139 0.3202 0.0 0
M  V30 21 C 6.4076 0.0000 0.0 0
M  V30 22 N 3.0800 6.9734 0.0 0
M  V30 23 C 2.3100 5.6398 0.0 0
M  V30 24 C 2.3100 8.3071 0.0 0
M  V30 25 C 0.7700 5.6398 0.0 0
M  V30 26 C 0.7700 8.3071 0.0 0
M  V30 27 O 0.0000 6.9734 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 22
M  V30 4 1 3 4
M  V30 5 1 3 13
M  V30 6 1 4 5
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 15
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 1 12 16
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1-[2-(4-morpholinyl)ethyl]-5-phenyl-2-propyl-1H-pyrrole-3-carboxamide
C21H29N3O2
898222-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.6398 0.0 0
M  V30 2 C 4.6200 6.9735 0.0 0
M  V30 3 C 7.3594 8.3502 0.0 0
M  V30 4 C 8.3898 9.4948 0.0 0
M  V30 5 C 7.9139 10.9593 0.0 0
M  V30 6 C 10.5457 7.3149 0.0 0
M  V30 7 N 11.9526 6.6886 0.0 0
M  V30 8 O 10.3847 8.8466 0.0 0
M  V30 9 C 13.1985 7.5938 0.0 0
M  V30 10 N 6.9300 5.6398 0.0 0
M  V30 11 C 7.8353 4.3938 0.0 0
M  V30 12 C 7.8353 6.8857 0.0 0
M  V30 13 C 9.2998 4.8698 0.0 0
M  V30 14 C 9.2998 6.4098 0.0 0
M  V30 15 C 7.3594 2.9292 0.0 0
M  V30 16 C 8.3898 1.7847 0.0 0
M  V30 17 C 5.8530 2.6091 0.0 0
M  V30 18 C 7.9139 0.3202 0.0 0
M  V30 19 C 5.3771 1.1444 0.0 0
M  V30 20 C 6.4075 0.0000 0.0 0
M  V30 21 N 3.0800 6.9735 0.0 0
M  V30 22 C 2.3100 8.3071 0.0 0
M  V30 23 C 2.3100 5.6398 0.0 0
M  V30 24 C 0.7700 8.3071 0.0 0
M  V30 25 C 0.7700 5.6398 0.0 0
M  V30 26 O 0.0000 6.9735 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 21
M  V30 4 1 3 4
M  V30 5 1 3 12
M  V30 6 1 4 5
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 14
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 898221-80-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 898222-08-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1740139
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-24-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 110-54-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for Weinreb Reaction.
Preparation of
5-tert-Butyl-2-propyl-1-pyridin-2-ylmethyl-1H-pyrrole-3-carboxylic Acid
(thiophen-2-ylmethyl)amide 61-A10. To a stirred solution of
thiophen-2-ylmethylamine (0.03 g, 0.26 mmol) in 1 mL of dry toluene, A2M
solution of AlMe3 in hexane (1.30 mL, 0.65 mmol) was added at room
temperature under an inert atmosphere, and the reaction mixture was
allowed to stir at room temperature for 15 min. A solution of
5-tert-butyl-2-propyl-1-pyridin-2-ylmethyl-1H-pyrrole-3-carboxylic acid
methyl ester (61, 0.04 g, 0.13 mmol) in dry toluene (2 mL) was added
dropwise under an inert atmosphere, and the mixture was heated at 90°C
overnight and then cooled to room temperature. The reaction mixture was
diluted with 2 mL of dichloromethane and 2 mL of 2 M NaOH. The crude
product was eluted through a phase separator cartridge, and the organic
phase was subsequently filtered on a silica gel cartridge.
1-(2-Morpholin-4-ylethyl)-5-phenyl-2-propyl-1H-pyrrole-3-carboxylic Acid
Methylamide (620-A8). Yield 90%. 1H NMR (300 MHz, chloroform-d): δ
7.32-7.44 (5H, m), 6.17 (1H, s), 5.67-5.76 (1H, m), 4.04 (2H, t, J = 7.24
Hz), 3.54-3.62 (4H, m), 2.99-3.06 (2H, m), 2.93 (3H, d, J = 5.03 Hz),
2.32-2.41 (2H, m), 2.19-2.28 (4H, m), 1.63-1.76 (2H, m), 1.04 (3H, t, J =
7.39 Hz). 13C NMR (DMSO-d6): δ 14.5, 23.8, 26.0, 27.1, 41.4, 53.7, 58.9,
66.5, 108.1, 115.3, 127.7, 129.0, 129.3, 132.5, 133.6, 138.5, 165.6.
LC-MS: m/z 356.4 [M + H]+ (Luna column, method A, 99.4%, 215 nm).
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solution Phase Synthesis of a Library of Tetrasubstituted Pyrrole Amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bianchi, Ivana; Forlani, Roberto; Minetto, Giacomo; Peretto, Ilaria;
Regalia, Nickolas; Taddei, Maurizio; Raveglia, Luca F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Combinatorial Chemistry (2006), 8(4), 491-499

$RFMT $RIREG SCHEME22 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Salicylaldehyde
C7H6O2
90-02-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 O 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(E)-(Methylimino)methyl]phenol
C8H9NO
107910-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 O 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90-02-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 107910-69-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41078227
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM (Phenoxyimine)nickel-Catalyzed C(sp2)-C(sp3) Suzuki-Miyaura
Cross-Coupling: Evidence for a Recovering Radical Chain Mechanism
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mills, L. Reginald; Simmons, Eric M.; Lee, Heejun; Nester, Eva; Kim,
Junho; Wisniewski, Steven R.; Pecoraro, Matthew V.; Chirik, Paul J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2024), 146(14), 10124-10141

$RFMT $RIREG SCHEME22 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Salicylaldehyde
C7H6O2
90-02-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 O 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(E)-(Methylimino)methyl]phenol
C8H9NO
107910-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 O 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90-02-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 107910-69-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39551172
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phenoxythiazoline (FTz)-Cobalt(II) Precatalysts Enable C(sp2)-C(sp3)
Bond-Formation for Key Intermediates in the Synthesis of Toll-like
Receptor 7/8 Antagonists**
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mills, L. Reginald; Di Mare, Francesca; Gygi, David; Lee, Heejun;
Simmons, Eric M.; Kim, Junho; Wisniewski, Steven R.; Chirik, Paul J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2023), 62(51), e202313848

$RFMT $RIREG SCHEME22 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Salicylaldehyde
C7H6O2
90-02-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 O 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(E)-(Methylimino)methyl]phenol
C8H9NO
107910-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 O 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90-02-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 107910-69-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37881712
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phenoxythiazoline (FTz)-Cobalt(II) precatalysts enable C(sp2)-C(sp3)
bond-formation for the key intermediate in the synthesis of afimetoran
and related toll-like receptor 7/8 (TLR7/8) antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mills, L. Reginald; DiMare, Francesca; Gygi, David; Lee, Heejun; Simmons,
Eric M.; Kim, Junho; Wisniewski, Steven R.; Chirik, Paul J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemRxiv (2023), 1-21

$RFMT $RIREG SCHEME23 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Salicylaldehyde
C7H6O2
90-02-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 O 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Methylamino)methyl]phenol
C8H11NO
60399-02-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 O 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90-02-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 60399-02-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-5331039
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of 2-Hydroxybenzylamines (2 in Scheme 1) Salicylaldehyde or
2,5-hydroxybenzaldehyde (40 mmol) was added slowly to a solution of amine
(40 mmol) in EtOH (50 mL), and the mixture was stirred at 60°C for 4-8 h.
The resulting solution was cooled to room temperature, and NaBH4 (0.76g,
20mmol) was added in small portions while stirring. When the reduction
was complete, 100 mL of water was added, and the resulting product was
extracted with diethyl ether, washed with water, dried over anhydrous
MgSO4 and concentrated to dryness. The resulting 2-hydroxybenzylamines
were colorless oils or white solids. 2-Hydroxy-N-methylbenzylamine, Yield
90%. mp = 39-41 °C. 1H NMR (400 MHz, CDCl3, ppm): δH 7.20- 6.70 (4H,
Ar-H), 6.35 (2H, OH and NH, broad), 3.91 (2H, Ar-CH2-N), 2.43 (3H,
N-CH3). 13C NMR (100.5 MHz, CDCl3, ppm): δC 158.6 (C-O), 128.9 (CH),
128.7 (CH), 122.6 (C), 119.3 (CH), 116.6 (CH), 54.9 (Ar-CH2N), 35.5
(N-CH3).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3,4-Dihydro-2H-1,3-benzoxazines by Condensation of
2-Hydroxyaldehydes and Primary Amines: Application to the Synthesis of
Hydroxy-Substituted and Deuterium-Labeled Compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andreu, R.; Ronda, J. C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2008), 38(14), 2316-2329

$RFMT $RIREG SCHEME24 STEP1
$RXN



  2  1
$MOL
rel-(1R,2R,3S)-3-[[3,5-Bis(trifluoromethyl)phenyl]methoxy]-2-phenylcyclopenta...
C21H19F6NO2
909784-51-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.2078 5.3901 0.0 0
M  V30 2 C 7.5416 6.1601 0.0 0
M  V30 3 C 0.9052 6.5172 0.0 0
M  V30 4 N 0.2789 5.1102 0.0 0
M  V30 5 O 0.0000 7.7631 0.0 0
M  V30 6 C 10.2089 1.5400 0.0 0
M  V30 7 F 11.7489 1.5400 0.0 0
M  V30 8 F 10.2089 0.0000 0.0 0
M  V30 9 F 8.6689 1.5400 0.0 0
M  V30 10 C 12.8764 6.1601 0.0 0
M  V30 11 F 12.1064 7.4937 0.0 0
M  V30 12 F 14.2100 6.9301 0.0 0
M  V30 13 F 13.6464 4.8264 0.0 0
M  V30 14 C 3.4673 5.5336 0.0 0 CFG=1
M  V30 15 C 4.8742 6.1601 0.0 0 CFG=1
M  V30 16 C 2.4368 6.6781 0.0 0 CFG=2
M  V30 17 C 4.7132 7.6916 0.0 0
M  V30 18 C 3.2068 8.0118 0.0 0
M  V30 19 C 3.1470 4.0273 0.0 0
M  V30 20 C 1.6825 3.5514 0.0 0
M  V30 21 C 4.2916 2.9969 0.0 0
M  V30 22 C 1.3623 2.0450 0.0 0
M  V30 23 C 3.9714 1.4904 0.0 0
M  V30 24 C 2.5067 1.0146 0.0 0
M  V30 25 C 8.8753 5.3901 0.0 0
M  V30 26 C 8.8753 3.8500 0.0 0
M  V30 27 C 10.2089 6.1601 0.0 0
M  V30 28 C 10.2089 3.0800 0.0 0
M  V30 29 C 11.5426 5.3901 0.0 0
M  V30 30 C 11.5426 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=3
M  V30 3 1 2 25
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 16 3 CFG=3
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 28
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 29
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 19 CFG=1
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 14 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(1R,2R,3S)-3-[[3,5-Bis(trifluoromethyl)phenyl]methoxy]-N-methyl-2-phenylc...
C22H21F6NO2
909784-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.3047 6.5172 0.0 0
M  V30 2 N 14.2099 7.7631 0.0 0
M  V30 3 O 13.9312 5.1103 0.0 0
M  V30 4 C 15.7415 7.6022 0.0 0
M  V30 5 O 8.0021 5.3901 0.0 0
M  V30 6 C 6.6684 6.1601 0.0 0
M  V30 7 C 4.0010 1.5400 0.0 0
M  V30 8 F 2.4610 1.5400 0.0 0
M  V30 9 F 4.0010 0.0000 0.0 0
M  V30 10 F 5.5410 1.5400 0.0 0
M  V30 11 C 1.3337 6.1601 0.0 0
M  V30 12 F 0.5636 4.8264 0.0 0
M  V30 13 F 0.0000 6.9301 0.0 0
M  V30 14 F 2.1037 7.4937 0.0 0
M  V30 15 C 10.7427 5.5336 0.0 0 CFG=2
M  V30 16 C 11.7732 6.6782 0.0 0 CFG=2
M  V30 17 C 9.3358 6.1601 0.0 0 CFG=1
M  V30 18 C 11.0031 8.0118 0.0 0
M  V30 19 C 9.4969 7.6916 0.0 0
M  V30 20 C 11.0629 4.0273 0.0 0
M  V30 21 C 12.5276 3.5514 0.0 0
M  V30 22 C 9.9185 2.9969 0.0 0
M  V30 23 C 12.8478 2.0450 0.0 0
M  V30 24 C 10.2387 1.4904 0.0 0
M  V30 25 C 11.7032 1.0146 0.0 0
M  V30 26 C 5.3348 5.3901 0.0 0
M  V30 27 C 5.3348 3.8501 0.0 0
M  V30 28 C 4.0010 6.1601 0.0 0
M  V30 29 C 4.0010 3.0800 0.0 0
M  V30 30 C 2.6673 5.3901 0.0 0
M  V30 31 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 17 5 CFG=1
M  V30 7 1 6 26
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 29
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 30
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 20 CFG=3
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 15 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 909784-51-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 909784-74-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-041-CAS-11655069
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cyclopentane-based human NK1 antagonists. Part 1: discovery and initial
SAR
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Finke, Paul E.; Meurer, Laura C.; Levorse, Dorothy A.; Mills, Sander G.;
MacCoss, Malcolm; Sadowski, Sharon; Cascieri, Margaret A.; Tsao,
Kwei-Lan; Chicchi, Gary G.; Metzger, Joseph M.; MacIntyre, D. Euan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2006), 16(17), 4497-4503

$RFMT $RIREG SCHEME25 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2R)-6-Methoxy-2-phenyl-2H-1-benzopyran-3-carboxaldehyde
C17H14O3
911107-23-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.3338 0.0 0
M  V30 2 O 5.3900 0.0000 0.0 0
M  V30 3 O 11.5500 5.3347 0.0 0
M  V30 4 C 12.3200 6.6685 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 6 C 5.3900 2.6674 0.0 0
M  V30 7 O 5.3900 5.3347 0.0 0
M  V30 8 C 6.9300 2.6674 0.0 0
M  V30 9 C 6.9300 5.3347 0.0 0
M  V30 10 C 7.7000 4.0011 0.0 0
M  V30 11 C 7.7000 6.6685 0.0 0
M  V30 12 C 9.2400 4.0011 0.0 0
M  V30 13 C 9.2400 6.6685 0.0 0
M  V30 14 C 10.0100 5.3347 0.0 0
M  V30 15 C 3.0800 4.0011 0.0 0
M  V30 16 C 2.3100 5.3347 0.0 0
M  V30 17 C 2.3100 2.6674 0.0 0
M  V30 18 C 0.7700 5.3347 0.0 0
M  V30 19 C 0.7700 2.6674 0.0 0
M  V30 20 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 15 CFG=1
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methanamine, N-[[(2R)-6-methoxy-2-phenyl-2H-1-benzopyran-3-yl]methylene]-, [N...
C18H17NO2
2921813-24-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 N 5.3900 1.3336 0.0 0
M  V30 3 C 4.6200 0.0000 0.0 0
M  V30 4 O 11.5500 6.6685 0.0 0
M  V30 5 C 12.3200 8.0021 0.0 0
M  V30 6 C 4.6200 5.3347 0.0 0 CFG=1
M  V30 7 C 5.3900 4.0011 0.0 0
M  V30 8 O 5.3900 6.6685 0.0 0
M  V30 9 C 6.9300 4.0011 0.0 0
M  V30 10 C 6.9300 6.6685 0.0 0
M  V30 11 C 7.7000 5.3347 0.0 0
M  V30 12 C 7.7000 8.0021 0.0 0
M  V30 13 C 9.2400 5.3347 0.0 0
M  V30 14 C 9.2400 8.0021 0.0 0
M  V30 15 C 10.0100 6.6685 0.0 0
M  V30 16 C 3.0800 5.3347 0.0 0
M  V30 17 C 2.3100 6.6685 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 C 0.7700 6.6685 0.0 0
M  V30 20 C 0.7700 4.0011 0.0 0
M  V30 21 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 16 CFG=1
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 911107-23-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2921813-24-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36124655
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multifaceted Domino Knoevenagel-Cyclization Reactions; Four Movements for
2H-Chromenes and Chromans
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Balazs Kiraly, Sandor; Toth, Laszlo; Kovacs, Tibor; Benyei, Attila;
Lisztes, Erika; Istvan Toth, Balazs; Biro, Tamas; Kiss-Szikszai, Attila;
Kover, Katalin E.; Mandi, Attila; Kurtan, Tibor
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2023), 365(19), 3301-3319

$RFMT $RIREG SCHEME26 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-[(2,4-dichlorophenyl)methyl]-1H-1,2,3-triazole-4-carboxylate
C12H11Cl2N3O2
912556-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 10.6374 2.6672 0.0 0
M  V30 3 O 11.5426 3.9130 0.0 0
M  V30 4 O 11.2639 1.2602 0.0 0
M  V30 5 C 13.0742 3.7521 0.0 0
M  V30 6 C 13.9794 4.9980 0.0 0
M  V30 7 Cl 2.6673 0.0000 0.0 0
M  V30 8 Cl 0.0000 4.6201 0.0 0
M  V30 9 N 6.6684 2.3100 0.0 0
M  V30 10 C 8.0754 1.6837 0.0 0
M  V30 11 N 6.8294 3.8416 0.0 0
M  V30 12 C 9.1058 2.8281 0.0 0
M  V30 13 N 8.3358 4.1618 0.0 0
M  V30 14 C 4.0011 2.3100 0.0 0
M  V30 15 C 2.6673 1.5400 0.0 0
M  V30 16 C 4.0011 3.8501 0.0 0
M  V30 17 C 1.3337 2.3100 0.0 0
M  V30 18 C 2.6673 4.6201 0.0 0
M  V30 19 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 12
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 7 15
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(2,4-Dichlorophenyl)methyl]-N-methyl-1H-1,2,3-triazole-4-carboxamide
C11H10Cl2N4O
942518-41-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 Cl 2.6673 0.0000 0.0 0
M  V30 3 Cl 0.0000 4.6201 0.0 0
M  V30 4 C 10.6375 2.6672 0.0 0
M  V30 5 N 11.5427 3.9131 0.0 0
M  V30 6 O 11.2638 1.2602 0.0 0
M  V30 7 C 13.0743 3.7521 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 2.6673 1.5400 0.0 0
M  V30 10 C 4.0012 3.8501 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 4.6201 0.0 0
M  V30 13 C 1.3337 3.8501 0.0 0
M  V30 14 N 6.6685 2.3101 0.0 0
M  V30 15 C 8.0755 1.6837 0.0 0
M  V30 16 N 6.8294 3.8416 0.0 0
M  V30 17 C 9.1059 2.8281 0.0 0
M  V30 18 N 8.3359 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 9
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 17
M  V30 8 1 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 912556-97-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 942518-41-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9885711
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-10-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of 3a-3m: Compounds 2a-2e (0.37
mmol) were placed in an appropriate saturated solution of ammonia and
methylamine in methanol and npropylamine, respectively. The mixture was
stirred at room temperature. A solid product was obtained after
filtration, which was then purified by recrystallization in methanol.
Compd.: 3i; Yield: 90%. M. p.: 190-192°C; IR ν (cm-1): 3342 (ν N-H) 1650
(ν C=O); MS (m/z) [M + H]+: 286; 1H-NMR (δ): 2.76 (m, 3H, CH3), 5.99 (s,
2H, PhCCH2), 7. (m 1H, NH), 8.58 (s, 1H, =CH) 29-7.71 (m, 3H, ArH), 8.49.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and anticonvulsant activity of 1-substituted benzyl
N-substituted 1,2,3-triazole-4-carboxanilides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Junmin; Jun, Changsoo; Chai, Kyuyun; Kwak, Kyungchell; Quan,
Zheshan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Progress in Natural Science (2006), 16(9), 925-929

$RFMT $RIREG SCHEME27 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-[Ethyl[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]amin...
C21H21F6NO4
913619-56-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.0467 8.0021 0.0 0
M  V30 2 C 1.3957 6.6064 0.0 0
M  V30 3 C 2.0467 9.5421 0.0 0
M  V30 4 O 0.5590 8.4007 0.0 0
M  V30 5 F 2.7916 5.9555 0.0 0
M  V30 6 F 0.0000 7.2572 0.0 0
M  V30 7 F 0.7449 5.2107 0.0 0
M  V30 8 F 3.5867 9.5421 0.0 0
M  V30 9 F 2.0467 11.0821 0.0 0
M  V30 10 F 0.5067 9.5421 0.0 0
M  V30 11 N 8.2067 8.0021 0.0 0
M  V30 12 C 8.9767 6.6685 0.0 0
M  V30 13 C 8.9767 9.3358 0.0 0
M  V30 14 C 8.2067 5.3347 0.0 0
M  V30 15 C 8.2067 10.6694 0.0 0
M  V30 16 O 8.9767 4.0011 0.0 0
M  V30 17 C 8.2067 2.6674 0.0 0
M  V30 18 C 8.9767 1.3336 0.0 0
M  V30 19 O 10.5167 1.3336 0.0 0
M  V30 20 O 8.2067 0.0000 0.0 0
M  V30 21 C 3.5867 8.0021 0.0 0
M  V30 22 C 4.3567 9.3358 0.0 0
M  V30 23 C 4.3567 6.6684 0.0 0
M  V30 24 C 5.8967 9.3358 0.0 0
M  V30 25 C 5.8967 6.6684 0.0 0
M  V30 26 C 6.6667 8.0021 0.0 0
M  V30 27 C 10.5167 6.6685 0.0 0
M  V30 28 C 11.2867 5.3347 0.0 0
M  V30 29 C 11.2867 8.0021 0.0 0
M  V30 30 C 12.8267 5.3347 0.0 0
M  V30 31 C 12.8267 8.0021 0.0 0
M  V30 32 C 13.5967 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 21
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 2 7
M  V30 8 1 3 8
M  V30 9 1 3 9
M  V30 10 1 3 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 26
M  V30 14 1 12 14
M  V30 15 1 12 27
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-[Ethyl[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]amin...
C22H24F6N2O3
913619-57-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 9.3358 0.0 0
M  V30 2 C 3.5507 10.5974 0.0 0
M  V30 3 C 1.3337 8.5658 0.0 0
M  V30 4 O 1.5784 10.4248 0.0 0
M  V30 5 F 4.8123 9.7141 0.0 0
M  V30 6 F 2.2891 11.4808 0.0 0
M  V30 7 F 4.4341 11.8589 0.0 0
M  V30 8 F 2.1037 7.2322 0.0 0
M  V30 9 F 0.0000 7.7958 0.0 0
M  V30 10 F 0.5637 9.8996 0.0 0
M  V30 11 N 5.7474 4.0010 0.0 0
M  V30 12 C 7.2874 4.0010 0.0 0
M  V30 13 C 4.9774 2.6673 0.0 0
M  V30 14 C 8.0575 5.3348 0.0 0
M  V30 15 C 3.4374 2.6673 0.0 0
M  V30 16 O 9.5975 5.3348 0.0 0
M  V30 17 C 10.3675 6.6685 0.0 0
M  V30 18 C 11.9075 6.6685 0.0 0
M  V30 19 N 12.6776 8.0022 0.0 0
M  V30 20 O 12.6776 5.3348 0.0 0
M  V30 21 C 14.2176 8.0022 0.0 0
M  V30 22 C 3.4374 8.0022 0.0 0
M  V30 23 C 2.6673 6.6685 0.0 0
M  V30 24 C 4.9774 8.0022 0.0 0
M  V30 25 C 3.4374 5.3348 0.0 0
M  V30 26 C 5.7474 6.6685 0.0 0
M  V30 27 C 4.9774 5.3348 0.0 0
M  V30 28 C 8.0575 2.6673 0.0 0
M  V30 29 C 9.5975 2.6673 0.0 0
M  V30 30 C 7.2874 1.3337 0.0 0
M  V30 31 C 10.3675 1.3337 0.0 0
M  V30 32 C 8.0575 0.0000 0.0 0
M  V30 33 C 9.5975 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 22
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 2 7
M  V30 8 1 3 8
M  V30 9 1 3 9
M  V30 10 1 3 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 27
M  V30 14 1 12 14
M  V30 15 1 12 28
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 29 2 28 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 2 30 32
M  V30 33 2 31 33
M  V30 34 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 913619-56-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 913619-57-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10374841
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7529-22-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and evaluation of anilinohexafluoroisopropanols as
activators/modulators of LXRα and β
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Panday, Narendra; Benz, Jorg; Blum-Kaelin, Denise; Bourgeaux, Vanessa;
Dehmlow, Henrietta; Hartman, Peter; Kuhn, Bernd; Ratni, Hassen; Warot,
Xavier; Wright, Matthew B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2006), 16(19), 5231-5237

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,4,9-Tetrahydro-4-methyl-1-oxo-1H-pyrido[3,4-b]indole-6-carboxylic acid
C13H12N2O3
916520-71-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.6207 0.0000 0.0 0
M  V30 2 O 0.0000 4.9836 0.0 0
M  V30 3 C 8.8076 2.3587 0.0 0
M  V30 4 O 8.8076 0.8187 0.0 0
M  V30 5 O 10.1413 3.1287 0.0 0
M  V30 6 C 3.3420 2.6528 0.0 0
M  V30 7 C 4.8065 3.1287 0.0 0
M  V30 8 C 2.4368 3.8987 0.0 0
M  V30 9 C 2.7155 1.2459 0.0 0
M  V30 10 C 4.8065 4.6687 0.0 0
M  V30 11 C 6.1402 2.3587 0.0 0
M  V30 12 N 3.3420 5.1446 0.0 0
M  V30 13 C 0.9052 3.7378 0.0 0
M  V30 14 C 1.1840 1.0849 0.0 0
M  V30 15 C 6.1402 5.4387 0.0 0
M  V30 16 C 7.4740 3.1287 0.0 0
M  V30 17 N 0.2787 2.3308 0.0 0
M  V30 18 C 7.4740 4.6687 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 2 2 13
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 16
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 10 12
M  V30 15 2 10 15
M  V30 16 1 11 16
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 2 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,4,9-Tetrahydro-N,4-dimethyl-1-oxo-1H-pyrido[3,4-b]indole-6-carboxamide
C14H15N3O2
916521-05-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.6207 0.0000 0.0 0
M  V30 2 C 8.8076 2.3587 0.0 0
M  V30 3 N 10.1413 3.1287 0.0 0
M  V30 4 O 8.8076 0.8187 0.0 0
M  V30 5 C 11.4749 2.3587 0.0 0
M  V30 6 O 0.0000 4.9836 0.0 0
M  V30 7 C 4.8065 3.1287 0.0 0
M  V30 8 C 3.3420 2.6528 0.0 0
M  V30 9 C 4.8065 4.6687 0.0 0
M  V30 10 C 6.1402 2.3587 0.0 0
M  V30 11 C 2.4368 3.8987 0.0 0
M  V30 12 C 2.7155 1.2459 0.0 0
M  V30 13 N 3.3420 5.1446 0.0 0
M  V30 14 C 6.1402 5.4387 0.0 0
M  V30 15 C 7.4740 3.1287 0.0 0
M  V30 16 C 0.9051 3.7378 0.0 0
M  V30 17 C 1.1840 1.0849 0.0 0
M  V30 18 C 7.4740 4.6687 0.0 0
M  V30 19 N 0.2787 2.3308 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 2 6 16
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 9 14
M  V30 14 1 10 15
M  V30 15 1 11 13
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 1 14 18
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 1 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 916520-71-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 916521-05-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14370300
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The discovery of carboline analogs as potent MAPKAP-K2 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wu, Jiang-Ping; Wang, Ji; Abeywardane, Asitha; Andersen, Denise;
Emmanuel, Michel; Gautschi, Elda; Goldberg, Daniel R.; Kashem, Mohammed
A.; Lukas, Susan; Wang, Mao; Martin, Leslie; Morwick, Tina; Moss, Neil;
Pargellis, Christopher; Patel, Usha R.; Patnaude, Lori; Peet, Gregory W.;
Skow, Donna; Snow, Roger J.; Ward, Yancey; Werneburg, Brian; White, Andre
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(16), 4664-4669

$RFMT $RIREG SCHEME29 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[4-[2-(Trifluoromethyl)benzoyl]-1-piperazinyl]-5-thiazolecarboxylic acid
C16H14F3N3O3S
916888-64-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.4137 4.0011 0.0 0
M  V30 2 O 3.6437 5.3348 0.0 0
M  V30 3 C 1.3337 4.0011 0.0 0
M  V30 4 F 2.6673 4.7711 0.0 0
M  V30 5 F 0.5636 5.3348 0.0 0
M  V30 6 F 0.0000 3.2311 0.0 0
M  V30 7 C 14.1895 5.6763 0.0 0
M  V30 8 O 14.0285 7.2079 0.0 0
M  V30 9 O 15.5963 5.0499 0.0 0
M  V30 10 C 3.6437 2.6675 0.0 0
M  V30 11 C 2.1037 2.6675 0.0 0
M  V30 12 C 4.4137 1.3337 0.0 0
M  V30 13 C 1.3337 1.3337 0.0 0
M  V30 14 C 3.6437 0.0000 0.0 0
M  V30 15 C 2.1037 0.0000 0.0 0
M  V30 16 N 5.9537 4.0011 0.0 0
M  V30 17 C 6.7237 2.6675 0.0 0
M  V30 18 C 6.7237 5.3348 0.0 0
M  V30 19 C 8.2637 2.6675 0.0 0
M  V30 20 C 8.2637 5.3348 0.0 0
M  V30 21 N 9.0337 4.0011 0.0 0
M  V30 22 C 10.5737 4.0011 0.0 0
M  V30 23 S 11.4790 5.2470 0.0 0
M  V30 24 N 11.4790 2.7552 0.0 0
M  V30 25 C 12.9437 4.7711 0.0 0
M  V30 26 C 12.9437 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 1 1 16
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 11
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 25
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 23 1 21 22
M  V30 24 1 22 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-[4-[2-(trifluoromethyl)benzoyl]-1-piperazinyl]-5-thiazolecarboxamide
C17H17F3N4O2S
916888-65-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.4137 4.0011 0.0 0
M  V30 2 O 3.6437 5.3348 0.0 0
M  V30 3 C 1.3337 4.0011 0.0 0
M  V30 4 F 0.0000 3.2311 0.0 0
M  V30 5 F 0.5636 5.3348 0.0 0
M  V30 6 F 2.6673 4.7711 0.0 0
M  V30 7 C 14.1896 5.6764 0.0 0
M  V30 8 N 15.5964 5.0499 0.0 0
M  V30 9 O 14.0285 7.2079 0.0 0
M  V30 10 C 16.8423 5.9551 0.0 0
M  V30 11 C 3.6437 2.6675 0.0 0
M  V30 12 C 2.1037 2.6675 0.0 0
M  V30 13 C 4.4137 1.3337 0.0 0
M  V30 14 C 1.3337 1.3337 0.0 0
M  V30 15 C 3.6437 0.0000 0.0 0
M  V30 16 C 2.1037 0.0000 0.0 0
M  V30 17 N 5.9537 4.0011 0.0 0
M  V30 18 C 6.7237 2.6675 0.0 0
M  V30 19 C 6.7237 5.3348 0.0 0
M  V30 20 C 8.2638 2.6675 0.0 0
M  V30 21 C 8.2638 5.3348 0.0 0
M  V30 22 N 9.0338 4.0011 0.0 0
M  V30 23 C 10.5738 4.0011 0.0 0
M  V30 24 S 11.4790 5.2470 0.0 0
M  V30 25 N 11.4790 2.7553 0.0 0
M  V30 26 C 12.9436 4.7711 0.0 0
M  V30 27 C 12.9436 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 11
M  V30 3 1 1 17
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 12
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 26
M  V30 11 1 8 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 24 1 22 23
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 916888-64-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 916888-65-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5279686
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thiazole analog as stearoyl-CoA desaturase 1 inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Chun Sing; Belair, Liette; Guay, Jocelyne; Murgasva, Renata;
Sturkenboom, Wayne; Ramtohul, Yeeman K.; Zhang, Lei; Huang, Zheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(17), 5214-5217

$RFMT $RIREG SCHEME30 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[3-[1-[(2-cyanophenyl)methyl]-1,4,5,6-tetrahydro-5-methyl...
C25H29N5O4
918931-32-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3940 6.6353 0.0 0
M  V30 2 O 1.0327 4.6948 0.0 0
M  V30 3 O 3.7433 0.0000 0.0 0
M  V30 4 C 0.6825 1.3628 0.0 0
M  V30 5 C 3.7535 9.6481 0.0 0
M  V30 6 N 4.8980 10.6785 0.0 0
M  V30 7 N 11.4558 4.5026 0.0 0
M  V30 8 C 12.7894 5.2726 0.0 0
M  V30 9 O 14.1233 4.5026 0.0 0
M  V30 10 O 12.7894 6.8126 0.0 0
M  V30 11 C 15.4569 5.2726 0.0 0
M  V30 12 C 14.6869 6.6062 0.0 0
M  V30 13 C 16.7906 6.0426 0.0 0
M  V30 14 C 16.2269 3.9389 0.0 0
M  V30 15 N 4.7142 5.1289 0.0 0
M  V30 16 C 3.6836 3.9845 0.0 0
M  V30 17 C 6.1210 4.5026 0.0 0
M  V30 18 C 4.4536 2.6508 0.0 0
M  V30 19 C 2.1773 3.6643 0.0 0
M  V30 20 N 5.9600 2.9710 0.0 0
M  V30 21 C 3.4232 1.5063 0.0 0
M  V30 22 N 2.0164 2.1328 0.0 0
M  V30 23 C 7.4546 5.2726 0.0 0
M  V30 24 C 8.7885 4.5026 0.0 0
M  V30 25 C 7.4546 6.8126 0.0 0
M  V30 26 C 10.1221 5.2726 0.0 0
M  V30 27 C 8.7885 7.5826 0.0 0
M  V30 28 C 10.1221 6.8126 0.0 0
M  V30 29 C 2.9293 7.1112 0.0 0
M  V30 30 C 2.6091 8.6177 0.0 0
M  V30 31 C 1.7849 6.0808 0.0 0
M  V30 32 C 1.1444 9.0935 0.0 0
M  V30 33 C 0.3202 6.5567 0.0 0
M  V30 34 C 0.0000 8.0630 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 29
M  V30 3 2 2 19
M  V30 4 2 3 21
M  V30 5 1 4 22
M  V30 6 3 5 6
M  V30 7 1 5 30
M  V30 8 1 7 8
M  V30 9 1 7 26
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 1 16 19
M  V30 20 2 17 20
M  V30 21 1 17 23
M  V30 22 1 18 20
M  V30 23 1 18 21
M  V30 24 1 19 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[3-[1-[(2-cyanophenyl)methyl]-4,5-bis[(methylamino)carbon...
C26H34N6O4
918931-46-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6788 8.0442 0.0 0
M  V30 2 C 2.4369 5.5543 0.0 0
M  V30 3 N 1.5317 4.3084 0.0 0
M  V30 4 O 1.8105 6.9612 0.0 0
M  V30 5 C 0.0000 4.4693 0.0 0
M  V30 6 C 4.1120 2.6527 0.0 0
M  V30 7 N 5.0173 1.4068 0.0 0
M  V30 8 O 2.5805 2.4918 0.0 0
M  V30 9 C 4.3909 0.0000 0.0 0
M  V30 10 C 4.0384 11.0569 0.0 0
M  V30 11 N 5.1828 12.0874 0.0 0
M  V30 12 N 11.7407 5.9114 0.0 0
M  V30 13 C 13.0744 6.6814 0.0 0
M  V30 14 O 14.4080 5.9114 0.0 0
M  V30 15 O 13.0744 8.2214 0.0 0
M  V30 16 C 15.7417 6.6814 0.0 0
M  V30 17 C 14.9717 8.0151 0.0 0
M  V30 18 C 17.0755 7.4514 0.0 0
M  V30 19 C 16.5117 5.3477 0.0 0
M  V30 20 N 4.9989 6.5379 0.0 0
M  V30 21 C 6.4059 5.9114 0.0 0
M  V30 22 C 3.9685 5.3933 0.0 0
M  V30 23 N 6.2448 4.3798 0.0 0
M  V30 24 C 4.7385 4.0597 0.0 0
M  V30 25 C 7.7396 6.6814 0.0 0
M  V30 26 C 9.0732 5.9114 0.0 0
M  V30 27 C 7.7396 8.2214 0.0 0
M  V30 28 C 10.4069 6.6814 0.0 0
M  V30 29 C 9.0732 8.9915 0.0 0
M  V30 30 C 10.4069 8.2214 0.0 0
M  V30 31 C 3.2140 8.5201 0.0 0
M  V30 32 C 2.8939 10.0265 0.0 0
M  V30 33 C 2.0696 7.4896 0.0 0
M  V30 34 C 1.4293 10.5024 0.0 0
M  V30 35 C 0.6049 7.9655 0.0 0
M  V30 36 C 0.2848 9.4719 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 20
M  V30 2 1 1 31
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 22
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 24
M  V30 10 1 7 9
M  V30 11 3 10 11
M  V30 12 1 10 32
M  V30 13 1 12 13
M  V30 14 1 12 28
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 1 21 25
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 918931-32-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 918931-46-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-11598649
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Xanthine mimetics as potent dipeptidyl peptidase IV inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kurukulasuriya, Ravi; Rohde, Jeffrey J.; Szczepankiewicz, Bruce G.;
Basha, Fatima; Lai, Chunqui; Jae, Hwan-Soo; Winn, Martin; Stewart, Kent
D.; Longenecker, Kenton L.; Lubben, Thomas W.; Ballaron, Stephen J.;
Sham, Hing L.; von Geldern, Thomas W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2006), 16(24), 6226-6230

$RFMT $RIREG SCHEME31 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[6-Methyl-5-[[4-[(5R)-5-(2-methylpropyl)-2-oxo-3-(tetrahydro-2H-pyran-4-yl...
C32H44N4O4S
926639-45-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.8391 2.6091 0.0 0
M  V30 2 C 4.8087 1.4645 0.0 0
M  V30 3 C 3.3024 1.7849 0.0 0
M  V30 4 C 5.2845 0.0000 0.0 0
M  V30 5 O 5.8391 8.0301 0.0 0
M  V30 6 C 12.4285 5.3196 0.0 0
M  V30 7 C 15.5085 5.3196 0.0 0
M  V30 8 S 15.5085 10.6544 0.0 0
M  V30 9 C 21.6685 10.6544 0.0 0
M  V30 10 C 22.4385 11.9880 0.0 0
M  V30 11 O 21.6685 13.3217 0.0 0
M  V30 12 O 23.9785 11.9880 0.0 0
M  V30 13 N 6.2684 5.3196 0.0 0
M  V30 14 C 5.3632 4.0736 0.0 0 CFG=2
M  V30 15 C 5.3632 6.5655 0.0 0
M  V30 16 C 3.8987 4.5496 0.0 0
M  V30 17 N 3.8987 6.0897 0.0 0
M  V30 18 C 7.8085 5.3196 0.0 0
M  V30 19 C 8.5785 6.6533 0.0 0
M  V30 20 C 8.5785 3.9858 0.0 0
M  V30 21 C 10.1185 6.6533 0.0 0
M  V30 22 C 10.1185 3.9858 0.0 0
M  V30 23 N 10.8885 5.3196 0.0 0
M  V30 24 C 2.6528 6.9947 0.0 0
M  V30 25 C 2.8137 8.5264 0.0 0
M  V30 26 C 1.2459 6.3684 0.0 0
M  V30 27 C 1.5679 9.4316 0.0 0
M  V30 28 C 0.0000 7.2736 0.0 0
M  V30 29 O 0.1609 8.8051 0.0 0
M  V30 30 C 13.1985 6.6533 0.0 0
M  V30 31 C 14.7385 6.6533 0.0 0
M  V30 32 C 12.4285 7.9869 0.0 0
M  V30 33 N 15.5085 7.9869 0.0 0
M  V30 34 C 13.1985 9.3206 0.0 0
M  V30 35 C 14.7385 9.3206 0.0 0
M  V30 36 C 17.0485 10.6544 0.0 0
M  V30 37 C 17.8185 9.3206 0.0 0
M  V30 38 C 17.8185 11.9880 0.0 0
M  V30 39 C 19.3585 9.3206 0.0 0
M  V30 40 C 19.3585 11.9880 0.0 0
M  V30 41 C 20.1285 10.6544 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 5 15
M  V30 6 1 6 23
M  V30 7 1 6 30
M  V30 8 1 7 31
M  V30 9 1 8 35
M  V30 10 1 8 36
M  V30 11 1 9 10
M  V30 12 1 9 41
M  V30 13 1 10 11
M  V30 14 2 10 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 18
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 16 17
M  V30 21 1 17 24
M  V30 22 1 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 23
M  V30 28 1 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-[[6-methyl-5-[[4-[(5R)-5-(2-methylpropyl)-2-oxo-3-(tetrahydro-2H-p...
C33H47N5O3S
926639-75-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.8391 2.6091 0.0 0
M  V30 2 C 4.8087 1.4645 0.0 0
M  V30 3 C 3.3024 1.7849 0.0 0
M  V30 4 C 5.2845 0.0000 0.0 0
M  V30 5 O 5.8391 8.0301 0.0 0
M  V30 6 C 12.4285 5.3196 0.0 0
M  V30 7 C 15.5085 5.3196 0.0 0
M  V30 8 S 15.5085 10.6544 0.0 0
M  V30 9 C 21.6685 10.6544 0.0 0
M  V30 10 C 22.4385 11.9880 0.0 0
M  V30 11 N 23.9785 11.9880 0.0 0
M  V30 12 O 21.6685 13.3217 0.0 0
M  V30 13 C 24.7485 13.3217 0.0 0
M  V30 14 N 6.2684 5.3196 0.0 0
M  V30 15 C 5.3632 4.0736 0.0 0 CFG=2
M  V30 16 C 5.3632 6.5655 0.0 0
M  V30 17 C 3.8987 4.5496 0.0 0
M  V30 18 N 3.8987 6.0897 0.0 0
M  V30 19 C 7.8085 5.3196 0.0 0
M  V30 20 C 8.5785 3.9858 0.0 0
M  V30 21 C 8.5785 6.6533 0.0 0
M  V30 22 C 10.1185 3.9858 0.0 0
M  V30 23 C 10.1185 6.6533 0.0 0
M  V30 24 N 10.8885 5.3196 0.0 0
M  V30 25 C 2.6528 6.9947 0.0 0
M  V30 26 C 1.2459 6.3684 0.0 0
M  V30 27 C 2.8137 8.5264 0.0 0
M  V30 28 C 0.0000 7.2736 0.0 0
M  V30 29 C 1.5679 9.4316 0.0 0
M  V30 30 O 0.1609 8.8051 0.0 0
M  V30 31 C 13.1985 6.6533 0.0 0
M  V30 32 C 14.7385 6.6533 0.0 0
M  V30 33 C 12.4285 7.9869 0.0 0
M  V30 34 N 15.5085 7.9869 0.0 0
M  V30 35 C 13.1985 9.3206 0.0 0
M  V30 36 C 14.7385 9.3206 0.0 0
M  V30 37 C 17.0485 10.6544 0.0 0
M  V30 38 C 17.8185 9.3206 0.0 0
M  V30 39 C 17.8185 11.9880 0.0 0
M  V30 40 C 19.3585 9.3206 0.0 0
M  V30 41 C 19.3585 11.9880 0.0 0
M  V30 42 C 20.1285 10.6544 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 5 16
M  V30 6 1 6 24
M  V30 7 1 6 31
M  V30 8 1 7 32
M  V30 9 1 8 36
M  V30 10 1 8 37
M  V30 11 1 9 10
M  V30 12 1 9 42
M  V30 13 1 10 11
M  V30 14 2 10 12
M  V30 15 1 11 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 19
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 22 1 18 25
M  V30 23 1 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 24
M  V30 29 1 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 41 2 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 2 39 41
M  V30 45 2 40 42
M  V30 46 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 926639-45-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 926639-75-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11810481
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General/Typical Procedure: General Procedure
E: EDCI coupling. To a stirred solution of a primary or secondary amine
(1 equivalent), a carboxylic acid (1.1-2.0 equivalents),
1-hydroxy-benzotriazole hydrate (HOBT) (1.1-2.0 equivalents) and
diisopropylethylamine (DIPEA) or N-methylmorpholine (NMM) (1.5-3
equivalents) in CH2Cl2 or DMF (concentration ∼0.05-1.5M) was added
1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (EDCI)
(1.1-2.0 equivalents). The solution was stirred at room temperature for
1-3 days and concentrated in vacuo. In a standard work-up, the mixture
was diluted with CH2Cl2 or EtOAc and washed consecutively with saturated
aqueous NaHCO3 and brine. The organic layer was dried (Na2SO4 or MgSO4),
filtered and concentrated under reduced pressure. The crude material was
purified by flash column chromatography or by radial chromatography on
silica gel. COMPOUND 14:
4-[4-(R)-3-Cyclohexyl-2-oxo-5-phenyl-imidazolidin-1-yl)-piperidin-1-ylmethyl]-N-cydopentyl-benzamide
COMPOUND 326:
2-{4-(5-{4-[(R)-5-Isobutyl-2-oxo-3-(tetrahydro-pyran-4-yl)-imidazolidin-1-yl]-piperidin-1-ylmethyl}-6-methyl-pyridin-
2-ylsulfanyl)-phenyl]-N-methyl-acetamide. Following general procedure
E:[4-(5-{4-[(R)-5-isobutyl-2-oxo-3-(tetrahydro-
pyran-4-yl)-imidazolidin-1-yl]-piperidin-1-ylmethyl}-6-methyl-pyridin-2-ylsulfanyl)-phenyl]-
acetic acid (COMPOUND 296) gave COMPOUND 326 as a white foam (40 mg,
90%). 1H NMR (CDCl3) δ 0.94 (t, 6H, J= 6.3 Hz), 1.61-1.76 (m, 10H),
2.01-2.11 (m, 3H), 2.53 (s, 3H), 2.80 (d, 3H, J= 4.8 Hz), 2.85-2.90 (m,
3H), 3.32-3.50 (m, 6H), 3.57-3.60 (m, 4H), 3.91-4.02 (m, 3H), 6.72 (d,
1H, J= 8.1 Hz), 7.30 (d, 2H, J= 8.1 Hz), 7.38 (d, 1H, J= 8.4 Hz), 7.56
(d, 2H, J= 8.1 Hz).
$DTYPE RXN:VAR(1):NOTES
$DATUM N-methylmorpholine and DMF can also be used as reagent and solvent
respectively
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted imidazolidinones and related compounds as chemokine receptor
binding compounds and their preparation, pharmaceutical compositions and
use in the treatment of infection of target cells by human
immunodeficiency virus
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Yuanxi; Bourque, Elyse; Zhu, Yongbao; McEachern, Ernest J.; Harwig,
Curtis; Skerlj, Renato T.; Bridger, Gary J.; Li, Tong-Shuang; Metz,
Markus
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007022371 A2 2007-02-22

$RFMT $RIREG SCHEME32 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxybenzeneacetonitrile
C10H11NO2
93-17-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3347 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 3.0800 0.0000 0.0 0
M  V30 5 C 5.3900 6.6685 0.0 0
M  V30 6 C 6.9300 6.6685 0.0 0
M  V30 7 N 8.4700 6.6685 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 3.0800 5.3347 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 4.6200 5.3347 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 3 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylhomoveratrylamine
C11H17NO2
3490-06-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3348 0.0 0
M  V30 5 C 6.9301 4.0011 0.0 0
M  V30 6 C 7.7001 5.3348 0.0 0
M  V30 7 N 9.2401 5.3348 0.0 0
M  V30 8 C 10.0101 6.6686 0.0 0
M  V30 9 C 3.0800 2.6675 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 4.6201 2.6675 0.0 0
M  V30 12 C 3.0800 5.3348 0.0 0
M  V30 13 C 5.3901 4.0011 0.0 0
M  V30 14 C 4.6201 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 93-17-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3490-06-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32794909
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 22031-12-5
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 60871-84-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-89-8
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nickel-catalyzed hydrogenative coupling of nitriles and amines for
general amine synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chandrashekhar, Vishwas G.; Baumann, Wolfgang; Beller, Matthias;
Jagadeesh, Rajenahally V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Science (Washington, DC, United States) (2022), 376(6600), 1433-1441

$RFMT $RIREG SCHEME33 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5R,8S)-5-[(1S)-1,5-Dimethyl-4-hexen-1-yl]-5,6,7,8-tetrahydro-2-methoxy-3,8-d...
C21H30O3
934500-97-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.3772 4.5278 0.0 0 CFG=1
M  V30 2 C 9.5569 3.5379 0.0 0
M  V30 3 C 8.6446 6.0444 0.0 0
M  V30 4 C 11.0040 4.0647 0.0 0
M  V30 5 C 12.1838 3.0748 0.0 0
M  V30 6 C 13.6310 3.6015 0.0 0
M  V30 7 C 13.8983 5.1181 0.0 0
M  V30 8 C 14.8106 2.6116 0.0 0
M  V30 9 O 5.3900 6.6686 0.0 0
M  V30 10 O 2.3100 1.3338 0.0 0
M  V30 11 C 4.6200 0.0000 0.0 0
M  V30 12 C 2.3100 6.6686 0.0 0
M  V30 13 O 0.7700 4.0011 0.0 0
M  V30 14 C 0.0000 5.3348 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 4.6200 2.6675 0.0 0
M  V30 17 C 6.9301 4.0011 0.0 0 CFG=1
M  V30 18 C 4.6200 5.3348 0.0 0
M  V30 19 C 3.0800 2.6675 0.0 0
M  V30 20 C 5.3900 1.3338 0.0 0 CFG=1
M  V30 21 C 7.7001 2.6675 0.0 0
M  V30 22 C 3.0800 5.3348 0.0 0
M  V30 23 C 2.3100 4.0011 0.0 0
M  V30 24 C 6.9301 1.3338 0.0 0
M  V30 25 H 6.6626 5.5177 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 9 18
M  V30 10 2 10 19
M  V30 11 1 20 11 CFG=3
M  V30 12 1 12 22
M  V30 13 1 13 14
M  V30 14 1 13 23
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 17 25 CFG=3
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 24
M  V30 26 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 17 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(5R,8S)-5-[(1S)-1,5-Dimethyl-4-hexen-1-yl]-5,6,7,8-tetrahydro-3,8-dimethyl-2-...
C21H31NO2
934501-02-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.3772 4.5278 0.0 0 CFG=1
M  V30 2 C 9.5569 3.5379 0.0 0
M  V30 3 C 8.6446 6.0444 0.0 0
M  V30 4 C 11.0040 4.0647 0.0 0
M  V30 5 C 12.1838 3.0748 0.0 0
M  V30 6 C 13.6310 3.6015 0.0 0
M  V30 7 C 13.8983 5.1181 0.0 0
M  V30 8 C 14.8106 2.6116 0.0 0
M  V30 9 O 5.3900 6.6686 0.0 0
M  V30 10 O 2.3100 1.3338 0.0 0
M  V30 11 C 4.6200 0.0000 0.0 0
M  V30 12 C 2.3100 6.6686 0.0 0
M  V30 13 N 0.7700 4.0011 0.0 0
M  V30 14 C 0.0000 5.3348 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 4.6200 2.6675 0.0 0
M  V30 17 C 6.9301 4.0011 0.0 0 CFG=1
M  V30 18 C 4.6200 5.3348 0.0 0
M  V30 19 C 3.0800 2.6675 0.0 0
M  V30 20 C 5.3900 1.3338 0.0 0 CFG=1
M  V30 21 C 7.7001 2.6675 0.0 0
M  V30 22 C 3.0800 5.3348 0.0 0
M  V30 23 C 2.3100 4.0011 0.0 0
M  V30 24 C 6.9301 1.3338 0.0 0
M  V30 25 H 6.6626 5.5177 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 9 18
M  V30 10 2 10 19
M  V30 11 1 20 11 CFG=3
M  V30 12 1 12 22
M  V30 13 1 13 14
M  V30 14 1 13 23
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 17 25 CFG=3
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 24
M  V30 26 2 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 17 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 934500-97-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 934501-02-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-1771762
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (5S,8R)-5,6,7,8-Tetrahydro-2,5-dimethyl-3-(methylamino)-8-
((S)-6-methylhept-5-en-2-yl)naphthalene-1,4-dione (20). To a solution of
dione 8 (40 mg, 0.121 mmol) in EtOH (5 mL) at 23 °C under argon was added
MeNH2 (1.21 mL, 2.42 mmol, 2.0 M solution in THF, 20.0 equiv). The yellow
solution was stirred at rt for 20 h and then concentrated. Purification
by pipet column on silica gel (eluting with 1/7 to 1/3 ether/pentane)
gave 20 (36 mg, 90% yield) as a red oil: red oil: R f 0.32 (1/5
ether/pentane); 1H NMR (500 MHz, CDCl3) δ 5.49 (br s, NH, 1H), 5.12 (br
t, J = 7.0 Hz, 1H), 3.14 (s, 3H), 2.93-2.85 (m, 2H), 2.11 (s, 3H),
2.08-1.94 (m, 2H), 1.88 (m, 1H), 1.78 (m, 1H), 1.72 (m, 1H), 1.69 (s,
3H), 1.61 (m, 1H), 1.60 (s, 3H), 1.41 (m, 1H), 1.34 (m, 1H), 1.26 (m,
1H), 1.05 (d, J = 7.0 Hz, 3H), 0.80 (d, J = 7.0 Hz, 3H); 13C NMR (75 MHz,
CDCl3) δ 186.5, 184.1, 148.3, 144.7, 142.8, 131.1, 124.8, 108.6, 36.9,
36.0, 35.7, 32.7, 26.4, 26.3, 26.2, 25.7, 20.8, 18.3, 17.7, 17.5, 10.3;
IR (neat) 2929, 1641, 1592, 1512, 1253 cm-1; HRMS (ESI) calcd for
C21H31NO2Na [M + Na]+, required m/z 352.2247, found 352.2249.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthetic and Isolation Studies Related to the Marine Natural Products
(+)-Elisabethadione and (+)-Elisabethamine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dai, Xing; Wan, Zhongliang; Kerr, Russell G.; Davies, Huw M. L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2007), 72(6), 1895-1900

$RFMT $RIREG SCHEME34 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[4-Chloro-6-[4-(methylsulfonyl)phenyl]-2-(trifluoromethyl)-5-pyrimidinyl]be...
C18H11Cl2F3N2O4S2
944245-28-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 7.7000 10.6694 0.0 0
M  V30 2 C 12.3200 8.0021 0.0 0
M  V30 3 F 12.3200 6.4621 0.0 0
M  V30 4 F 13.8600 8.0021 0.0 0
M  V30 5 F 12.3200 9.5421 0.0 0
M  V30 6 S 5.3900 1.3336 0.0 0 VAL=6
M  V30 7 C 4.6200 0.0000 0.0 0
M  V30 8 O 4.0564 2.1036 0.0 0
M  V30 9 O 6.7236 0.5636 0.0 0
M  V30 10 S 1.5400 8.0021 0.0 0 VAL=6
M  V30 11 Cl 0.0000 8.0021 0.0 0
M  V30 12 O 1.5400 9.5421 0.0 0
M  V30 13 O 1.5400 6.4621 0.0 0
M  V30 14 C 8.4700 6.6684 0.0 0
M  V30 15 C 7.7000 8.0021 0.0 0
M  V30 16 N 10.0100 6.6684 0.0 0
M  V30 17 C 8.4700 9.3358 0.0 0
M  V30 18 C 10.7800 8.0021 0.0 0
M  V30 19 N 10.0100 9.3358 0.0 0
M  V30 20 C 7.7000 5.3347 0.0 0
M  V30 21 C 6.1600 5.3347 0.0 0
M  V30 22 C 8.4700 4.0011 0.0 0
M  V30 23 C 5.3900 4.0011 0.0 0
M  V30 24 C 7.7000 2.6673 0.0 0
M  V30 25 C 6.1600 2.6673 0.0 0
M  V30 26 C 6.1600 8.0021 0.0 0
M  V30 27 C 5.3900 6.6684 0.0 0
M  V30 28 C 5.3900 9.3358 0.0 0
M  V30 29 C 3.8500 6.6684 0.0 0
M  V30 30 C 3.8500 9.3358 0.0 0
M  V30 31 C 3.0800 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 18
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 6 9
M  V30 9 1 6 25
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 10 13
M  V30 13 1 10 31
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 20
M  V30 17 2 15 17
M  V30 18 1 15 26
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[4-Chloro-6-[4-(methylsulfonyl)phenyl]-2-(trifluoromethyl)-5-pyrimidinyl]-N...
C19H15ClF3N3O4S2
944245-29-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 8.4700 10.6694 0.0 0
M  V30 2 C 13.0900 8.0021 0.0 0
M  V30 3 F 13.0900 6.4621 0.0 0
M  V30 4 F 14.6300 8.0021 0.0 0
M  V30 5 F 13.0900 9.5421 0.0 0
M  V30 6 S 2.3100 8.0021 0.0 0 VAL=6
M  V30 7 N 0.7700 8.0021 0.0 0
M  V30 8 O 2.3100 9.5421 0.0 0
M  V30 9 O 2.3100 6.4621 0.0 0
M  V30 10 C 0.0000 9.3358 0.0 0
M  V30 11 S 6.1600 1.3336 0.0 0 VAL=6
M  V30 12 C 5.3900 0.0000 0.0 0
M  V30 13 O 7.4936 0.5636 0.0 0
M  V30 14 O 4.8264 2.1036 0.0 0
M  V30 15 C 8.4700 8.0021 0.0 0
M  V30 16 C 9.2400 6.6684 0.0 0
M  V30 17 C 9.2400 9.3358 0.0 0
M  V30 18 N 10.7800 6.6684 0.0 0
M  V30 19 N 10.7800 9.3358 0.0 0
M  V30 20 C 11.5500 8.0021 0.0 0
M  V30 21 C 6.9300 8.0021 0.0 0
M  V30 22 C 6.1600 6.6684 0.0 0
M  V30 23 C 6.1600 9.3358 0.0 0
M  V30 24 C 4.6200 6.6684 0.0 0
M  V30 25 C 4.6200 9.3358 0.0 0
M  V30 26 C 3.8500 8.0021 0.0 0
M  V30 27 C 8.4700 5.3347 0.0 0
M  V30 28 C 6.9300 5.3347 0.0 0
M  V30 29 C 9.2400 4.0011 0.0 0
M  V30 30 C 6.1600 4.0011 0.0 0
M  V30 31 C 8.4700 2.6674 0.0 0
M  V30 32 C 6.9300 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 20
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 6 9
M  V30 9 1 6 26
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 2 11 14
M  V30 14 1 11 32
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 21
M  V30 18 2 16 18
M  V30 19 1 16 27
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 944245-28-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 944245-29-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-8265584
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of
4-{4-chloro-6-[4-(methylsulfonyl)phenyl]-2-(trifluoromethyl)pyrimidin-5-yl}-N-methylbenzenesulfonamide
To a solution of
4-{4-chloro-6-[4-(methylsulfonyl)phenyl]-2-(trifluoromethyl)pyrimidin-5-yl}benzenesulfonyl
chloride (0.5 g, 0.98 mmol, prepared according to the procedure described
for example 3) in dichloromethane (5 ml) was added methylamine solution
(0.08 ml, 0.98 mmol, 40% aqueous solution) under stirring at 0-10 °C.
After 15 minutes of the stirring, TLC confirmed the completion of the
reaction. Subsequently the solvent was distilled off under reduced
pressure and the solid thus obtained was filtered, washed thoroughly with
cold water. (0.446 g, yield 90.1%, purity by HPLC 98.1%). M.p: 226-230°C.
1H-NMR (400 MHz, DMSO-d6) δ: 2.09-2.10 (d, 3H), 3.1 (s, 3H), 7.43-7.44
(m, 1H, D2O exchangeable), 7.54-7.56 (d, 2H), 7.69-7.81 (m, 4H),
7.86-7.88 (d, 2H). IR (KBr) cm-1: 3335, 1562 and 1530; MS m/z:
506.1(M++1).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel heterocycles as PDE4 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reddy, Gaddam Om; Srinivas, Akella Satya Surya Visweswara; Tadiparthi,
Ravikumar; Sharma, Ganapavarapu Veera Raghava; Sappanimuthu,
Thirunavukkarasu; Bhakiaraj, Durairaj Peter; Kachhadia, Virendra;
Narasimhan, Kilambi; Thara, Sathya Narayana; Rajagopal, Sriram;
Narayanan, Sukunath; Parameswaran, Venkatesan; Janarthanam, Venkatesan;
Narayanam, Maruthikumar; Gadde, Sathyanarayana; Ramachandran, Uma;
Balasubramanian, Gopalan; Surendran, Narayanan; Narayanan, Shridhar;
Vishwakarma, Lolaknath Santosh; Saxena, Sanjeev
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009095773 A2 2009-08-06

$RFMT $RIREG SCHEME34 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[4-Chloro-6-[4-(methylsulfonyl)phenyl]-2-(trifluoromethyl)-5-pyrimidinyl]be...
C18H11Cl2F3N2O4S2
944245-28-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 7.7000 10.6694 0.0 0
M  V30 2 C 12.3200 8.0021 0.0 0
M  V30 3 F 12.3200 6.4621 0.0 0
M  V30 4 F 13.8600 8.0021 0.0 0
M  V30 5 F 12.3200 9.5421 0.0 0
M  V30 6 S 5.3900 1.3336 0.0 0 VAL=6
M  V30 7 C 4.6200 0.0000 0.0 0
M  V30 8 O 4.0564 2.1036 0.0 0
M  V30 9 O 6.7236 0.5636 0.0 0
M  V30 10 S 1.5400 8.0021 0.0 0 VAL=6
M  V30 11 Cl 0.0000 8.0021 0.0 0
M  V30 12 O 1.5400 9.5421 0.0 0
M  V30 13 O 1.5400 6.4621 0.0 0
M  V30 14 C 8.4700 6.6684 0.0 0
M  V30 15 C 7.7000 8.0021 0.0 0
M  V30 16 N 10.0100 6.6684 0.0 0
M  V30 17 C 8.4700 9.3358 0.0 0
M  V30 18 C 10.7800 8.0021 0.0 0
M  V30 19 N 10.0100 9.3358 0.0 0
M  V30 20 C 7.7000 5.3347 0.0 0
M  V30 21 C 6.1600 5.3347 0.0 0
M  V30 22 C 8.4700 4.0011 0.0 0
M  V30 23 C 5.3900 4.0011 0.0 0
M  V30 24 C 7.7000 2.6673 0.0 0
M  V30 25 C 6.1600 2.6673 0.0 0
M  V30 26 C 6.1600 8.0021 0.0 0
M  V30 27 C 5.3900 6.6684 0.0 0
M  V30 28 C 5.3900 9.3358 0.0 0
M  V30 29 C 3.8500 6.6684 0.0 0
M  V30 30 C 3.8500 9.3358 0.0 0
M  V30 31 C 3.0800 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 18
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 6 9
M  V30 9 1 6 25
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 10 13
M  V30 13 1 10 31
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 20
M  V30 17 2 15 17
M  V30 18 1 15 26
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[4-Chloro-6-[4-(methylsulfonyl)phenyl]-2-(trifluoromethyl)-5-pyrimidinyl]-N...
C19H15ClF3N3O4S2
944245-29-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 8.4700 10.6694 0.0 0
M  V30 2 C 13.0900 8.0021 0.0 0
M  V30 3 F 13.0900 6.4621 0.0 0
M  V30 4 F 14.6300 8.0021 0.0 0
M  V30 5 F 13.0900 9.5421 0.0 0
M  V30 6 S 2.3100 8.0021 0.0 0 VAL=6
M  V30 7 N 0.7700 8.0021 0.0 0
M  V30 8 O 2.3100 9.5421 0.0 0
M  V30 9 O 2.3100 6.4621 0.0 0
M  V30 10 C 0.0000 9.3358 0.0 0
M  V30 11 S 6.1600 1.3336 0.0 0 VAL=6
M  V30 12 C 5.3900 0.0000 0.0 0
M  V30 13 O 7.4936 0.5636 0.0 0
M  V30 14 O 4.8264 2.1036 0.0 0
M  V30 15 C 8.4700 8.0021 0.0 0
M  V30 16 C 9.2400 6.6684 0.0 0
M  V30 17 C 9.2400 9.3358 0.0 0
M  V30 18 N 10.7800 6.6684 0.0 0
M  V30 19 N 10.7800 9.3358 0.0 0
M  V30 20 C 11.5500 8.0021 0.0 0
M  V30 21 C 6.9300 8.0021 0.0 0
M  V30 22 C 6.1600 6.6684 0.0 0
M  V30 23 C 6.1600 9.3358 0.0 0
M  V30 24 C 4.6200 6.6684 0.0 0
M  V30 25 C 4.6200 9.3358 0.0 0
M  V30 26 C 3.8500 8.0021 0.0 0
M  V30 27 C 8.4700 5.3347 0.0 0
M  V30 28 C 6.9300 5.3347 0.0 0
M  V30 29 C 9.2400 4.0011 0.0 0
M  V30 30 C 6.1600 4.0011 0.0 0
M  V30 31 C 8.4700 2.6674 0.0 0
M  V30 32 C 6.9300 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 20
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 6 9
M  V30 9 1 6 26
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 2 11 14
M  V30 14 1 11 32
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 21
M  V30 18 2 16 18
M  V30 19 1 16 27
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 944245-28-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 944245-29-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-8604062
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: EXAMPLE 4. Synthesis of
4-{4-chloro-6-[4-(methylsulfonyl)phenyl]-2-(trifluoromethyl)pyrimidin-5-yl}-N-methyl-benzene
sulfonamide. To a solution of
4-{4-chloro-6-[4-(methylsulfonyl)phenyl]-2-(trifluoromethyl)pyrimidin-5-yl}benzenesulfonyl
chloride (0.5 g, 0.98 mmol, prepared according to the procedure described
for example 3) in dichloromethane (5 ml) was added methylamine solution
(0.08 ml, 0.98 mmol, 40% aqueous solution) under stirring at 0-10°C.
After 15 minutes of the stirring, TLC confirmed the completion of the
reaction. Subsequently the solvent was distilled off under reduced
pressure and the solid thus obtained was filtered, washed thoroughly with
cold water.
4-{4-chloro-6-[4-(methylsulfonyl)phenyl]-2-(trifluoromethyl)pyrimidin-5-yl}-N-methyl-benzene
sulfonamide, (0.446 g, yield 90.1%, purity by HPLC 98.1 %). m.p:
226-230°C. 1H-NMR (400 MHz, DMSO-d6) δ: 2.09-2.10 (d, 3H), 3.1 (s, 3H),
7.43-7.44 (m, 1H, D2O exchangeable), 7.54-7.56 (d, 2H), 7.69-7.81 (m,
4H), 7.86-7.88 (d, 2H). IR (KBr) cm-1: 3335, 1562, and 1530. MS m/z:
506.1(M++1).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine derivatives as inhibitors of cytokines for the
treatment of immunological and other diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srinivas, Akella Satya Surya Visweswara; Tadiparthi, Ravikumar; Sharma,
Ganapavarapu Veera Raghava; Thirunavukkarasu, Sappanimuthu; Bhakiaraj,
Durairaj Peter; Kachhadia, Virendra; Narsimhan, Kilambi; Thara, Sathya
Narayana; Rajagopal, Sriram; Reddy, Gaddam Om; Narayanan, Sukunath;
Parameswaran, Venkatesan; Janarthanam, Venkatesan; Narayanam,
Maruthikumar; Gadde, Sathyanarayana; Ramachandran, Uma
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20080207606 A1 2008-08-28

$RFMT $RIREG SCHEME34 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[4-Chloro-6-[4-(methylsulfonyl)phenyl]-2-(trifluoromethyl)-5-pyrimidinyl]be...
C18H11Cl2F3N2O4S2
944245-28-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 7.7000 10.6694 0.0 0
M  V30 2 C 12.3200 8.0021 0.0 0
M  V30 3 F 12.3200 6.4621 0.0 0
M  V30 4 F 13.8600 8.0021 0.0 0
M  V30 5 F 12.3200 9.5421 0.0 0
M  V30 6 S 5.3900 1.3336 0.0 0 VAL=6
M  V30 7 C 4.6200 0.0000 0.0 0
M  V30 8 O 4.0564 2.1036 0.0 0
M  V30 9 O 6.7236 0.5636 0.0 0
M  V30 10 S 1.5400 8.0021 0.0 0 VAL=6
M  V30 11 Cl 0.0000 8.0021 0.0 0
M  V30 12 O 1.5400 9.5421 0.0 0
M  V30 13 O 1.5400 6.4621 0.0 0
M  V30 14 C 8.4700 6.6684 0.0 0
M  V30 15 C 7.7000 8.0021 0.0 0
M  V30 16 N 10.0100 6.6684 0.0 0
M  V30 17 C 8.4700 9.3358 0.0 0
M  V30 18 C 10.7800 8.0021 0.0 0
M  V30 19 N 10.0100 9.3358 0.0 0
M  V30 20 C 7.7000 5.3347 0.0 0
M  V30 21 C 6.1600 5.3347 0.0 0
M  V30 22 C 8.4700 4.0011 0.0 0
M  V30 23 C 5.3900 4.0011 0.0 0
M  V30 24 C 7.7000 2.6673 0.0 0
M  V30 25 C 6.1600 2.6673 0.0 0
M  V30 26 C 6.1600 8.0021 0.0 0
M  V30 27 C 5.3900 6.6684 0.0 0
M  V30 28 C 5.3900 9.3358 0.0 0
M  V30 29 C 3.8500 6.6684 0.0 0
M  V30 30 C 3.8500 9.3358 0.0 0
M  V30 31 C 3.0800 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 18
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 6 9
M  V30 9 1 6 25
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 10 13
M  V30 13 1 10 31
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 20
M  V30 17 2 15 17
M  V30 18 1 15 26
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[4-Chloro-6-[4-(methylsulfonyl)phenyl]-2-(trifluoromethyl)-5-pyrimidinyl]-N...
C19H15ClF3N3O4S2
944245-29-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 8.4700 10.6694 0.0 0
M  V30 2 C 13.0900 8.0021 0.0 0
M  V30 3 F 13.0900 6.4621 0.0 0
M  V30 4 F 14.6300 8.0021 0.0 0
M  V30 5 F 13.0900 9.5421 0.0 0
M  V30 6 S 2.3100 8.0021 0.0 0 VAL=6
M  V30 7 N 0.7700 8.0021 0.0 0
M  V30 8 O 2.3100 9.5421 0.0 0
M  V30 9 O 2.3100 6.4621 0.0 0
M  V30 10 C 0.0000 9.3358 0.0 0
M  V30 11 S 6.1600 1.3336 0.0 0 VAL=6
M  V30 12 C 5.3900 0.0000 0.0 0
M  V30 13 O 7.4936 0.5636 0.0 0
M  V30 14 O 4.8264 2.1036 0.0 0
M  V30 15 C 8.4700 8.0021 0.0 0
M  V30 16 C 9.2400 6.6684 0.0 0
M  V30 17 C 9.2400 9.3358 0.0 0
M  V30 18 N 10.7800 6.6684 0.0 0
M  V30 19 N 10.7800 9.3358 0.0 0
M  V30 20 C 11.5500 8.0021 0.0 0
M  V30 21 C 6.9300 8.0021 0.0 0
M  V30 22 C 6.1600 6.6684 0.0 0
M  V30 23 C 6.1600 9.3358 0.0 0
M  V30 24 C 4.6200 6.6684 0.0 0
M  V30 25 C 4.6200 9.3358 0.0 0
M  V30 26 C 3.8500 8.0021 0.0 0
M  V30 27 C 8.4700 5.3347 0.0 0
M  V30 28 C 6.9300 5.3347 0.0 0
M  V30 29 C 9.2400 4.0011 0.0 0
M  V30 30 C 6.1600 4.0011 0.0 0
M  V30 31 C 8.4700 2.6674 0.0 0
M  V30 32 C 6.9300 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 20
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 6 9
M  V30 9 1 6 26
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 2 11 14
M  V30 14 1 11 32
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 21
M  V30 18 2 16 18
M  V30 19 1 16 27
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 944245-28-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 944245-29-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-6978989
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: EXAMPLE 4. Synthesis of
4-{4-chloro-6-[4-(methylsulfonyl)phenyl]-2-(trifluoromethyl)pyrimidin-5-yl}-N-methyl-benzene
sulfonamide. To a solution of
4-{4-chloro-6-[4-(methylsulfonyl)phenyl]-2-(trifluoromethyl)pyrimidin-5-yl}benzenesulfonylchloride
(0.5 g, 0.98 mmol, prepared according to theprocedure described for
Example 3) in dichloromethane (5 ml) was added methylamine solution (0.08
ml, 0.98 mmol, 40% aqueous solution) under stirring at 0-10°C. After 15
minutes of the stirring, TLC confirmed the completion of the reaction.
The solvent was distilled off under reduced pressure and the solid thus
obtained was filtered, washed thoroughly with cold water to yield the
title compound.
4-{4-chloro-6-[4-(methylsulfonyl)phenyl]-2-(trifluoromethyl)pyrimidin-5-yl}-N-methyl-benzene
sulfonamide (0.446 g, yield 90.1%, purity by HPLC 98.1%). M.p: 226-230°C.
1H-NMR (400 MHz, DMSO-d6) δ 2.09-2.10 (d, 3H), 3.1 (s, 3H), 7.43-7.44
(m,1H, D2O exchangeable), 7.54-7.56 (d, 2H), 7.69-7.81 (m, 4H), 7.86-7.88
(d, 2H). IR (KBr) cm-1: 3335, 1562, and 1530. MS m/z: 506.1 (M++1).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine derivatives as inhibitors of cytokines for the
treatment of immunological and other diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srinivas, Akella Satya Surya Visweswara; Tadiparthi, Ravikumar; Sharma,
Ganapavarapu Veera Raghava; Thirunavukkarasu, Sappanimuthu; Bhakiaraj,
Durairaj Peter; Kachhadia, Virendra; Narsimhan, Kilambi; Thara, Sathya
Narayana; Rajagopal, Sriram; Reddy, Gaddam Om; Narayanan, Sukunath;
Parameswaran, Venkatesan; Janarthanam, Venkatesan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20070167413 A1 2007-07-19

$RFMT $RIREG SCHEME35 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-4-(4-fluoro-3-methylphenyl)-2-(methylthio)thieno[2,3-d]pyrimidine-6-c...
C15H12FN3O2S2
945001-16-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.8704 7.9855 0.0 0
M  V30 2 C 9.9310 6.6228 0.0 0
M  V30 3 O 11.2648 5.8528 0.0 0
M  V30 4 O 9.9310 8.1628 0.0 0
M  V30 5 S 3.8500 1.3336 0.0 0
M  V30 6 C 4.6200 0.0000 0.0 0
M  V30 7 C 0.0000 8.0021 0.0 0
M  V30 8 F 1.5400 10.6694 0.0 0
M  V30 9 C 6.1600 5.3347 0.0 0
M  V30 10 C 4.6200 5.3347 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 7.1906 6.4791 0.0 0
M  V30 13 N 3.8500 4.0011 0.0 0
M  V30 14 S 8.4364 4.3212 0.0 0
M  V30 15 N 6.1600 2.6673 0.0 0
M  V30 16 C 8.5974 5.8528 0.0 0
M  V30 17 C 4.6200 2.6673 0.0 0
M  V30 18 C 3.8500 6.6684 0.0 0
M  V30 19 C 2.3100 6.6684 0.0 0
M  V30 20 C 4.6200 8.0021 0.0 0
M  V30 21 C 1.5400 8.0021 0.0 0
M  V30 22 C 3.8500 9.3358 0.0 0
M  V30 23 C 2.3100 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 16
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 7 21
M  V30 8 1 8 23
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 18
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Amino-4-(4-fluoro-3-methylphenyl)-N-methyl-2-(methylthio)thieno[2,3-d]pyrim...
C16H15FN4OS2
945001-17-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.8702 7.9855 0.0 0
M  V30 2 C 9.9310 6.6228 0.0 0
M  V30 3 N 11.2648 5.8528 0.0 0
M  V30 4 O 9.9310 8.1628 0.0 0
M  V30 5 C 12.5984 6.6228 0.0 0
M  V30 6 S 3.8500 1.3336 0.0 0
M  V30 7 C 4.6200 0.0000 0.0 0
M  V30 8 C 0.0000 8.0021 0.0 0
M  V30 9 F 1.5400 10.6694 0.0 0
M  V30 10 C 6.1600 5.3347 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 C 6.9300 4.0011 0.0 0
M  V30 13 C 7.1906 6.4791 0.0 0
M  V30 14 N 3.8500 4.0011 0.0 0
M  V30 15 S 8.4364 4.3212 0.0 0
M  V30 16 N 6.1600 2.6673 0.0 0
M  V30 17 C 8.5974 5.8528 0.0 0
M  V30 18 C 4.6200 2.6673 0.0 0
M  V30 19 C 3.8500 6.6684 0.0 0
M  V30 20 C 2.3100 6.6684 0.0 0
M  V30 21 C 4.6200 8.0021 0.0 0
M  V30 22 C 1.5400 8.0021 0.0 0
M  V30 23 C 3.8500 9.3358 0.0 0
M  V30 24 C 2.3100 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 17
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 18
M  V30 8 1 8 22
M  V30 9 1 9 24
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 19
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 2 14 18
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 945001-16-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 945001-17-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1190712
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step g:
5-Amino-4-(4-fluoro-3-methyl-phenyl)-2-methylsulfanyl-thieno[2,3-d]pyrimidine-6-carboxylic
acid methylamide. The title compound was prepared from
5-Amino-4-(4-fluoro-3-methyl-phenyl)-2-methylsulfanyl-thieno[2,3-d]pyrimidine-6-carboxylic
acid (0.16g, 0.45mmol) and Methylamine (2M in THF, 2mL) using standard
coupling conditions (HOBT/EDAC). The crude reaction mixture was treated
with water and extracted with ethyl ether to yield the title compound
(0.15g, 90% yield). LC-MS: MH+ = 363.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thieno[2,3-d]pyrimidines as inhibitors of TNFα, PDE4 and
B-raf, their compositions and use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McKenna, Jeffrey; Papa, Patrick W.; Sakata, Steven T.; Erdman, Paul E.;
Packard, Garrick K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007084560 A2 2007-07-26

$RFMT $RIREG SCHEME36 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[3-(4-Fluorophenyl)-1-(2-furanylcarbonyl)-3-oxopropyl]benzoic acid
C21H15FO5
945375-39-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.1618 0.0 0
M  V30 2 C 6.6685 2.6218 0.0 0
M  V30 3 C 5.3348 4.9318 0.0 0
M  V30 4 O 8.0022 1.8517 0.0 0
M  V30 5 C 5.3348 6.4718 0.0 0
M  V30 6 O 6.6685 7.2419 0.0 0
M  V30 7 C 12.0033 7.2419 0.0 0
M  V30 8 O 12.0033 8.7819 0.0 0
M  V30 9 O 13.3370 6.4718 0.0 0
M  V30 10 F 0.0000 9.5519 0.0 0
M  V30 11 C 8.0022 4.9318 0.0 0
M  V30 12 C 9.3360 4.1618 0.0 0
M  V30 13 C 8.0022 6.4718 0.0 0
M  V30 14 C 10.6697 4.9318 0.0 0
M  V30 15 C 9.3360 7.2419 0.0 0
M  V30 16 C 10.6697 6.4718 0.0 0
M  V30 17 C 5.3348 1.8517 0.0 0
M  V30 18 C 3.9279 2.4782 0.0 0
M  V30 19 O 5.1737 0.3202 0.0 0
M  V30 20 C 2.8974 1.3337 0.0 0
M  V30 21 C 3.6674 0.0000 0.0 0
M  V30 22 C 4.0010 7.2419 0.0 0
M  V30 23 C 4.0010 8.7819 0.0 0
M  V30 24 C 2.6673 6.4718 0.0 0
M  V30 25 C 2.6673 9.5519 0.0 0
M  V30 26 C 1.3337 7.2419 0.0 0
M  V30 27 C 1.3337 8.7819 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 2 2 4
M  V30 5 1 2 17
M  V30 6 1 3 5
M  V30 7 2 5 6
M  V30 8 1 5 22
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 7 16
M  V30 12 1 10 27
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[5-(4-Fluorophenyl)-2-(2-furanyl)-1-methyl-1H-pyrrol-3-yl]benzoic acid
C22H16FNO3
945375-26-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.9622 7.8788 0.0 0
M  V30 2 C 1.3337 1.5400 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 F 15.2321 4.4943 0.0 0
M  V30 6 C 6.8294 6.1518 0.0 0
M  V30 7 C 6.6685 4.6201 0.0 0
M  V30 8 N 8.3359 6.4720 0.0 0
M  V30 9 C 8.0753 3.9938 0.0 0
M  V30 10 C 9.1059 5.1383 0.0 0
M  V30 11 C 5.6850 7.1822 0.0 0
M  V30 12 C 5.8459 8.7138 0.0 0
M  V30 13 O 4.1786 6.8621 0.0 0
M  V30 14 C 4.4390 9.3403 0.0 0
M  V30 15 C 3.4085 8.1957 0.0 0
M  V30 16 C 5.3348 3.8501 0.0 0
M  V30 17 C 4.0010 4.6201 0.0 0
M  V30 18 C 5.3348 2.3100 0.0 0
M  V30 19 C 2.6673 3.8501 0.0 0
M  V30 20 C 4.0010 1.5400 0.0 0
M  V30 21 C 2.6673 2.3100 0.0 0
M  V30 22 C 10.6374 4.9772 0.0 0
M  V30 23 C 11.5427 6.2231 0.0 0
M  V30 24 C 11.2638 3.5704 0.0 0
M  V30 25 C 13.0742 6.0622 0.0 0
M  V30 26 C 12.7953 3.4095 0.0 0
M  V30 27 C 13.7006 4.6554 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 21
M  V30 5 1 5 27
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 7 16
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 1 10 22
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 945375-39-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 945375-26-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-11889854
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: A solution of this material (2.35 mmol) in
EtOH (10 mL) was treated with primary amine (11.8 mmol) and-in the case
of amines other than methylamine-acetic acid (7 mmol). The mixture was
heated to reflux for 3 h or irradiated in an Emrys Optimizer™ for 5 min
at 180 °C. After cooling, the mixture was partitioned between 1 N HCl and
EtOAc. After exhaustive extraction of the aqueous layer, the combined
extracts were washed with brine, dried (Na2SO4), and evaporated. The
crude product was recrystallized from, or triturated with, EtOAc.
4-[5-(4-Fluorophenyl)-2-furan-2-yl-1-methyl-1H-pyrrol-3-yl]benzoic acid
(1b), yield 90%. mp = 211 °C. 1H NMR (400 MHz, CDCl3): δ (ppm) = 7.98 (d,
2H, J = 8.6 Hz); 7.53 (dd, 1H, J = 1.9 Hz, 0.8 Hz); 7.45 (dd, 2H, J = 8.8
Hz, 5.3 Hz); 7.36 (d, 2H, J = 6.8 Hz); 7.14 (t, 2H, J = 8.6 Hz); 6.50
(dd, 1H, J = 3.3 Hz, 1.9 Hz); 6.47 (s, 1H); 6.40 (dd, 1H, J = 3.3 Hz, 0.8
Hz), 3.51 (s, 3H). MS (ESI): m/z = 362 [MH + ].
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Scope and applicability of an expedient synthesis leading to
polysubstituted 3-(carboxyphenyl)pyrroles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ullrich, Thomas; Ghobrial, Michael; Weigand, Klaus; Marzinzik, Andreas L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2007), 37(7), 1109-1119

$RFMT $RIREG SCHEME37 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2R,3R,4S)-2-(2,6-Dichloro-9H-purin-9-yl)tetrahydro-3,4-thiophenediol
C9H8Cl2N4O2S
945457-82-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.6201 0.0 0
M  V30 2 Cl 2.6673 0.0000 0.0 0
M  V30 3 O 7.6353 7.1223 0.0 0
M  V30 4 O 10.5369 5.4472 0.0 0
M  V30 5 C 4.0010 3.8501 0.0 0
M  V30 6 N 5.1455 4.8805 0.0 0
M  V30 7 C 2.6673 4.6201 0.0 0
M  V30 8 N 4.0010 2.3100 0.0 0
M  V30 9 C 4.5191 6.2873 0.0 0
M  V30 10 N 2.9875 6.1264 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 N 1.3337 2.3100 0.0 0
M  V30 14 C 6.6518 4.5603 0.0 0 CFG=2
M  V30 15 C 7.7964 5.5908 0.0 0 CFG=2
M  V30 16 S 7.2783 3.1534 0.0 0
M  V30 17 C 9.1301 4.8208 0.0 0 CFG=2
M  V30 18 C 8.8099 3.3145 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 12
M  V30 3 1 15 3 CFG=3
M  V30 4 1 17 4 CFG=3
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 14 6 CFG=1
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 2 9 10
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 14 15 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2R,3R,4S)-2-[2-Chloro-6-(methylamino)-9H-purin-9-yl]tetrahydro-3,4-thiophene...
C10H12ClN5O2S
945457-92-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 10.5371 4.6201 0.0 0
M  V30 2 C 11.8709 3.8501 0.0 0
M  V30 3 Cl 7.8697 0.0000 0.0 0
M  V30 4 O 2.9016 7.1223 0.0 0
M  V30 5 O 0.0000 5.4473 0.0 0
M  V30 6 C 6.5361 3.8501 0.0 0
M  V30 7 N 5.3915 4.8805 0.0 0
M  V30 8 C 7.8697 4.6201 0.0 0
M  V30 9 N 6.5361 2.3101 0.0 0
M  V30 10 C 6.0178 6.2873 0.0 0
M  V30 11 C 9.2034 3.8501 0.0 0
M  V30 12 N 7.5496 6.1264 0.0 0
M  V30 13 C 7.8697 1.5400 0.0 0
M  V30 14 N 9.2034 2.3101 0.0 0
M  V30 15 C 3.8852 4.5603 0.0 0 CFG=2
M  V30 16 C 2.7406 5.5908 0.0 0 CFG=2
M  V30 17 S 3.2587 3.1534 0.0 0
M  V30 18 C 1.4070 4.8208 0.0 0 CFG=2
M  V30 19 C 1.7271 3.3145 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 13
M  V30 4 1 16 4 CFG=1
M  V30 5 1 18 5 CFG=1
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 1 15 7 CFG=3
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 10 12
M  V30 15 1 11 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 15 16 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 945457-82-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 945457-92-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12803027
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 3. Preparation of
(2R,3R,4S)-2-(2-chloro-6-(3-fluorobenzylamino)-9H-purin-9-yl)tetrahydrothiophen-3,4-diol.
(2R,3S,4S)-2-(2,6-dichloro-9H-purin-9-yl)tetrahydrothiophen-3,4-diol (1
equivalent), prepared in Step 2, and 3-fluorobenzylamine (1.5
equivalents) were dissolved in ethanol (5 ml) at room temperature for 2∼3
hrs with stirring. The reaction mixture was concentrated in a vacuum and
the concentrate was purified through silica gel column chromatography
using a mixture of dichloromethane:methanol (20:1, v/v) as an elution
solvent to afford the object compound (0.10 g, 80%). Step 3. Preparation
of
2-(2-chloro-6-methylamino-purin-9-yl)(2R,3S,4R)-tetrahydrothiophen-3,4-diol.
A procedure similar to that of Step 3 of Example 1 was conducted, with
the exception that methylamine was used instead of 3-fluorobenzylamine,
to give the object compound (0.89 g, 90%). UV (MeOH) λmax 269.5 nm(pH 7);
1H-NMR (CDCl3) δ 2.99(1H, dd, 4'-CH, J= 4.4, 10.8 Hz), 3.12 (3H, brs,
NH-CH3), 3.44 1H, dd, 4'-CH, J= 4, 10.8 Hz), 4.41(1H, m, 2'-CH, J= 5.6
Hz), 4.47(1H, m, 3'-CH), 5.89(1H, d, 1'-CH, J= 5.6 Hz), 8.40(s, 1H,
8-CH); [α]25D -34.8 (c 0.115, DMSO); FAB-MS m/z 302.3[M + H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of adenosine nucleoside analogs for the prevention and
treatment of the inflammatory diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jeong, Lak Shin; Kim, Hea Ok; Jacobson, Kenneth A.; Choe, Seung Ah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008108508 A1 2008-09-12

$RFMT $RIREG SCHEME38 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Morpholinedimethanol, 3-phenyl-4-(phenylmethyl)-, 2,6-dimethanesulfonate,...
C21H27NO7S2
947682-06-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 8.4702 0.0 0
M  V30 2 C 4.0010 8.4702 0.0 0
M  V30 3 O 2.6673 7.7002 0.0 0
M  V30 4 S 1.3337 8.4702 0.0 0 VAL=6
M  V30 5 C 0.5637 7.1365 0.0 0
M  V30 6 O 0.0000 9.2402 0.0 0
M  V30 7 O 2.1037 9.8039 0.0 0
M  V30 8 C 6.6685 3.8501 0.0 0
M  V30 9 O 5.3348 3.0801 0.0 0
M  V30 10 S 5.3348 1.5400 0.0 0 VAL=6
M  V30 11 C 6.8749 1.5400 0.0 0
M  V30 12 O 5.3348 0.0000 0.0 0
M  V30 13 O 3.7948 1.5400 0.0 0
M  V30 14 C 6.6685 8.4702 0.0 0 CFG=1
M  V30 15 N 8.0022 7.7002 0.0 0
M  V30 16 C 5.3348 7.7002 0.0 0 CFG=1
M  V30 17 C 8.0022 6.1601 0.0 0
M  V30 18 O 5.3348 6.1601 0.0 0
M  V30 19 C 6.6685 5.3901 0.0 0 CFG=2
M  V30 20 C 6.6685 10.0102 0.0 0
M  V30 21 C 8.0022 10.7802 0.0 0
M  V30 22 C 5.3348 10.7802 0.0 0
M  V30 23 C 8.0022 12.3203 0.0 0
M  V30 24 C 5.3348 12.3203 0.0 0
M  V30 25 C 6.6685 13.0903 0.0 0
M  V30 26 C 10.6697 7.7002 0.0 0
M  V30 27 C 10.6697 6.1601 0.0 0
M  V30 28 C 12.0033 8.4702 0.0 0
M  V30 29 C 12.0033 5.3901 0.0 0
M  V30 30 C 13.3370 7.7002 0.0 0
M  V30 31 C 13.3370 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 26
M  V30 3 1 2 3
M  V30 4 1 16 2 CFG=3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 2 4 7
M  V30 9 1 8 9
M  V30 10 1 19 8 CFG=3
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 20 CFG=3
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 14 16 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,2S,5S)-7-Methyl-2-phenyl-3-(phenylmethyl)-9-oxa-3,7-diazabicyclo[3.3.1]no...
C20H24N2O
947682-08-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 5.0926 0.0 0
M  V30 2 C 10.1846 5.0926 0.0 0
M  V30 3 N 4.6200 5.0926 0.0 0
M  V30 4 C 5.2052 3.6655 0.0 0 CFG=1
M  V30 5 C 5.2052 6.5197 0.0 0
M  V30 6 C 6.6323 3.0803 0.0 0 CFG=1
M  V30 7 C 6.6323 7.1049 0.0 0 CFG=2
M  V30 8 O 7.4023 5.0926 0.0 0
M  V30 9 C 8.0491 3.6655 0.0 0
M  V30 10 C 8.0491 6.5197 0.0 0
M  V30 11 N 8.6446 5.0926 0.0 0
M  V30 12 C 4.1163 2.5766 0.0 0
M  V30 13 C 4.5148 1.0889 0.0 0
M  V30 14 C 2.6288 2.9751 0.0 0
M  V30 15 C 3.4259 0.0000 0.0 0
M  V30 16 C 1.5398 1.8862 0.0 0
M  V30 17 C 1.9384 0.3987 0.0 0
M  V30 18 C 2.3100 6.4263 0.0 0
M  V30 19 C 0.7700 6.4263 0.0 0
M  V30 20 C 3.0800 7.7599 0.0 0
M  V30 21 C 0.0000 7.7599 0.0 0
M  V30 22 C 2.3100 9.0937 0.0 0
M  V30 23 C 0.7700 9.0937 0.0 0
M  V30 24 H 6.6343 1.5403 0.0 0
M  V30 25 H 6.6343 8.6449 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 18
M  V30 3 1 2 11
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 12 CFG=3
M  V30 8 1 5 7
M  V30 9 1 6 8 CFG=1
M  V30 10 1 6 9
M  V30 11 1 6 24
M  V30 12 1 7 8 CFG=1
M  V30 13 1 7 10
M  V30 14 1 7 25
M  V30 15 1 9 11
M  V30 16 1 10 11
M  V30 17 2 12 13
M  V30 18 1 12 14
M  V30 19 1 13 15
M  V30 20 2 14 16
M  V30 21 2 15 17
M  V30 22 1 16 17
M  V30 23 2 18 19
M  V30 24 1 18 20
M  V30 25 1 19 21
M  V30 26 2 20 22
M  V30 27 2 21 23
M  V30 28 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 4 6 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 947682-06-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 947682-08-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-11995750
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (+)-(1R,2S,5S)-3-Benzyl-7-methyl-2-phenyl-9-oxa-3,7-diazabicyclo[3.3.1]nonane
(10b) A solution of aqueous methylamine (40%, 48 mL, 556 mmol) and 9
(3.44 g, 7.34 mmol) was stirred for 36 h at 50 °C. The mixture was
diluted with H2O (150 mL) and extracted with Et2O (3 × 300 mL). The
combined organic layers were washed with brine (200 mL), dried (Na2SO4),
and concentrated in vacuo. Purification by column chromatography [silica
gel, deactivated with concd NH3 (7.5 wt%), n-pentane-Et2O (3:1 → 1:3)]
afforded 10b. Slightly yellow oil, yield (2.05 g, 90%). [α ]D 22 +26.8 (c
= 0.16, CHCl3); Rf = 0.90 (Et2O, deactivated with NH3). IR (film): 3038,
2791, 1496, 1453, 996 cm-1. 1H NMR (400 MHz, CDCl3): δ = 2.02 (dd, 1 H, J
= 11.8, 3.7 Hz, NCHH), 2.19 (s, 3 H, NCH3), 2.43 (ddd, 1 H, J = 11.2,
4.0, 1.7 Hz, NCHH), 2.65 (m, 2 H, NCH2), 2.84 (d, 1 H, J = 11.2 Hz,
NCHH), 2.95 (dd, 1 H, J = 11.5, 0.8 Hz, NCHH), 2.97 (d, 1 H, J = 14.1 Hz,
NCHHPh), 3.71 (m, 1 H, OCH), 3.87 (m, 3 H, NCHHPh, NCHPh, OCH), 7.15-7.40
(m, 9 H, ArH), 7.80-8.20 (br s, 1 H, ArH). 13C NMR (100 MHz, CDCl3): δ =
46.86, 54.17, 55.30, 58.30, 58.56, 60.28, 69.08, 69.29, 73.59, 126.8,
127.5, 128.3, 128.7, 128.9, 138.7, 140.9. MS (ESI, +): m/z (%) = 309.1956
([M+H]+, 100), 217.1323 ([M-CH2Ph]+, 2). HRMS (ESI, +): m/z [M+H]+ calcd
for C20H25N2O: 309.1967; found: 309.1956. Anal. Calcd for C20H24N2O: C,
77.89; H, 7.84; N, 9.08. Found: C, 77.88; H, 7.62; N, 8.91.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective synthesis of 2-phenyl-9-oxabispidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Breuning, Matthias; Steiner, Melanie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2007), (11), 1702-1706

$RFMT $RIREG SCHEME39 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6-Bis(4-methoxyphenyl)-4-(methylthio)-2-oxo-2H-pyran-3-carbonitrile
C21H17NO4S
950583-52-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.0800 5.3347 0.0 0
M  V30 2 C 1.5400 5.3347 0.0 0
M  V30 3 C 1.5400 8.0021 0.0 0
M  V30 4 N 0.0000 8.0021 0.0 0
M  V30 5 O 3.0800 10.6694 0.0 0
M  V30 6 O 8.4700 1.3336 0.0 0
M  V30 7 C 7.7000 0.0000 0.0 0
M  V30 8 O 12.3200 8.0021 0.0 0
M  V30 9 C 13.0900 9.3358 0.0 0
M  V30 10 C 5.3900 6.6684 0.0 0
M  V30 11 C 6.1600 8.0021 0.0 0
M  V30 12 C 3.8500 6.6684 0.0 0
M  V30 13 O 5.3900 9.3358 0.0 0
M  V30 14 C 3.0800 8.0021 0.0 0
M  V30 15 C 3.8500 9.3358 0.0 0
M  V30 16 C 6.1600 5.3347 0.0 0
M  V30 17 C 5.3900 4.0011 0.0 0
M  V30 18 C 7.7000 5.3347 0.0 0
M  V30 19 C 6.1600 2.6673 0.0 0
M  V30 20 C 8.4700 4.0011 0.0 0
M  V30 21 C 7.7000 2.6673 0.0 0
M  V30 22 C 7.7000 8.0021 0.0 0
M  V30 23 C 8.4700 9.3358 0.0 0
M  V30 24 C 8.4700 6.6684 0.0 0
M  V30 25 C 10.0100 9.3358 0.0 0
M  V30 26 C 10.0100 6.6684 0.0 0
M  V30 27 C 10.7800 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 3 3 4
M  V30 4 1 3 14
M  V30 5 2 5 15
M  V30 6 1 6 7
M  V30 7 1 6 21
M  V30 8 1 8 9
M  V30 9 1 8 27
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 1 11 22
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6-Bis(4-methoxyphenyl)-4-(methylamino)-2-oxo-2H-pyran-3-carbonitrile
C21H18N2O4
1119194-71-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0800 5.3347 0.0 0
M  V30 2 C 1.5400 5.3347 0.0 0
M  V30 3 C 1.5400 8.0021 0.0 0
M  V30 4 N 0.0000 8.0021 0.0 0
M  V30 5 O 3.0800 10.6694 0.0 0
M  V30 6 O 8.4700 1.3336 0.0 0
M  V30 7 C 7.7000 0.0000 0.0 0
M  V30 8 O 12.3200 8.0021 0.0 0
M  V30 9 C 13.0900 9.3358 0.0 0
M  V30 10 C 5.3900 6.6684 0.0 0
M  V30 11 C 6.1600 8.0021 0.0 0
M  V30 12 C 3.8500 6.6684 0.0 0
M  V30 13 O 5.3900 9.3358 0.0 0
M  V30 14 C 3.0800 8.0021 0.0 0
M  V30 15 C 3.8500 9.3358 0.0 0
M  V30 16 C 6.1600 5.3347 0.0 0
M  V30 17 C 7.7000 5.3347 0.0 0
M  V30 18 C 5.3900 4.0011 0.0 0
M  V30 19 C 8.4700 4.0011 0.0 0
M  V30 20 C 6.1600 2.6673 0.0 0
M  V30 21 C 7.7000 2.6673 0.0 0
M  V30 22 C 7.7000 8.0021 0.0 0
M  V30 23 C 8.4700 6.6684 0.0 0
M  V30 24 C 8.4700 9.3358 0.0 0
M  V30 25 C 10.0100 6.6684 0.0 0
M  V30 26 C 10.0100 9.3358 0.0 0
M  V30 27 C 10.7800 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 3 3 4
M  V30 4 1 3 14
M  V30 5 2 5 15
M  V30 6 1 6 7
M  V30 7 1 6 21
M  V30 8 1 8 9
M  V30 9 1 8 27
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 1 11 22
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 950583-52-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1119194-71-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-9993887
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly convenient regioselective synthesis of functionalized arylated
benzene from ketene-S,S-acetal under mild conditions at room temperature
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kumar, Vijay; Singh, Fateh V.; Parihar, Amrita; Goel, Atul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2009), 50(6), 680-683

$RFMT $RIREG SCHEME40 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3β,4α,5α,16α,20S)-20-(Dimethylamino)-4-formyl-16-hydroxy-4,14-dimethyl-11...
C30H48N2O4
957775-93-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.4002 6.5076 0.0 0
M  V30 2 C 5.0633 0.9667 0.0 0
M  V30 3 C 10.9829 0.9898 0.0 0
M  V30 4 O 12.1626 0.0000 0.0 0
M  V30 5 C 12.6974 1.9797 0.0 0
M  V30 6 C 3.4149 5.0861 0.0 0
M  V30 7 N 13.5603 3.8402 0.0 0
M  V30 8 C 14.3303 5.1739 0.0 0
M  V30 9 C 15.8704 5.1739 0.0 0
M  V30 10 O 13.5603 6.5076 0.0 0
M  V30 11 C 16.6404 3.8402 0.0 0
M  V30 12 C 16.6404 6.5076 0.0 0
M  V30 13 C 2.6527 5.0516 0.0 0 CFG=2
M  V30 14 N 1.2459 5.6779 0.0 0
M  V30 15 C 3.8987 5.9569 0.0 0
M  V30 16 C 0.0000 4.7727 0.0 0
M  V30 17 C 1.0850 7.2095 0.0 0
M  V30 18 O 1.3190 1.2183 0.0 0
M  V30 19 C 7.4002 3.8402 0.0 0 CFG=1
M  V30 20 C 8.9402 3.8402 0.0 0 CFG=1
M  V30 21 C 6.6302 2.5066 0.0 0 CFG=1
M  V30 22 C 8.1702 5.1739 0.0 0
M  V30 23 C 6.6302 5.1739 0.0 0
M  V30 24 C 9.7102 2.5064 0.0 0 CFG=1
M  V30 25 C 9.7102 5.1739 0.0 0
M  V30 26 C 5.0901 2.5064 0.0 0 CFG=1
M  V30 27 C 7.4002 1.1727 0.0 0
M  V30 28 C 5.0901 5.1739 0.0 0
M  V30 29 C 11.2503 2.5066 0.0 0 CFG=2
M  V30 30 C 8.9402 1.1727 0.0 0
M  V30 31 C 11.2503 5.1739 0.0 0
M  V30 32 C 4.3201 3.8402 0.0 0 CFG=2
M  V30 33 C 4.0597 1.3620 0.0 0
M  V30 34 C 12.0203 3.8402 0.0 0 CFG=1
M  V30 35 C 2.8138 3.5201 0.0 0 CFG=1
M  V30 36 C 2.6527 1.9883 0.0 0 CFG=1
M  V30 37 H 6.2316 1.0189 0.0 0
M  V30 38 H 10.4802 1.1727 0.0 0
M  V30 39 H 1.2738 3.5201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 23
M  V30 2 1 26 2 CFG=1
M  V30 3 2 3 4
M  V30 4 1 29 3 CFG=1
M  V30 5 1 29 5 CFG=3
M  V30 6 1 32 6 CFG=3
M  V30 7 1 7 8
M  V30 8 1 34 7 CFG=3
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 1 13 15 CFG=1
M  V30 15 1 13 35
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 36 18 CFG=1
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22 CFG=3
M  V30 22 1 19 23
M  V30 23 1 20 22 CFG=3
M  V30 24 1 20 24
M  V30 25 1 20 25
M  V30 26 1 21 26
M  V30 27 1 21 27
M  V30 28 1 21 37 CFG=3
M  V30 29 1 23 28
M  V30 30 1 24 29
M  V30 31 1 24 30
M  V30 32 1 24 38 CFG=1
M  V30 33 1 25 31
M  V30 34 1 26 32
M  V30 35 1 26 33
M  V30 36 1 27 30
M  V30 37 1 28 32
M  V30 38 1 29 34
M  V30 39 1 31 34
M  V30 40 1 32 35
M  V30 41 1 33 36
M  V30 42 1 35 36
M  V30 43 1 35 39 CFG=1
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 13 19 20 21 24 26 29 32 34 35 36)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(3β,4α,5α,16α,20S)-20-(Dimethylamino)-16-hydroxy-4,14-dimethyl-4-[(methyla...
C31H53N3O3
1310344-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.4001 8.0241 0.0 0
M  V30 2 C 5.0633 2.4833 0.0 0
M  V30 3 C 10.9828 2.5064 0.0 0
M  V30 4 N 12.1624 1.5166 0.0 0
M  V30 5 C 11.8951 0.0000 0.0 0
M  V30 6 C 12.6973 3.4963 0.0 0
M  V30 7 C 3.4148 6.6027 0.0 0
M  V30 8 N 13.5601 5.3568 0.0 0
M  V30 9 C 14.3301 6.6904 0.0 0
M  V30 10 C 15.8702 6.6904 0.0 0
M  V30 11 O 13.5601 8.0241 0.0 0
M  V30 12 C 16.6402 5.3568 0.0 0
M  V30 13 C 16.6402 8.0241 0.0 0
M  V30 14 C 2.6527 6.5682 0.0 0 CFG=2
M  V30 15 N 1.2459 7.1945 0.0 0
M  V30 16 C 3.8987 7.4734 0.0 0
M  V30 17 C 1.0849 8.7260 0.0 0
M  V30 18 C 0.0000 6.2893 0.0 0
M  V30 19 O 1.3190 2.7349 0.0 0
M  V30 20 C 7.4001 5.3568 0.0 0 CFG=1
M  V30 21 C 8.9401 5.3568 0.0 0 CFG=1
M  V30 22 C 6.6301 4.0231 0.0 0 CFG=1
M  V30 23 C 8.1701 6.6904 0.0 0
M  V30 24 C 6.6301 6.6904 0.0 0
M  V30 25 C 9.7101 4.0231 0.0 0 CFG=1
M  V30 26 C 9.7101 6.6904 0.0 0
M  V30 27 C 5.0901 4.0231 0.0 0 CFG=1
M  V30 28 C 7.4001 2.6893 0.0 0
M  V30 29 C 5.0901 6.6904 0.0 0
M  V30 30 C 11.2501 4.0231 0.0 0 CFG=2
M  V30 31 C 8.9401 2.6893 0.0 0
M  V30 32 C 11.2501 6.6904 0.0 0
M  V30 33 C 4.3200 5.3568 0.0 0 CFG=2
M  V30 34 C 4.0596 2.8786 0.0 0
M  V30 35 C 12.0201 5.3568 0.0 0 CFG=1
M  V30 36 C 2.8138 5.0366 0.0 0 CFG=1
M  V30 37 C 2.6527 3.5049 0.0 0 CFG=1
M  V30 38 H 6.2315 2.5355 0.0 0
M  V30 39 H 10.4801 2.6893 0.0 0
M  V30 40 H 1.2737 5.0366 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 24
M  V30 2 1 27 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 30 3 CFG=1
M  V30 5 1 4 5
M  V30 6 1 30 6 CFG=3
M  V30 7 1 33 7 CFG=3
M  V30 8 1 8 9
M  V30 9 1 35 8 CFG=3
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 1 14 16 CFG=1
M  V30 16 1 14 36
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 37 19 CFG=1
M  V30 20 1 20 21
M  V30 21 1 20 22
M  V30 22 1 20 23 CFG=3
M  V30 23 1 20 24
M  V30 24 1 21 23 CFG=3
M  V30 25 1 21 25
M  V30 26 1 21 26
M  V30 27 1 22 27
M  V30 28 1 22 28
M  V30 29 1 22 38 CFG=3
M  V30 30 1 24 29
M  V30 31 1 25 30
M  V30 32 1 25 31
M  V30 33 1 25 39 CFG=1
M  V30 34 1 26 32
M  V30 35 1 27 33
M  V30 36 1 27 34
M  V30 37 1 28 31
M  V30 38 1 29 33
M  V30 39 1 30 35
M  V30 40 1 32 35
M  V30 41 1 33 36
M  V30 42 1 34 37
M  V30 43 1 36 37
M  V30 44 1 36 40 CFG=1
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(11 14 20 21 22 25 27 30 33 35 36 37)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 957775-93-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1310344-12-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14389559
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-82-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New potent human acetylcholinesterase inhibitors in the tetracyclic
triterpene series with inhibitory potency on amyloid β aggregation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rouleau, Julien; Iorga, Bogdan I.; Guillou, Catherine
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2011), 46(6), 2193-2205

$RFMT $RIREG SCHEME41 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetophenone
C8H8O
98-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-α-oxobenzeneacetamide
C9H9NO2
83490-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 N 6.6685 1.5400 0.0 0
M  V30 5 O 5.3347 3.8500 0.0 0
M  V30 6 C 8.0021 2.3100 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-86-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 83490-71-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30117876
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 516-12-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-reagent, photochemical (UV lamp used (210nm)), sealed
flask used, aerobic
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM UV Assisted High-Efficient Synthesis of α-Ketoamides using Air Promoted
by A Non-Metal Catalyst in Aqueous Solution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Jianhui; He, Shaopo; Zhang, Kuan; Quan, Ziyi; Shan, Qiheng; Sun,
Zhongliang; Wang, Bo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemCatChem (2018), 10(21), 4868-4873

$RFMT $RIREG SCHEME42 STEP1
$RXN



  3  2
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl carbazate
C3H8N2O2
4114-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 N 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 N 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Imidazole
C3H4N2
288-32-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 N 0.4759 2.3698 0.0 0
M  V30 4 N 2.4917 0.9052 0.0 0
M  V30 5 C 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[(methylamino)carbonyl]hydrazinecarboxylate
C5H11N3O3
13482-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 2.3101 0.0 0
M  V30 2 N 4.0012 1.5400 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 C 2.6673 2.3101 0.0 0
M  V30 5 O 8.0023 2.3101 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 N 1.3337 1.5400 0.0 0
M  V30 8 O 2.6673 3.8501 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4114-31-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 288-32-4
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 13482-66-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26587942
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of a Scalable and Sublimation-Free Route to MTAD
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Siddiqi, Zohaib R.; Ungarean, Chad N.; Bingham, Tanner W.; Sarlah, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2020), 24(12), 2953-2959

$RFMT $RIREG SCHEME43 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-3-chlorobenzaldehyde
C7H4BrClO
120077-69-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 O 6.9302 4.0010 0.0 0
M  V30 3 Cl 1.5400 0.0000 0.0 0
M  V30 4 Br 0.0000 2.6673 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-3-chloro-N-methylbenzenemethanamine
C8H9BrClN
1338326-96-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 N 6.9302 4.0010 0.0 0
M  V30 3 C 8.4702 4.0010 0.0 0
M  V30 4 Cl 1.5400 0.0000 0.0 0
M  V30 5 Br 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 1.3337 0.0 0
M  V30 8 C 3.8501 4.0010 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 C 2.3101 4.0010 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(Z)]-N-[(4-Bromo-3-chlorophenyl)methylene]methanamine
C8H7BrClN
1338326-97-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6674 0.0 0
M  V30 2 N 0.0000 4.0011 0.0 0
M  V30 3 C 0.7700 5.3349 0.0 0
M  V30 4 Cl 5.3900 0.0000 0.0 0
M  V30 5 Br 6.9300 2.6674 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 3.0800 1.3338 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 4.6200 1.3338 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120077-69-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1338326-96-7
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 1338326-97-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-1030226
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 7
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate 17: (Z)-N-(4-bromo-3-chlorobenzylidene)methanamine Sodium
triacetoxyborohydride (4.81 g, 22.69 mmol) was added in one portion to
4-bromo- 3-chlorobenzaldehyde (3.32 g, 15.13 mmol), acetic acid (0.866
mL, 15.13 mmol) and methylamine (2M in THF) (37.8 mL, 75.64 mmol) in THF
(80 mL) at 20°C under nitrogen. The resulting mixture was stirred at R.T.
for 4 hours. The reaction mixture was concentrated ~ half volume and then
quenched with saturated NaHCO3 (50 mL), extracted with EtOAc (100 mL).
The combined organics were washed with brine (50 mL), dried over Na2SO4,
filtered and evaporated to afford
(Z)-N-(4-bromo-3-chlorobenzylidene)methanamine. The crude product
containing ~7% of the corresponding amine reduction product and ~10% of
the starting aldehyde was used without further purification. Yield 3.48
g, 99 %, yellow oil.
$DTYPE RXN:VAR(1):NOTES
$DATUM unreacted reactant also recovered
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 4-amino-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-5(6)-one
based DGAT1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Birch, Alan Martin; Goldberg, Frederick Woolf; Leach, Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011121350 A1 2011-10-06

$RFMT $RIREG SCHEME44 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2R)-2-(3-Nitrophenyl)oxirane
C8H7NO3
129215-12-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 3.0801 0.0 0 VAL=5
M  V30 2 O 1.3338 4.6201 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 C 5.3348 2.3101 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 5.3348 0.7700 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 6.6687 3.0801 0.0 0 CFG=1
M  V30 11 C 8.2087 3.0801 0.0 0
M  V30 12 O 7.4387 4.4137 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 10 4 CFG=1
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Benzenemethanol, α-[(methylamino)methyl]-3-nitro-, (R)-
C9H12N2O3
50741-73-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 3.0800 0.0 0 CFG=1
M  V30 2 C 8.0022 2.3100 0.0 0
M  V30 3 O 6.6684 4.6201 0.0 0
M  V30 4 N 9.3359 3.0800 0.0 0
M  V30 5 C 10.6695 2.3100 0.0 0
M  V30 6 N 1.3337 3.0800 0.0 0 VAL=5
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 3.0800 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6673 2.3100 0.0 0
M  V30 13 C 4.0011 0.0000 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
β-(Methylamino)-3-nitrobenzeneethanol
C9H12N2O3
1337334-68-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.0800 0.0 0
M  V30 2 C 2.6675 4.6201 0.0 0
M  V30 3 N 1.3337 2.3100 0.0 0
M  V30 4 O 1.3337 5.3901 0.0 0
M  V30 5 C 0.0000 3.0800 0.0 0
M  V30 6 N 8.0022 3.0800 0.0 0 VAL=5
M  V30 7 O 9.3359 2.3100 0.0 0
M  V30 8 O 8.0022 4.6201 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 5.3348 3.0800 0.0 0
M  V30 11 C 4.0011 0.7700 0.0 0
M  V30 12 C 6.6684 2.3100 0.0 0
M  V30 13 C 5.3348 0.0000 0.0 0
M  V30 14 C 6.6684 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 129215-12-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 50741-73-6
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 1337334-68-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-5995010
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Whole-cell yeast-mediated preparation of
(R)-2-chloro-1-(3-nitrophenyl)ethanol as a synthetic precursor for
(R)-phenylephrine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tokoshima, Daisuke; Hanaya, Kengo; Shoji, Mitsuru; Sugai, Takeshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Catalysis B: Enzymatic (2013), 9795-99

$RFMT $RIREG SCHEME45 STEP1
$RXN



  2  2
$MOL
5-(Hydroxymethyl)furfural
C6H6O3
67-47-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2079 2.6218 0.0 0
M  V30 2 O 7.5415 1.8517 0.0 0
M  V30 3 C 0.9052 1.4946 0.0 0
M  V30 4 O 0.0000 0.2487 0.0 0
M  V30 5 C 4.8742 1.8517 0.0 0
M  V30 6 O 3.4672 2.4782 0.0 0
M  V30 7 C 4.7131 0.3202 0.0 0
M  V30 8 C 2.4368 1.3337 0.0 0
M  V30 9 C 3.2068 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 3 4
M  V30 4 1 3 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N′-(2,5-Furandiyldimethylidyne)bis[methanamine]
C8H10N2O
92259-17-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.6218 0.0 0
M  V30 2 N 1.3337 1.8517 0.0 0
M  V30 3 C 0.0000 2.6218 0.0 0
M  V30 4 C 7.9701 1.4946 0.0 0
M  V30 5 N 8.8754 0.2487 0.0 0
M  V30 6 C 10.4069 0.4096 0.0 0
M  V30 7 C 4.0012 1.8517 0.0 0
M  V30 8 O 5.4080 2.4782 0.0 0
M  V30 9 C 4.1621 0.3202 0.0 0
M  V30 10 C 6.4386 1.3337 0.0 0
M  V30 11 C 5.6686 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 4 5 CFG=2
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(Methylimino)methyl]-2-furanmethanol
C7H9NO2
1309775-27-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2079 2.6218 0.0 0
M  V30 2 N 7.5415 1.8517 0.0 0
M  V30 3 C 8.8752 2.6218 0.0 0
M  V30 4 C 0.9052 1.4946 0.0 0
M  V30 5 O 0.0000 0.2487 0.0 0
M  V30 6 C 4.8742 1.8517 0.0 0
M  V30 7 O 3.4672 2.4782 0.0 0
M  V30 8 C 4.7131 0.3202 0.0 0
M  V30 9 C 2.4368 1.3337 0.0 0
M  V30 10 C 3.2068 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 67-47-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 92259-17-1
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 1309775-27-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24485215
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 98
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1313-13-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM manganese oxide catalyst prepared and used, optimization study (optimized
on catalyst), conversion = 100%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient approach to synthesizing 2,5-bis(N-methyl-aminomethyl)furan
from 5-hydroxymethylfurfural via 2,5-bis(N-methyl-iminomethyl)furan using
a two-step reaction in one pot
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Jie; Jia, Wenlong; Sun, Yong; Yang, Shuliang; Tang, Xing; Zeng,
Xianhai; Lin, Lu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2021), 23(15), 5656-5664

$RFMT $RIREG SCHEME46 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-(3,5-dimethylphenyl)-3-[methyl(1-oxo-3-phenyl-2-propyn-1-yl)amino]-2...
C22H21NO3
2097490-91-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 N 6.6685 5.3901 0.0 0
M  V30 3 C 5.3348 3.0801 0.0 0
M  V30 4 C 8.0022 4.6201 0.0 0
M  V30 5 C 6.6685 6.9302 0.0 0
M  V30 6 C 4.0010 2.3101 0.0 0
M  V30 7 C 9.3358 5.3901 0.0 0
M  V30 8 O 8.0022 3.0801 0.0 0
M  V30 9 O 4.0010 0.7700 0.0 0
M  V30 10 O 2.6673 3.0801 0.0 0
M  V30 11 C 10.6697 6.1601 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 0.0000 4.6201 0.0 0
M  V30 14 C 2.6673 9.2402 0.0 0
M  V30 15 C 4.0010 5.3901 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 4.0010 6.9302 0.0 0
M  V30 18 C 1.3337 5.3901 0.0 0
M  V30 19 C 2.6673 7.7002 0.0 0
M  V30 20 C 1.3337 6.9302 0.0 0
M  V30 21 C 12.0033 6.9302 0.0 0
M  V30 22 C 13.3370 6.1601 0.0 0
M  V30 23 C 12.0033 8.4702 0.0 0
M  V30 24 C 14.6707 6.9302 0.0 0
M  V30 25 C 13.3370 9.2402 0.0 0
M  V30 26 C 14.6707 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 3 7 11
M  V30 12 1 9 12
M  V30 13 1 11 21
M  V30 14 1 13 18
M  V30 15 1 14 19
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylacetylene
C8H6
536-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 6.1601 1.3337 0.0 0
M  V30 3 C 3.0800 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(3,5-Dimethylphenyl)-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione
C14H16N2O2
1345826-43-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 O 0.0000 3.8500 0.0 0
M  V30 3 O 2.6674 8.4700 0.0 0
M  V30 4 C 9.3358 4.6200 0.0 0
M  V30 5 C 6.6684 0.0000 0.0 0
M  V30 6 C 0.0000 6.9300 0.0 0
M  V30 7 C 4.0011 4.6200 0.0 0
M  V30 8 N 2.6674 3.8500 0.0 0
M  V30 9 C 4.0011 6.1600 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 2.6674 6.9300 0.0 0
M  V30 12 N 1.3336 6.1600 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 14 C 6.6684 4.6200 0.0 0
M  V30 15 C 5.3347 2.3100 0.0 0
M  V30 16 C 8.0021 3.8500 0.0 0
M  V30 17 C 6.6684 1.5400 0.0 0
M  V30 18 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 10
M  V30 3 2 3 11
M  V30 4 1 4 16
M  V30 5 1 5 17
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2097490-91-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 536-74-3
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 1345826-43-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-17222949
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 96
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Regioselective Synthesis of 6-Alkyl- and 6-Aryluracils by Cs2CO3- or
K3PO4-Promoted Dimerization of 3-Alkyl- and 3-Aryl-2-Propynamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rajapaksha, Suranga M.; Mlsna, Todd E.; Pittman, Charles U.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2017), 82(11), 5678-5688

$RFMT $RIREG SCHEME47 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxyacetophenone
C10H12O3
1131-62-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 0.7700 0.0 0
M  V30 2 C 2.6675 0.0000 0.0 0
M  V30 3 O 6.6687 2.3101 0.0 0
M  V30 4 C 8.0023 3.0801 0.0 0
M  V30 5 C 1.3337 5.3901 0.0 0
M  V30 6 C 0.0000 4.6201 0.0 0
M  V30 7 O 1.3337 6.9302 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 2.6675 3.0801 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 4.0012 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[1-(3,4-Dimethoxyphenyl)ethylidene]methanamine
C11H15NO2
1810713-38-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 N 7.7000 5.3349 0.0 0
M  V30 7 C 7.7000 2.6674 0.0 0
M  V30 8 C 9.2400 5.3349 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 3.0800 5.3349 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 13
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(Z)]-N-[1-(3,4-Dimethoxyphenyl)ethylidene]methanamine
C11H15NO2
1810713-48-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 0.7700 0.0 0
M  V30 2 C 2.6675 0.0000 0.0 0
M  V30 3 O 6.6686 2.3100 0.0 0
M  V30 4 C 8.0022 3.0800 0.0 0
M  V30 5 C 1.3337 5.3901 0.0 0
M  V30 6 N 1.3337 6.9301 0.0 0
M  V30 7 C 0.0000 4.6201 0.0 0
M  V30 8 C 2.6675 7.7001 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 5.3348 3.0800 0.0 0
M  V30 11 C 2.6675 3.0800 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 2.6675 4.6201 0.0 0
M  V30 14 C 4.0011 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 13
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1131-62-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1810713-38-2
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 1810713-48-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-1862524
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, sealed flask used, molecular sieves used (4 A)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Disulfonimide-Catalyzed Asymmetric Reduction of N-Alkyl Imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wakchaure, Vijay N.; Kaib, Philip S. J.; Leutzsch, Markus; List, Benjamin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2015), 54(40), 11852-11856

$RFMT $RIREG SCHEME48 STEP1
$RXN



  3  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenyl [C(Z)]-N-[(3R,7S)-7-[[[1-(3-chloro-2-fluorophenyl)-5-methyl-1H-1,2,3-t...
C36H31ClFN9O3
1422448-80-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  50 55 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 5.3347 0.0 0
M  V30 2 C 4.6200 4.0009 0.0 0
M  V30 3 O 3.0800 4.0009 0.0 0
M  V30 4 N 5.3900 2.6673 0.0 0
M  V30 5 C 4.6200 1.3336 0.0 0
M  V30 6 N 3.8500 0.0000 0.0 0
M  V30 7 O 7.7000 9.3356 0.0 0
M  V30 8 N 16.1700 8.0020 0.0 0
M  V30 9 C 16.9400 9.3356 0.0 0
M  V30 10 O 16.1700 10.6694 0.0 0
M  V30 11 C 9.2400 12.0031 0.0 0
M  V30 12 C 18.9094 12.0462 0.0 0
M  V30 13 F 23.6635 8.8530 0.0 0
M  V30 14 Cl 26.1554 10.6633 0.0 0
M  V30 15 C 10.0100 5.3347 0.0 0
M  V30 16 C 11.5500 5.3347 0.0 0
M  V30 17 C 9.2400 6.6684 0.0 0
M  V30 18 C 9.2400 4.0009 0.0 0
M  V30 19 C 12.3200 6.6684 0.0 0
M  V30 20 C 12.3200 4.0009 0.0 0
M  V30 21 C 7.7000 6.6684 0.0 0
M  V30 22 N 10.0100 8.0020 0.0 0
M  V30 23 C 7.7000 4.0009 0.0 0
M  V30 24 C 13.8600 6.6684 0.0 0
M  V30 25 C 13.8600 4.0009 0.0 0
M  V30 26 C 6.9300 5.3347 0.0 0
M  V30 27 C 9.2400 9.3356 0.0 0
M  V30 28 C 14.6300 8.0020 0.0 0 CFG=1
M  V30 29 N 14.6300 5.3347 0.0 0
M  V30 30 C 10.0100 10.6694 0.0 0 CFG=2
M  V30 31 C 13.8600 9.3356 0.0 0
M  V30 32 C 11.5500 10.6694 0.0 0
M  V30 33 C 12.3200 9.3356 0.0 0
M  V30 34 C 18.4800 9.3356 0.0 0
M  V30 35 C 19.3852 10.5816 0.0 0
M  V30 36 N 19.3852 8.0898 0.0 0
M  V30 37 N 20.8499 10.1056 0.0 0
M  V30 38 N 20.8499 8.5656 0.0 0
M  V30 39 C 2.3100 5.3347 0.0 0
M  V30 40 C 3.0800 6.6684 0.0 0
M  V30 41 C 0.7700 5.3347 0.0 0
M  V30 42 C 2.3100 8.0020 0.0 0
M  V30 43 C 0.0000 6.6684 0.0 0
M  V30 44 C 0.7700 8.0020 0.0 0
M  V30 45 C 22.0958 11.0108 0.0 0
M  V30 46 C 23.5026 10.3845 0.0 0
M  V30 47 C 21.9347 12.5424 0.0 0
M  V30 48 C 24.7484 11.2897 0.0 0
M  V30 49 C 23.1807 13.4476 0.0 0
M  V30 50 C 24.5875 12.8213 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 26
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 39
M  V30 6 1 4 5 CFG=3
M  V30 7 3 5 6
M  V30 8 2 7 27
M  V30 9 1 8 9
M  V30 10 1 28 8 CFG=3
M  V30 11 2 9 10
M  V30 12 1 9 34
M  V30 13 1 30 11 CFG=3
M  V30 14 1 12 35
M  V30 15 1 13 46
M  V30 16 1 14 48
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 2 16 20
M  V30 22 2 17 21
M  V30 23 1 17 22
M  V30 24 1 18 23
M  V30 25 2 19 24
M  V30 26 1 20 25
M  V30 27 1 21 26
M  V30 28 1 22 27
M  V30 29 2 23 26
M  V30 30 1 24 28
M  V30 31 1 24 29
M  V30 32 2 25 29
M  V30 33 1 27 30
M  V30 34 1 28 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 1 37 38
M  V30 43 1 37 45
M  V30 44 2 39 40
M  V30 45 1 39 41
M  V30 46 1 40 42
M  V30 47 2 41 43
M  V30 48 2 42 44
M  V30 49 1 43 44
M  V30 50 2 45 46
M  V30 51 1 45 47
M  V30 52 1 46 48
M  V30 53 2 47 49
M  V30 54 2 48 50
M  V30 55 1 49 50
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 28 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Trifluoroacetic acid
C2HF3O2
76-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 F 2.1037 3.6437 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 F 0.5637 0.9764 0.0 0
M  V30 6 O 4.0010 2.3101 0.0 0
M  V30 7 O 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-1,2,3-Triazole-4-carboxamide, 1-(3-chloro-2-fluorophenyl)-N-[(3R,7S)-15-[[...
C31H30ClFN10O2.xC2HF3O2
1422448-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  52 55 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.8500 9.1848 0.0 0
M  V30 2 C 3.0800 7.8510 0.0 0
M  V30 3 N 1.5400 7.8510 0.0 0
M  V30 4 N 3.8500 6.5174 0.0 0
M  V30 5 C 0.7700 9.1848 0.0 0
M  V30 6 C 3.0800 5.1837 0.0 0
M  V30 7 N 0.0000 10.5184 0.0 0
M  V30 8 O 6.1600 13.1857 0.0 0
M  V30 9 N 14.6300 11.8521 0.0 0
M  V30 10 C 15.4000 13.1857 0.0 0
M  V30 11 O 14.6300 14.5195 0.0 0
M  V30 12 C 7.7000 15.8531 0.0 0
M  V30 13 C 17.3694 15.8963 0.0 0
M  V30 14 F 22.1236 12.7031 0.0 0
M  V30 15 Cl 24.6154 14.5133 0.0 0
M  V30 16 C 8.4700 9.1848 0.0 0
M  V30 17 C 10.0100 9.1848 0.0 0
M  V30 18 C 7.7000 10.5184 0.0 0
M  V30 19 C 7.7000 7.8510 0.0 0
M  V30 20 C 10.7800 10.5184 0.0 0
M  V30 21 C 10.7800 7.8510 0.0 0
M  V30 22 C 6.1600 10.5184 0.0 0
M  V30 23 N 8.4700 11.8521 0.0 0
M  V30 24 C 6.1600 7.8510 0.0 0
M  V30 25 C 12.3200 10.5184 0.0 0
M  V30 26 C 12.3200 7.8510 0.0 0
M  V30 27 C 5.3900 9.1848 0.0 0
M  V30 28 C 7.7000 13.1857 0.0 0
M  V30 29 C 13.0900 11.8521 0.0 0 CFG=1
M  V30 30 N 13.0900 9.1848 0.0 0
M  V30 31 C 8.4700 14.5195 0.0 0 CFG=2
M  V30 32 C 12.3200 13.1857 0.0 0
M  V30 33 C 10.0100 14.5195 0.0 0
M  V30 34 C 10.7800 13.1857 0.0 0
M  V30 35 C 16.9400 13.1857 0.0 0
M  V30 36 C 17.8452 14.4316 0.0 0
M  V30 37 N 17.8452 11.9399 0.0 0
M  V30 38 N 19.3099 13.9557 0.0 0
M  V30 39 N 19.3099 12.4157 0.0 0
M  V30 40 C 20.5558 14.8609 0.0 0
M  V30 41 C 21.9626 14.2346 0.0 0
M  V30 42 C 20.3947 16.3925 0.0 0
M  V30 43 C 23.2084 15.1398 0.0 0
M  V30 44 C 21.6407 17.2977 0.0 0
M  V30 45 C 23.0475 16.6714 0.0 0
M  V30 46 C 11.6408 2.3101 0.0 0
M  V30 47 C 12.9745 1.5400 0.0 0
M  V30 48 F 12.4109 3.6437 0.0 0
M  V30 49 F 10.3072 3.0801 0.0 0
M  V30 50 F 10.8708 0.9764 0.0 0
M  V30 51 O 14.3082 2.3101 0.0 0
M  V30 52 O 12.9745 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 27
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5 CFG=1
M  V30 6 1 4 6
M  V30 7 3 5 7
M  V30 8 2 8 28
M  V30 9 1 9 10
M  V30 10 1 29 9 CFG=3
M  V30 11 2 10 11
M  V30 12 1 10 35
M  V30 13 1 31 12 CFG=3
M  V30 14 1 13 36
M  V30 15 1 14 41
M  V30 16 1 15 43
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 2 18 22
M  V30 23 1 18 23
M  V30 24 1 19 24
M  V30 25 2 20 25
M  V30 26 1 21 26
M  V30 27 1 22 27
M  V30 28 1 23 28
M  V30 29 2 24 27
M  V30 30 1 25 29
M  V30 31 1 25 30
M  V30 32 2 26 30
M  V30 33 1 28 31
M  V30 34 1 29 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 34
M  V30 38 2 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 39
M  V30 42 1 38 39
M  V30 43 1 38 40
M  V30 44 2 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 2 42 44
M  V30 48 2 43 45
M  V30 49 1 44 45
M  V30 50 1 46 47
M  V30 51 1 46 48
M  V30 52 1 46 49
M  V30 53 1 46 50
M  V30 54 1 47 51
M  V30 55 2 47 52
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 29 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1H-1,2,3-Triazole-4-carboxamide, 1-(3-chloro-2-fluorophenyl)-N-[(3S,7S)-15-[[...
C31H30ClFN10O2.xC2HF3O2
1422448-78-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  52 55 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 20.6479 9.0338 0.0 0
M  V30 2 C 21.9817 9.8038 0.0 0
M  V30 3 N 21.9817 11.3438 0.0 0
M  V30 4 N 23.3153 9.0338 0.0 0
M  V30 5 C 23.3153 12.1138 0.0 0
M  V30 6 C 23.3153 7.4938 0.0 0
M  V30 7 N 24.6490 12.8838 0.0 0
M  V30 8 O 16.6469 6.7237 0.0 0
M  V30 9 N 9.9783 12.1138 0.0 0
M  V30 10 C 8.6446 11.3438 0.0 0
M  V30 11 O 8.6446 9.8038 0.0 0
M  V30 12 C 13.9794 5.1837 0.0 0
M  V30 13 C 5.5838 9.9810 0.0 0
M  V30 14 F 3.0631 15.1237 0.0 0
M  V30 15 Cl 0.0000 14.8018 0.0 0
M  V30 16 C 16.6469 11.3438 0.0 0
M  V30 17 C 15.3131 12.1138 0.0 0
M  V30 18 C 16.6469 9.8038 0.0 0
M  V30 19 C 17.9806 12.1138 0.0 0
M  V30 20 C 13.9794 11.3438 0.0 0
M  V30 21 C 15.3131 13.6539 0.0 0
M  V30 22 C 17.9806 9.0338 0.0 0
M  V30 23 N 15.3131 9.0338 0.0 0
M  V30 24 C 19.3142 11.3438 0.0 0
M  V30 25 C 12.6458 12.1138 0.0 0
M  V30 26 C 13.9794 14.4239 0.0 0
M  V30 27 C 19.3142 9.8038 0.0 0
M  V30 28 C 15.3131 7.4938 0.0 0
M  V30 29 C 11.3121 11.3438 0.0 0 CFG=1
M  V30 30 N 12.6458 13.6539 0.0 0
M  V30 31 C 13.9794 6.7237 0.0 0 CFG=1
M  V30 32 C 11.3121 9.8038 0.0 0
M  V30 33 C 12.6458 7.4938 0.0 0
M  V30 34 C 12.6458 9.0338 0.0 0
M  V30 35 C 7.3110 12.1138 0.0 0
M  V30 36 C 5.9040 11.4873 0.0 0
M  V30 37 N 7.1500 13.6454 0.0 0
M  V30 38 N 4.8736 12.6319 0.0 0
M  V30 39 N 5.6436 13.9656 0.0 0
M  V30 40 C 3.3420 12.4710 0.0 0
M  V30 41 C 2.4368 13.7168 0.0 0
M  V30 42 C 2.7155 11.0640 0.0 0
M  V30 43 C 0.9052 13.5558 0.0 0
M  V30 44 C 1.1840 10.9031 0.0 0
M  V30 45 C 0.2787 12.1489 0.0 0
M  V30 46 C 11.6577 2.3101 0.0 0
M  V30 47 C 12.9913 1.5400 0.0 0
M  V30 48 F 12.4277 3.6437 0.0 0
M  V30 49 F 10.3240 3.0801 0.0 0
M  V30 50 F 10.8877 0.9764 0.0 0
M  V30 51 O 14.3250 2.3101 0.0 0
M  V30 52 O 12.9913 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 27
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5 CFG=3
M  V30 6 1 4 6
M  V30 7 3 5 7
M  V30 8 2 8 28
M  V30 9 1 9 10
M  V30 10 1 29 9 CFG=3
M  V30 11 2 10 11
M  V30 12 1 10 35
M  V30 13 1 31 12 CFG=1
M  V30 14 1 13 36
M  V30 15 1 14 41
M  V30 16 1 15 43
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 2 18 22
M  V30 23 1 18 23
M  V30 24 1 19 24
M  V30 25 2 20 25
M  V30 26 1 21 26
M  V30 27 1 22 27
M  V30 28 1 23 28
M  V30 29 2 24 27
M  V30 30 1 25 29
M  V30 31 1 25 30
M  V30 32 2 26 30
M  V30 33 1 28 31
M  V30 34 1 29 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 34
M  V30 38 2 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 39
M  V30 42 1 38 39
M  V30 43 1 38 40
M  V30 44 2 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 2 42 44
M  V30 48 2 43 45
M  V30 49 1 44 45
M  V30 50 1 46 47
M  V30 51 1 46 48
M  V30 52 1 46 49
M  V30 53 1 46 50
M  V30 54 1 47 51
M  V30 55 2 47 52
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 29 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1422448-80-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1422448-74-5
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 1422448-78-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14593568
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 147.
1-(3-Chloro-2-fluorophenyl)-N-[(10R,14S)-5-[(E)-2-cyano-1-methylcarbamimidamido]-10-methyl-9-oxo-8,
16-diazatricyclo[l 3.3.1.02,7]nonadeca-1(19),2(7),3,5, 15,
17-hexaen-14-yl]-5-methyl-1H-1,2,3-triazole-4-carboxamide, TFA salt: A
mixture of 147A (11 mg, 0.016 mmol) and monomethylamine (0.795 mL, 1.589
mmol) in 2-propanol (0.2 mL) was stirred in a pressure-tested vial at
room temperature for 1h. Monomethylamine (0.795 mL, 1.589 mmol) was added
again and the reaction was stirred at rt for another hour. The reaction
was concentrated and purified by reverse phase HPLC to yield the desired
product. White solid, yield 6.2 mg, 95%. 1H NMR (500 MHz,
acetonitrile-d3) δ 8.62 (d, J = 5.78 Hz, 1H), 8.39 (d, J = 6.88 Hz, 1H),
8.25 (s, 1H), 7.90 (s, 1H), 7.67 (ddd, J = 1.51, 6.88, 8.12 Hz, 1H), 7.56
(dd, J = 1.38, 5.78 Hz, 1H), 7.51 (d, J = 8.53 Hz, 1H), 7.46 (br. s.,
1H), 7.42 (ddd, J = 1.65, 6.53, 8.05 Hz, 1H), 7.33 (dt, J = 1.38, 8.12
Hz, 1H), 7.28 (dd, J = 1.79, 8.39 Hz, 1H), 7.23 (br. s., 1H), 5.96 (d, J
= 3.58 Hz, 1H), 5.26 (td, J = 6.57, 11.07 Hz, 1H), 2.80 (d, J = 4.68 Hz,
3H), 2.52-2.60 (m, 2H), 2.33 (s, 2H), 2.01-2.09 (m, 2H), 1.90-1.99 (m,
2H), 1.77 (t, J = 12.10 Hz, 1H), 1.33-1.46 (m, 2H), 0.81 (d, J = 6.88 Hz,
3H), 0.24-0.36 (m, 1H) ppm. MS(ESI) m/z: 629.6 (M+H)+. Analytical HPLC RT
= 5.92 min (Method A). [00608] Example 148.
1-(3-Chloro-2-fluorophenyl)-N-[(10S,14S)-5-[(E)-2-cyano-1-methylcarbamimidamido]-10-methyl-9-oxo-8,
16-diazatricyclo [13.3.1.02,7]nonadeca-1(19),2(7),3,5, 15,
17-hexaen-14-yl]-5-methyl-1H-1,2,3-triazole-4-carboxamide, TFA salt:
Example 148 was made in the same way as Example 147 by using the other
isomer. 1H NMR (500 MHz, acetonitrile-d3) δ 8.62 (d, J = 5.50 Hz, 1H),
8.33 (d, J = 6.88 Hz, 1H), 7.88 (s, 1H), 7.64-7.70 (m, 1H), 7.61 (s, 1H),
7.50 (d, J = 8.25 Hz, 1H), 7.39-7.46 (m, 2H), 7.30-7.36 (m, 2H), 7.26
(br. s., 1H), 5.90 (br. s., 1H), 5.13-5.20 (m, 1H), 2.80 (d, J = 4.95 Hz,
3H), 2.42 (d, J = 6.05 Hz, 1H), 2.35 (d, J = 0.55 Hz, 3H), 2.03-2.18 (m,
2H), 1.67-1.78 (m, 2H), 1.66-1.60 (m, 1H), 1.25-1.35 (m, 4H), 1.08 (d, J
= 7.15 Hz, 3H), 0.88-83 (m, 1H) ppm. MS(ESI) m/z: 629.6 (M+H)+.
Analytical HPLC RT = 5.90 min (Method A).
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, last stage is carried out using RP-HPLC, incremental
addition of MeNH2 in stage 1, reaction in a pressure vial in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel macrocycles as factor XIa inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pinto, Donald J.; Corte, James R.; Gilligan, Paul J.; Fang, Tianan;
Smith, Leon M., II; Wang, Yufeng; Yang, Wu; Ewing, William R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013022818 A1 2013-02-14

$RFMT $RIREG SCHEME49 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2,3,5-Tri-O-benzoyl-β-D-ribofuranosyl)-1H-imidazo[4,5-c]pyridin-4-amine
C32H26N4O7
2265218-19-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 48 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.2211 7.9889 0.0 0
M  V30 2 C 4.5947 9.3957 0.0 0
M  V30 3 O 5.4999 10.6416 0.0 0
M  V30 4 O 7.4629 10.4786 0.0 0
M  V30 5 C 8.6075 11.5092 0.0 0
M  V30 6 O 10.0721 11.0332 0.0 0
M  V30 7 C 10.5237 9.1159 0.0 0
M  V30 8 O 11.8574 8.3458 0.0 0
M  V30 9 C 13.1911 9.1159 0.0 0
M  V30 10 O 13.1912 10.6559 0.0 0
M  V30 11 N 6.0812 0.0000 0.0 0
M  V30 12 C 7.5227 6.4941 0.0 0 CFG=2
M  V30 13 C 6.7527 7.8278 0.0 0 CFG=2
M  V30 14 O 9.0290 6.8143 0.0 0
M  V30 15 C 7.7831 8.9723 0.0 0 CFG=2
M  V30 16 C 9.1901 8.3458 0.0 0 CFG=2
M  V30 17 N 6.8964 5.0873 0.0 0
M  V30 18 C 7.6664 3.7535 0.0 0
M  V30 19 C 5.3899 4.7671 0.0 0
M  V30 20 C 6.6358 2.6091 0.0 0
M  V30 21 C 9.1727 3.4333 0.0 0
M  V30 22 N 5.2290 3.2354 0.0 0
M  V30 23 C 7.1117 1.1444 0.0 0
M  V30 24 C 9.6485 1.9688 0.0 0
M  V30 25 N 8.6181 0.8242 0.0 0
M  V30 26 C 3.0631 9.5566 0.0 0
M  V30 27 C 2.1579 8.3107 0.0 0
M  V30 28 C 2.4368 10.9636 0.0 0
M  V30 29 C 0.6263 8.4718 0.0 0
M  V30 30 C 0.9052 11.1245 0.0 0
M  V30 31 C 0.0000 9.8786 0.0 0
M  V30 32 C 8.2872 13.0155 0.0 0
M  V30 33 C 6.8226 13.4914 0.0 0
M  V30 34 C 9.4317 14.0459 0.0 0
M  V30 35 C 6.5024 14.9978 0.0 0
M  V30 36 C 9.1115 15.5524 0.0 0
M  V30 37 C 7.6468 16.0282 0.0 0
M  V30 38 C 14.5249 8.3458 0.0 0
M  V30 39 C 14.5249 6.8058 0.0 0
M  V30 40 C 15.8585 9.1159 0.0 0
M  V30 41 C 15.8585 6.0358 0.0 0
M  V30 42 C 17.1922 8.3458 0.0 0
M  V30 43 C 17.1922 6.8058 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 13 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 2 26
M  V30 5 1 4 5
M  V30 6 1 15 4 CFG=3
M  V30 7 2 5 6
M  V30 8 1 5 32
M  V30 9 1 7 8
M  V30 10 1 16 7 CFG=1
M  V30 11 1 8 9
M  V30 12 2 9 10
M  V30 13 1 9 38
M  V30 14 1 11 23
M  V30 15 1 12 13
M  V30 16 1 12 14
M  V30 17 1 12 17 CFG=1
M  V30 18 1 13 15
M  V30 19 1 14 16
M  V30 20 1 15 16
M  V30 21 1 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 18 21
M  V30 25 2 19 22
M  V30 26 1 20 22
M  V30 27 2 20 23
M  V30 28 1 21 24
M  V30 29 1 23 25
M  V30 30 2 24 25
M  V30 31 2 26 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 2 28 30
M  V30 35 2 29 31
M  V30 36 1 30 31
M  V30 37 2 32 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 2 34 36
M  V30 41 2 35 37
M  V30 42 1 36 37
M  V30 43 2 38 39
M  V30 44 1 38 40
M  V30 45 1 39 41
M  V30 46 2 40 42
M  V30 47 2 41 43
M  V30 48 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 12 13 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Methylbenzamide
C8H9NO
613-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 O 5.3901 0.0000 0.0 0
M  V30 4 C 6.9302 2.6673 0.0 0
M  V30 5 C 3.0801 1.3337 0.0 0
M  V30 6 C 2.3101 0.0000 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 0.7700 2.6673 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Deazaadenosine
C11H14N4O4
6736-58-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.9016 6.4170 0.0 0
M  V30 2 N 10.5369 3.9148 0.0 0
M  V30 3 C 0.6966 1.4646 0.0 0
M  V30 4 O 1.1724 0.0000 0.0 0
M  V30 5 O 0.0000 4.7418 0.0 0
M  V30 6 N 5.3914 4.1752 0.0 0
M  V30 7 C 6.5359 3.1447 0.0 0
M  V30 8 C 6.0178 5.5820 0.0 0
M  V30 9 C 7.8696 3.9148 0.0 0
M  V30 10 C 6.5359 1.6047 0.0 0
M  V30 11 N 7.5494 5.4211 0.0 0
M  V30 12 C 9.2032 3.1447 0.0 0
M  V30 13 C 7.8696 0.8347 0.0 0
M  V30 14 N 9.2032 1.6047 0.0 0
M  V30 15 C 3.8850 3.8550 0.0 0 CFG=1
M  V30 16 O 3.2586 2.4480 0.0 0
M  V30 17 C 2.7405 4.8854 0.0 0 CFG=2
M  V30 18 C 1.7270 2.6091 0.0 0 CFG=2
M  V30 19 C 1.4068 4.1154 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 17 1 CFG=1
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 1 18 3 CFG=3
M  V30 5 1 19 5 CFG=1
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 15 6 CFG=3
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 15 17 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2265218-19-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 613-93-4
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 6736-58-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-19662048
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile synthesis of a 3-deazaadenosine phosphoramidite for RNA
solid-phase synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mairhofer, Elisabeth; Fuchs, Elisabeth; Micura, Ronald
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Beilstein Journal of Organic Chemistry (2016), 122556-2562

$RFMT $RIREG SCHEME50 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2-Fluoro-4-nitrophenyl)(2-fluorophenyl)methanone
C13H7F2NO3
928790-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 O 4.0011 6.1600 0.0 0
M  V30 3 F 6.6684 6.1600 0.0 0
M  V30 4 F 1.3336 6.1600 0.0 0
M  V30 5 N 9.3358 1.5400 0.0 0 VAL=5
M  V30 6 O 10.6694 2.3100 0.0 0
M  V30 7 O 9.3358 0.0000 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 6.6684 4.6200 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 8.0021 3.8500 0.0 0
M  V30 12 C 6.6684 1.5400 0.0 0
M  V30 13 C 8.0021 2.3100 0.0 0
M  V30 14 C 2.6673 3.8500 0.0 0
M  V30 15 C 1.3336 4.6200 0.0 0
M  V30 16 C 2.6673 2.3100 0.0 0
M  V30 17 C 0.0000 3.8500 0.0 0
M  V30 18 C 1.3336 1.5400 0.0 0
M  V30 19 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 1 14
M  V30 4 1 3 9
M  V30 5 1 4 15
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 13
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
10-Methyl-3-nitro-9(10H)-acridinone
C14H10N2O3
34811-55-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 6.1600 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 N 9.3358 4.6200 0.0 0 VAL=5
M  V30 4 O 9.3358 6.1600 0.0 0
M  V30 5 O 10.6694 3.8500 0.0 0
M  V30 6 C 5.3347 3.8500 0.0 0
M  V30 7 C 5.3347 2.3100 0.0 0
M  V30 8 N 4.0011 4.6200 0.0 0
M  V30 9 C 6.6684 4.6200 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 6.6684 1.5400 0.0 0
M  V30 12 C 2.6673 3.8500 0.0 0
M  V30 13 C 8.0021 3.8500 0.0 0
M  V30 14 C 2.6673 2.3100 0.0 0
M  V30 15 C 8.0021 2.3100 0.0 0
M  V30 16 C 1.3336 4.6200 0.0 0
M  V30 17 C 1.3336 1.5400 0.0 0
M  V30 18 C 0.0000 3.8500 0.0 0
M  V30 19 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 10
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 2 12 16
M  V30 17 2 13 15
M  V30 18 2 14 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2-Fluorophenyl)[2-(methylamino)-4-nitrophenyl]methanone
C14H11FN2O3
928790-60-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.6201 0.0 0
M  V30 2 O 4.0012 6.1601 0.0 0
M  V30 3 N 6.6685 6.1601 0.0 0
M  V30 4 C 8.0022 6.9302 0.0 0
M  V30 5 N 9.3360 1.5400 0.0 0 VAL=5
M  V30 6 O 9.3360 0.0000 0.0 0
M  V30 7 O 10.6697 2.3101 0.0 0
M  V30 8 F 1.3337 6.1601 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 6.6685 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 8.0022 3.8501 0.0 0
M  V30 13 C 6.6685 1.5400 0.0 0
M  V30 14 C 8.0022 2.3101 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 17 C 2.6673 2.3101 0.0 0
M  V30 18 C 0.0000 3.8501 0.0 0
M  V30 19 C 1.3337 1.5400 0.0 0
M  V30 20 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 1 15
M  V30 4 1 3 4
M  V30 5 1 3 10
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 14
M  V30 9 1 8 16
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 928790-45-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 34811-55-7
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 928790-60-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-383959
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 2
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of heterocyclic compounds via nucleophilic aroylation catalyzed
by imidazolidenyl carbene
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Suzuki, Yumiko; Toyota, Tomonori; Miyashita, Akira; Sato, Masayuki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical & Pharmaceutical Bulletin (2006), 54(12), 1653-1658

$RFMT $RIREG SCHEME51 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4S)-3-[(3S)-3-Hydroxy-1-oxo-3-phenylpropyl]-4-(1-methylethyl)-1-[(1R)-1-phen...
C23H28N2O3
1375257-32-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.2221 2.3932 0.0 0
M  V30 2 C 9.5559 3.1632 0.0 0
M  V30 3 O 8.2221 0.8532 0.0 0
M  V30 4 C 10.8895 2.3932 0.0 0 CFG=1
M  V30 5 O 10.8895 0.8532 0.0 0
M  V30 6 C 5.1615 1.0304 0.0 0
M  V30 7 C 3.6968 0.5546 0.0 0
M  V30 8 C 6.3059 0.0000 0.0 0
M  V30 9 O 7.8719 5.7253 0.0 0
M  V30 10 C 4.5948 6.4218 0.0 0 CFG=2
M  V30 11 C 5.5000 7.6677 0.0 0
M  V30 12 N 6.8884 3.1632 0.0 0
M  V30 13 C 5.4816 2.5368 0.0 0 CFG=1
M  V30 14 C 6.7275 4.6947 0.0 0
M  V30 15 C 4.4511 3.6812 0.0 0
M  V30 16 N 5.2211 5.0150 0.0 0
M  V30 17 C 3.0632 6.5827 0.0 0
M  V30 18 C 2.4367 7.9897 0.0 0
M  V30 19 C 2.1580 5.3369 0.0 0
M  V30 20 C 0.9052 8.1506 0.0 0
M  V30 21 C 0.6265 5.4978 0.0 0
M  V30 22 C 0.0000 6.9048 0.0 0
M  V30 23 C 12.2232 3.1632 0.0 0
M  V30 24 C 13.5568 2.3932 0.0 0
M  V30 25 C 12.2232 4.7032 0.0 0
M  V30 26 C 14.8906 3.1632 0.0 0
M  V30 27 C 13.5568 5.4732 0.0 0
M  V30 28 C 14.8906 4.7032 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5 CFG=1
M  V30 6 1 4 23
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 13 6 CFG=1
M  V30 10 2 9 14
M  V30 11 1 10 11 CFG=1
M  V30 12 1 10 16
M  V30 13 1 10 17
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 4 10 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(βS)-β-Hydroxy-N-methylbenzenepropanamide
C10H13NO2
134619-76-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0 CFG=1
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 4.6200 0.0 0
M  V30 4 C 6.6684 3.0800 0.0 0
M  V30 5 N 8.0021 2.3100 0.0 0
M  V30 6 O 6.6684 4.6200 0.0 0
M  V30 7 C 9.3358 3.0800 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 1.3336 3.0800 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3336 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(4S)-4-(1-Methylethyl)-1-[(1R)-1-phenylethyl]-2-imidazolidinone
C14H20N2O
1375257-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.7106 0.0 0 CFG=2
M  V30 2 C 2.3100 1.3769 0.0 0
M  V30 3 O 5.0494 0.0000 0.0 0
M  V30 4 C 8.2358 4.3858 0.0 0
M  V30 5 C 8.0747 5.9173 0.0 0
M  V30 6 C 9.6426 3.7593 0.0 0
M  V30 7 N 4.6200 2.7106 0.0 0
M  V30 8 C 5.5252 3.9564 0.0 0
M  V30 9 C 5.5252 1.4647 0.0 0
M  V30 10 C 6.9898 3.4806 0.0 0 CFG=2
M  V30 11 N 6.9898 1.9406 0.0 0
M  V30 12 C 2.3100 4.0442 0.0 0
M  V30 13 C 3.0800 5.3779 0.0 0
M  V30 14 C 0.7700 4.0442 0.0 0
M  V30 15 C 2.3100 6.7117 0.0 0
M  V30 16 C 0.0000 5.3779 0.0 0
M  V30 17 C 0.7700 6.7117 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 7
M  V30 3 1 1 12
M  V30 4 2 3 9
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 10 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1375257-32-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 134619-76-4
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 1375257-29-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-14272286
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 88
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Synthesis of
(S)/(R)-3-hydroxy-N-methyl-3-phenylpropanamide (12/15). To a solution of
8a(i) or 9a(i) (3.0 g, 7.88 mmol, 1.0 equiv) in methanol (50 mL) was
added aq methylamine (1.8 mL, 23.6 mmol, 3.0 equiv; 40% in H2O), and
refluxed for 5 h. After completion of the reaction the solvent was
removed under vacuum, and the reaction mixture was extracted with ethyl
acetate, dried, concentrated and purified by column chromatography[silica
gel (60-120 mesh), eluent EtOAc:hexanes = 3:7] to afford the chiral
auxiliary and the corresponding hydroxy amide (eluent EtOAc:hexanes =
4:6;). (S)-3-Hydroxy-3-phenylpropanoic acid (10) (1.7 g, 94%),
(S)-3-Hydroxy-N-methyl-3-phenylpropanamide (12). White solid, .yield 1.24
g, 88%. 10: Mp 116-118 °C;[α]D20 -17.9 (c 1, EtOH),[α]D20 -57.5 (c 1,
CHCl3); for its antipode: 11 lit 1a[α]D20 +15.5 (c 0.9, EtOH), lit
1b[α]D20 +54.8 (c 1.00, CHCl3); 1H NMR (400 MHz, CDCl3) δ 2.72-2.85 (m,
2H), 5.15 (dd, J= 9.29, 3.76 Hz, 1H), 7.28-7.37 (m, 5H); 13C NMR (100
MHz, CDCl3) δ 43.04, 70.24, 125.69, 128.00, 128.66, 142.18, 176.55; HRMS
(ESI-TOF) calcd for C9H10O3[M]+:166.0630; found: 166.1227; and
C9H10O3Na[M+Na]+: 189.0528; found: 189.1081. 12: Mp 133-136 °C;[α]D20
-76.3 (c 0.5, CHCl3); 1H NMR (400 MHz, CDCl3) δ 2.49-2.59 (m, 2H), 2.82
(s, 3H), 5.07-5.10 (m, 1H), 5.91 (brs, NH, 1H), 7.28-7.36 (m, 5H); 13C
NMR (100 MHz, CDCl3) δ 26.20, 44.57, 70.91, 125.57, 127.69, 128.52,
143.05, 172.47; HRMS (ESI-TOF) calcd for C10H13NO2Na [M+Na]+: 202.0844;
found: 202.0847.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown for 2-Imidazolidinone,
4-(1-methylethyl)-1-[(1R)-1-phenylethyl]-, (4S)-
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reversal of selectivity in acetate aldol reactions of
N-acetyl-(S)-4-isopropyl-1-[(R)-1-phenylethyl]imidazolidin-2-one
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khatik, Gopal L.; Kumar, Varun; Nair, Vipin A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(10), 2442-2445

$RFMT $RIREG SCHEME52 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4′-Fluoroacetophenone
C8H7FO
403-42-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 F 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[1-(4-Fluorophenyl)ethylidene]methanamine
C9H10FN
1810713-31-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 C 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 F 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 6.1601 0.0000 0.0 0
M  V30 10 C 6.1601 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(Z)]-N-[1-(4-Fluorophenyl)ethylidene]methanamine
C9H10FN
1810713-42-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 N 0.0000 1.3337 0.0 0
M  V30 3 C 0.0000 4.0010 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 F 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 3.0801 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 4.6201 1.3337 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 403-42-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1810713-31-5
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 1810713-42-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6450631
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, sealed flask used, molecular sieves used (4 A)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Disulfonimide-Catalyzed Asymmetric Reduction of N-Alkyl Imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wakchaure, Vijay N.; Kaib, Philip S. J.; Leutzsch, Markus; List, Benjamin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2015), 54(40), 11852-11856

$RFMT $RIREG SCHEME53 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxyacetophenone
C9H10O2
586-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 O 6.6687 1.5400 0.0 0
M  V30 5 C 8.0023 2.3101 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[1-(3-Methoxyphenyl)ethylidene]methanamine
C10H13NO
1810713-36-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.0801 0.0 0
M  V30 2 N 1.3337 2.3101 0.0 0
M  V30 3 C 2.6675 4.6201 0.0 0
M  V30 4 C 0.0000 3.0801 0.0 0
M  V30 5 O 8.0023 3.0801 0.0 0
M  V30 6 C 9.3360 2.3101 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 5.3348 3.0801 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(Z)]-N-[1-(3-Methoxyphenyl)ethylidene]methanamine
C10H13NO
1810713-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3100 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 3.8500 0.0 0
M  V30 5 O 6.6686 1.5400 0.0 0
M  V30 6 C 8.0022 2.3100 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 586-37-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1810713-36-0
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 1810713-46-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3727911
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, sealed flask used, molecular sieves used (4 A)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Disulfonimide-Catalyzed Asymmetric Reduction of N-Alkyl Imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wakchaure, Vijay N.; Kaib, Philip S. J.; Leutzsch, Markus; List, Benjamin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2015), 54(40), 11852-11856

$RFMT $RIREG SCHEME54 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4′-Methoxyacetophenone
C9H10O2
100-06-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, N-[1-(4-methoxyphenyl)ethylidene]-, (E)-
C10H13NO
51983-49-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 N 1.3337 2.3101 0.0 0
M  V30 3 C 2.6675 0.0000 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 O 8.0023 4.6201 0.0 0
M  V30 6 C 9.3360 3.8501 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, N-[1-(4-methoxyphenyl)ethylidene]-, (Z)-
C10H13NO
51983-55-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3100 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 3.8500 0.0 0
M  V30 5 O 6.6686 4.6201 0.0 0
M  V30 6 C 8.0022 3.8500 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-06-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 51983-49-4
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 51983-55-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-4307742
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, sealed flask used, molecular sieves used (4 A)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Disulfonimide-Catalyzed Asymmetric Reduction of N-Alkyl Imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wakchaure, Vijay N.; Kaib, Philip S. J.; Leutzsch, Markus; List, Benjamin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2015), 54(40), 11852-11856

$RFMT $RIREG SCHEME55 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Acetylbenzonitrile
C9H7NO
1443-80-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 6.9302 1.3337 0.0 0
M  V30 5 N 8.4702 1.3337 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 3.0801 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 4.6201 2.6673 0.0 0
M  V30 11 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 3 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(1E)-1-(Methylimino)ethyl]benzonitrile
C10H10N2
1810713-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 C 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 C 8.4701 1.3337 0.0 0
M  V30 6 N 10.0101 1.3337 0.0 0
M  V30 7 C 3.8500 1.3337 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 6.1601 2.6673 0.0 0
M  V30 11 C 6.1601 0.0000 0.0 0
M  V30 12 C 6.9301 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 3 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(1Z)-1-(Methylimino)ethyl]benzonitrile
C10H10N2
1810713-45-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 N 0.0000 1.3337 0.0 0
M  V30 3 C 0.0000 4.0010 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 N 8.4702 2.6673 0.0 0
M  V30 7 C 2.3101 2.6673 0.0 0
M  V30 8 C 3.0801 1.3337 0.0 0
M  V30 9 C 3.0801 4.0010 0.0 0
M  V30 10 C 4.6201 1.3337 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 12 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 3 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1443-80-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1810713-34-8
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 1810713-45-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-14970064
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, sealed flask used, molecular sieves used (4 A)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Disulfonimide-Catalyzed Asymmetric Reduction of N-Alkyl Imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wakchaure, Vijay N.; Kaib, Philip S. J.; Leutzsch, Markus; List, Benjamin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2015), 54(40), 11852-11856

$RFMT $RIREG SCHEME56 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E,6E)-1,8-Diphenyl-2,6-octadiene-1,8-dione
C20H18O2
182888-28-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 5.3347 3.0800 0.0 0
M  V30 3 O 4.0011 0.7700 0.0 0
M  V30 4 C 6.6685 2.3100 0.0 0
M  V30 5 C 8.0021 3.0800 0.0 0
M  V30 6 C 9.3358 2.3100 0.0 0
M  V30 7 C 10.6694 3.0800 0.0 0
M  V30 8 C 12.0032 2.3100 0.0 0
M  V30 9 C 13.3369 3.0800 0.0 0
M  V30 10 O 13.3369 4.6200 0.0 0
M  V30 11 C 2.6674 3.0800 0.0 0
M  V30 12 C 2.6674 4.6200 0.0 0
M  V30 13 C 1.3338 2.3100 0.0 0
M  V30 14 C 1.3338 5.3900 0.0 0
M  V30 15 C 0.0000 3.0800 0.0 0
M  V30 16 C 0.0000 4.6200 0.0 0
M  V30 17 C 14.6705 2.3100 0.0 0
M  V30 18 C 14.6705 0.7700 0.0 0
M  V30 19 C 16.0041 3.0800 0.0 0
M  V30 20 C 16.0041 0.0000 0.0 0
M  V30 21 C 17.3379 2.3100 0.0 0
M  V30 22 C 17.3379 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 2 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 7 8
M  V30 9 1 8 9
M  V30 10 2 9 10
M  V30 11 1 9 17
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanone, 2,2′-[(2R,5R)-1-methyl-2,5-pyrrolidinediyl]bis[1-phenyl-, rel-
C21H23NO2
875608-46-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3100 0.0 0
M  V30 2 C 4.0010 3.0801 0.0 0
M  V30 3 O 4.0010 4.6201 0.0 0
M  V30 4 C 8.3955 0.9473 0.0 0
M  V30 5 C 10.6374 3.4372 0.0 0
M  V30 6 C 11.5427 4.6831 0.0 0
M  V30 7 O 10.9162 6.0899 0.0 0
M  V30 8 C 6.6685 3.0801 0.0 0 CFG=2
M  V30 9 N 8.0753 2.4536 0.0 0
M  V30 10 C 6.8294 4.6116 0.0 0
M  V30 11 C 9.1059 3.5981 0.0 0 CFG=2
M  V30 12 C 8.3359 4.9318 0.0 0
M  V30 13 C 2.6673 2.3100 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 15 C 1.3337 3.0801 0.0 0
M  V30 16 C 1.3337 0.0000 0.0 0
M  V30 17 C 0.0000 2.3100 0.0 0
M  V30 18 C 0.0000 0.7700 0.0 0
M  V30 19 C 13.0742 4.5220 0.0 0
M  V30 20 C 13.9795 5.7680 0.0 0
M  V30 21 C 13.7006 3.1152 0.0 0
M  V30 22 C 15.5110 5.6069 0.0 0
M  V30 23 C 15.2323 2.9542 0.0 0
M  V30 24 C 16.1373 4.2001 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 8 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 2 13
M  V30 5 1 4 9
M  V30 6 1 5 6
M  V30 7 1 11 5 CFG=1
M  V30 8 2 6 7
M  V30 9 1 6 19
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 8 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-2,2′-[(2R,5S)-1-Methyl-2,5-pyrrolidinediyl]bis[1-phenylethanone]
C21H23NO2
1395349-05-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3100 0.0 0
M  V30 2 C 4.0010 3.0801 0.0 0
M  V30 3 O 4.0010 4.6201 0.0 0
M  V30 4 C 8.3955 0.9473 0.0 0
M  V30 5 C 10.6374 3.4372 0.0 0
M  V30 6 C 11.5427 4.6831 0.0 0
M  V30 7 O 10.9162 6.0899 0.0 0
M  V30 8 C 6.6685 3.0801 0.0 0 CFG=2
M  V30 9 N 8.0753 2.4536 0.0 0
M  V30 10 C 6.8294 4.6116 0.0 0
M  V30 11 C 9.1059 3.5981 0.0 0 CFG=1
M  V30 12 C 8.3359 4.9318 0.0 0
M  V30 13 C 2.6673 2.3100 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 15 C 1.3337 3.0801 0.0 0
M  V30 16 C 1.3337 0.0000 0.0 0
M  V30 17 C 0.0000 2.3100 0.0 0
M  V30 18 C 0.0000 0.7700 0.0 0
M  V30 19 C 13.0742 4.5220 0.0 0
M  V30 20 C 13.9795 5.7680 0.0 0
M  V30 21 C 13.7006 3.1152 0.0 0
M  V30 22 C 15.5110 5.6069 0.0 0
M  V30 23 C 15.2323 2.9542 0.0 0
M  V30 24 C 16.1373 4.2001 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 8 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 2 13
M  V30 5 1 4 9
M  V30 6 1 5 6
M  V30 7 1 11 5 CFG=3
M  V30 8 2 6 7
M  V30 9 1 6 19
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 8 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 182888-28-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 875608-46-1
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 1395349-05-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-3772345
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 5
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, Aza-Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thermodynamic epimeric equilibration and crystallisation-induced dynamic
resolution of lobelanine, norlobelanine and related analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Amara, Z.; Bernadat, G.; Venot, P.-E.; Retailleau, P.; Troufflard, C.;
Drege, E.; Le Bideau, F.; Joseph, D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2014), 12(48), 9797-9810

$RFMT $RIREG SCHEME57 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4,6-Tris(1,1-dimethylethyl) α2,α4,α6-tris[(1,1-dimethylethoxy)carbonyl]-α2,...
C36H54N6O18
209979-80-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  60 60 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3349 5.3347 0.0 0
M  V30 2 C 4.0011 6.1047 0.0 0
M  V30 3 C 4.5649 4.0011 0.0 0
M  V30 4 N 6.6685 4.5647 0.0 0 VAL=5
M  V30 5 O 2.6674 5.3347 0.0 0
M  V30 6 O 4.0011 7.6447 0.0 0
M  V30 7 O 5.3349 2.6673 0.0 0
M  V30 8 O 3.0249 4.0011 0.0 0
M  V30 9 O 8.0021 5.3347 0.0 0
M  V30 10 O 6.6685 3.0247 0.0 0
M  V30 11 C 1.3338 6.1047 0.0 0
M  V30 12 C 4.5649 1.3336 0.0 0
M  V30 13 C 0.5638 4.7711 0.0 0
M  V30 14 C 0.0000 6.8747 0.0 0
M  V30 15 C 2.1038 7.4384 0.0 0
M  V30 16 C 3.2311 2.1036 0.0 0
M  V30 17 C 3.7949 0.0000 0.0 0
M  V30 18 C 5.8985 0.5636 0.0 0
M  V30 19 C 5.3349 10.6694 0.0 0
M  V30 20 C 4.5649 12.0031 0.0 0
M  V30 21 C 6.6685 11.4394 0.0 0
M  V30 22 N 4.0011 9.8994 0.0 0 VAL=5
M  V30 23 O 3.0247 12.0031 0.0 0
M  V30 24 O 5.3349 13.3367 0.0 0
M  V30 25 O 6.6685 12.9794 0.0 0
M  V30 26 O 8.0021 10.6694 0.0 0
M  V30 27 O 2.6674 10.6694 0.0 0
M  V30 28 O 4.0011 8.3594 0.0 0
M  V30 29 C 2.2549 13.3367 0.0 0
M  V30 30 C 8.0021 13.7494 0.0 0
M  V30 31 C 3.5885 14.1067 0.0 0
M  V30 32 C 1.4847 14.6705 0.0 0
M  V30 33 C 0.9211 12.5667 0.0 0
M  V30 34 C 7.2321 15.0831 0.0 0
M  V30 35 C 9.3358 14.5194 0.0 0
M  V30 36 C 8.7721 12.4158 0.0 0
M  V30 37 C 9.9549 8.0020 0.0 0
M  V30 38 C 9.9549 6.4620 0.0 0
M  V30 39 C 11.4949 8.0020 0.0 0
M  V30 40 N 9.9549 9.5420 0.0 0 VAL=5
M  V30 41 O 11.2885 5.6920 0.0 0
M  V30 42 O 8.6211 5.6920 0.0 0
M  V30 43 O 12.2649 9.3358 0.0 0
M  V30 44 O 12.2649 6.6684 0.0 0
M  V30 45 O 8.6211 10.3120 0.0 0
M  V30 46 O 11.2885 10.3120 0.0 0
M  V30 47 C 11.2885 4.1520 0.0 0
M  V30 48 C 13.8047 9.3358 0.0 0
M  V30 49 C 12.8285 4.1520 0.0 0
M  V30 50 C 11.2885 2.6120 0.0 0
M  V30 51 C 9.7485 4.1520 0.0 0
M  V30 52 C 13.8049 7.7958 0.0 0
M  V30 53 C 15.3449 9.3358 0.0 0
M  V30 54 C 13.8049 10.8758 0.0 0
M  V30 55 C 6.1049 6.6684 0.0 0
M  V30 56 N 5.3349 8.0020 0.0 0
M  V30 57 N 7.6449 6.6684 0.0 0
M  V30 58 C 6.1049 9.3358 0.0 0
M  V30 59 C 8.4149 8.0020 0.0 0
M  V30 60 N 7.6449 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 55
M  V30 5 1 2 5
M  V30 6 2 2 6
M  V30 7 1 3 7
M  V30 8 2 3 8
M  V30 9 2 4 9
M  V30 10 2 4 10
M  V30 11 1 5 11
M  V30 12 1 7 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 1 12 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 22 1 19 58
M  V30 23 1 20 23
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 2 21 26
M  V30 27 2 22 27
M  V30 28 2 22 28
M  V30 29 1 23 29
M  V30 30 1 25 30
M  V30 31 1 29 31
M  V30 32 1 29 32
M  V30 33 1 29 33
M  V30 34 1 30 34
M  V30 35 1 30 35
M  V30 36 1 30 36
M  V30 37 1 37 38
M  V30 38 1 37 39
M  V30 39 1 37 40
M  V30 40 1 37 59
M  V30 41 1 38 41
M  V30 42 2 38 42
M  V30 43 1 39 43
M  V30 44 2 39 44
M  V30 45 2 40 45
M  V30 46 2 40 46
M  V30 47 1 41 47
M  V30 48 1 43 48
M  V30 49 1 47 49
M  V30 50 1 47 50
M  V30 51 1 47 51
M  V30 52 1 48 52
M  V30 53 1 48 53
M  V30 54 1 48 54
M  V30 55 1 55 56
M  V30 56 2 55 57
M  V30 57 2 56 58
M  V30 58 1 57 59
M  V30 59 1 58 60
M  V30 60 2 59 60
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Bis(1,1-dimethylethyl) α2,α4-bis[(1,1-dimethylethoxy)carbonyl]-6-(methyla...
C26H40N6O12
306315-45-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3349 5.3347 0.0 0
M  V30 2 C 4.0011 6.1047 0.0 0
M  V30 3 C 4.5649 4.0011 0.0 0
M  V30 4 N 6.6685 4.5647 0.0 0 VAL=5
M  V30 5 O 2.6674 5.3347 0.0 0
M  V30 6 O 4.0011 7.6447 0.0 0
M  V30 7 O 5.3349 2.6674 0.0 0
M  V30 8 O 3.0249 4.0011 0.0 0
M  V30 9 O 6.6685 3.0247 0.0 0
M  V30 10 O 8.0021 5.3347 0.0 0
M  V30 11 C 1.3338 6.1047 0.0 0
M  V30 12 C 4.5649 1.3336 0.0 0
M  V30 13 C 2.1038 7.4385 0.0 0
M  V30 14 C 0.0000 6.8747 0.0 0
M  V30 15 C 0.5638 4.7711 0.0 0
M  V30 16 C 5.8985 0.5636 0.0 0
M  V30 17 C 3.7949 0.0000 0.0 0
M  V30 18 C 3.2311 2.1036 0.0 0
M  V30 19 C 9.9549 8.0021 0.0 0
M  V30 20 C 9.9549 9.5421 0.0 0
M  V30 21 C 11.4949 8.0021 0.0 0
M  V30 22 N 9.9549 6.4621 0.0 0 VAL=5
M  V30 23 O 11.2885 10.3121 0.0 0
M  V30 24 O 8.6211 10.3121 0.0 0
M  V30 25 O 12.2649 6.6685 0.0 0
M  V30 26 O 12.2649 9.3358 0.0 0
M  V30 27 O 11.2885 5.6921 0.0 0
M  V30 28 O 8.6211 5.6921 0.0 0
M  V30 29 C 11.2885 11.8521 0.0 0
M  V30 30 C 13.8049 6.6685 0.0 0
M  V30 31 C 12.8285 11.8521 0.0 0
M  V30 32 C 11.2885 13.3921 0.0 0
M  V30 33 C 9.7485 11.8521 0.0 0
M  V30 34 C 13.8049 5.1285 0.0 0
M  V30 35 C 15.3449 6.6685 0.0 0
M  V30 36 C 13.8049 8.2085 0.0 0
M  V30 37 N 5.3349 10.6694 0.0 0
M  V30 38 C 6.1049 12.0032 0.0 0
M  V30 39 C 6.1049 6.6685 0.0 0
M  V30 40 N 7.6449 6.6685 0.0 0
M  V30 41 N 5.3349 8.0021 0.0 0
M  V30 42 C 8.4149 8.0021 0.0 0
M  V30 43 C 6.1049 9.3358 0.0 0
M  V30 44 N 7.6449 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 39
M  V30 5 1 2 5
M  V30 6 2 2 6
M  V30 7 1 3 7
M  V30 8 2 3 8
M  V30 9 2 4 9
M  V30 10 2 4 10
M  V30 11 1 5 11
M  V30 12 1 7 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 1 12 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 22 1 19 42
M  V30 23 1 20 23
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 2 21 26
M  V30 27 2 22 27
M  V30 28 2 22 28
M  V30 29 1 23 29
M  V30 30 1 25 30
M  V30 31 1 29 31
M  V30 32 1 29 32
M  V30 33 1 29 33
M  V30 34 1 30 34
M  V30 35 1 30 35
M  V30 36 1 30 36
M  V30 37 1 37 38
M  V30 38 1 37 43
M  V30 39 1 39 40
M  V30 40 2 39 41
M  V30 41 2 40 42
M  V30 42 1 41 43
M  V30 43 1 42 44
M  V30 44 2 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Propanedioic acid, 2-nitro-, 1,3-bis(1,1-dimethylethyl) ester compd. with met...
C11H19NO6.CH5N
676487-55-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.8501 0.0 0
M  V30 2 C 4.0012 4.6201 0.0 0
M  V30 3 C 6.6685 4.6201 0.0 0
M  V30 4 N 5.3348 2.3100 0.0 0 VAL=5
M  V30 5 O 2.6673 3.8501 0.0 0
M  V30 6 O 4.0012 6.1601 0.0 0
M  V30 7 O 8.0023 3.8501 0.0 0
M  V30 8 O 6.6685 6.1601 0.0 0
M  V30 9 O 6.6685 1.5400 0.0 0
M  V30 10 O 4.0012 1.5400 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 9.3360 4.6201 0.0 0
M  V30 13 C 2.1037 5.9537 0.0 0
M  V30 14 C 0.0000 5.3901 0.0 0
M  V30 15 C 0.5637 3.2864 0.0 0
M  V30 16 C 10.1060 3.2864 0.0 0
M  V30 17 C 10.6697 5.3901 0.0 0
M  V30 18 C 8.5660 5.9537 0.0 0
M  V30 19 C 4.5648 0.0000 0.0 0
M  V30 20 N 6.1048 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 2 4 9
M  V30 9 2 4 10
M  V30 10 1 5 11
M  V30 11 1 7 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 12 17
M  V30 17 1 12 18
M  V30 18 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 209979-80-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 306315-45-7
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 676487-55-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28548914
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 83
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Trisubstituted 1,3,5-triazines. 5. Reaction of
2,4,6-tris[di(tert-butoxycarbonyl)nitromethyl]-1,3,5-triazine with
nucleophiles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shastin, A. V.; Godovikova, T. I.; Korsunskii, B. L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United
States)(Translation of Khimiya Geterotsiklicheskikh Soedinenii) (2003),
39(5), 624-631

$RFMT $RIREG SCHEME58 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(5S)-2-Amino-5-[(1R)-1-(1H-indol-3-yl)ethyl]-4(5H)-oxazolone
C13H13N3O2
32475-93-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3182 3.8850 0.0 0 CFG=2
M  V30 2 C 5.7941 5.3497 0.0 0
M  V30 3 O 6.4922 0.0000 0.0 0
M  V30 4 N 10.1196 4.0286 0.0 0
M  V30 5 C 2.6674 4.5954 0.0 0
M  V30 6 C 3.8118 3.5648 0.0 0
M  V30 7 C 1.3336 3.8254 0.0 0
M  V30 8 C 2.6674 6.1354 0.0 0
M  V30 9 C 3.1855 2.1580 0.0 0
M  V30 10 N 1.6538 2.3189 0.0 0
M  V30 11 C 0.0000 4.5954 0.0 0
M  V30 12 C 1.3336 6.9054 0.0 0
M  V30 13 C 0.0000 6.1354 0.0 0
M  V30 14 C 6.3486 2.7406 0.0 0 CFG=2
M  V30 15 O 7.3791 3.8850 0.0 0
M  V30 16 C 7.1186 1.4069 0.0 0
M  V30 17 C 8.7860 3.2586 0.0 0
M  V30 18 N 8.6249 1.7271 0.0 0
M  V30 19 H 5.1028 1.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 6
M  V30 3 1 1 14
M  V30 4 2 3 16
M  V30 5 1 4 17
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 10
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 19 CFG=3
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(5S)-5-[(1R)-1-(1H-Indol-3-yl)ethyl]-2-(methylamino)-4(5H)-oxazolone
C14H15N3O2
13786-41-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3182 3.8850 0.0 0 CFG=2
M  V30 2 C 5.7942 5.3498 0.0 0
M  V30 3 O 6.4923 0.0000 0.0 0
M  V30 4 N 10.1199 4.0287 0.0 0
M  V30 5 C 11.4535 3.2587 0.0 0
M  V30 6 C 2.6673 4.5955 0.0 0
M  V30 7 C 3.8119 3.5649 0.0 0
M  V30 8 C 1.3337 3.8254 0.0 0
M  V30 9 C 2.6673 6.1355 0.0 0
M  V30 10 C 3.1856 2.1580 0.0 0
M  V30 11 N 1.6538 2.3190 0.0 0
M  V30 12 C 0.0000 4.5955 0.0 0
M  V30 13 C 1.3337 6.9055 0.0 0
M  V30 14 C 0.0000 6.1355 0.0 0
M  V30 15 C 6.3488 2.7406 0.0 0 CFG=2
M  V30 16 O 7.3792 3.8850 0.0 0
M  V30 17 C 7.1188 1.4070 0.0 0
M  V30 18 C 8.7860 3.2587 0.0 0
M  V30 19 N 8.6251 1.7271 0.0 0
M  V30 20 H 5.1029 1.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 7
M  V30 3 1 1 15
M  V30 4 2 3 17
M  V30 5 1 4 5
M  V30 6 1 4 18
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 11
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 20 CFG=3
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(5R)-5-[(1R)-1-(1H-Indol-3-yl)ethyl]-2-(methylamino)-4(5H)-oxazolone
C14H15N3O2
32475-91-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3182 3.8850 0.0 0 CFG=2
M  V30 2 C 5.7942 5.3498 0.0 0
M  V30 3 O 6.4923 0.0000 0.0 0
M  V30 4 N 10.1199 4.0287 0.0 0
M  V30 5 C 11.4535 3.2587 0.0 0
M  V30 6 C 2.6673 4.5955 0.0 0
M  V30 7 C 3.8119 3.5649 0.0 0
M  V30 8 C 1.3337 3.8254 0.0 0
M  V30 9 C 2.6673 6.1355 0.0 0
M  V30 10 C 3.1856 2.1580 0.0 0
M  V30 11 N 1.6538 2.3190 0.0 0
M  V30 12 C 0.0000 4.5955 0.0 0
M  V30 13 C 1.3337 6.9055 0.0 0
M  V30 14 C 0.0000 6.1355 0.0 0
M  V30 15 C 6.3488 2.7406 0.0 0 CFG=1
M  V30 16 O 7.3792 3.8850 0.0 0
M  V30 17 C 7.1188 1.4070 0.0 0
M  V30 18 C 8.7860 3.2587 0.0 0
M  V30 19 N 8.6251 1.7271 0.0 0
M  V30 20 H 5.1029 1.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 7
M  V30 3 1 1 15
M  V30 4 2 3 17
M  V30 5 1 4 5
M  V30 6 1 4 18
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 11
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 20 CFG=1
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 32475-93-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13786-41-9
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 32475-91-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-033-CAS-4025002
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of a stereoselective practical synthetic route to indolmycin,
a candidate anti-H. pylori agent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hasuoka, Atsushi; Nakayama, Yutaka; Adachi, Mari; Kamiguchi, Hidenori;
Kamiyama, Keiji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical & Pharmaceutical Bulletin (2001), 49(12), 1604-1608

$RFMT $RIREG SCHEME59 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3′-(Trifluoromethyl)acetophenone
C9H7F3O
349-76-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 F 0.5637 1.7464 0.0 0
M  V30 3 F 0.0000 3.8501 0.0 0
M  V30 4 F 2.1037 4.4137 0.0 0
M  V30 5 C 6.6687 3.0801 0.0 0
M  V30 6 C 6.6687 4.6201 0.0 0
M  V30 7 O 8.0023 2.3101 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 2.6675 0.7700 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[1-[3-(Trifluoromethyl)phenyl]ethylidene]methanamine
C10H10F3N
1810713-37-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 6.6685 4.6201 0.0 0
M  V30 4 C 9.3360 3.0801 0.0 0
M  V30 5 C 1.3337 3.0801 0.0 0
M  V30 6 F 2.1037 4.4137 0.0 0
M  V30 7 F 0.0000 3.8501 0.0 0
M  V30 8 F 0.5637 1.7464 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(Z)]-N-[1-[3-(Trifluoromethyl)phenyl]ethylidene]methanamine
C10H10F3N
1810713-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3336 0.0 0
M  V30 2 N 0.7700 1.3336 0.0 0
M  V30 3 C 3.0800 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 C 6.9300 4.0009 0.0 0
M  V30 6 F 6.9300 2.4609 0.0 0
M  V30 7 F 8.4700 4.0009 0.0 0
M  V30 8 F 6.9300 5.5409 0.0 0
M  V30 9 C 3.0800 2.6673 0.0 0
M  V30 10 C 4.6200 2.6673 0.0 0
M  V30 11 C 2.3100 4.0009 0.0 0
M  V30 12 C 5.3900 4.0009 0.0 0
M  V30 13 C 3.0800 5.3347 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 349-76-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1810713-37-1
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 1810713-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-5842240
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, sealed flask used, molecular sieves used (4 A)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Disulfonimide-Catalyzed Asymmetric Reduction of N-Alkyl Imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wakchaure, Vijay N.; Kaib, Philip S. J.; Leutzsch, Markus; List, Benjamin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2015), 54(40), 11852-11856

$RFMT $RIREG SCHEME60 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Trifluoromethyl)acetophenone
C9H7F3O
709-63-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 1.5400 0.0 0
M  V30 2 F 6.9300 3.0800 0.0 0
M  V30 3 F 8.4700 1.5400 0.0 0
M  V30 4 F 6.9300 0.0000 0.0 0
M  V30 5 C 0.7700 1.5400 0.0 0
M  V30 6 C 0.0000 0.2064 0.0 0
M  V30 7 O 0.0000 2.8736 0.0 0
M  V30 8 C 5.3900 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 3.0800 0.2064 0.0 0
M  V30 12 C 3.0800 2.8736 0.0 0
M  V30 13 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[1-[4-(Trifluoromethyl)phenyl]ethylidene]methanamine
C10H10F3N
1810713-33-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 N 8.4700 2.8736 0.0 0
M  V30 7 C 8.4700 0.2064 0.0 0
M  V30 8 C 10.0100 2.8736 0.0 0
M  V30 9 C 3.0800 1.5400 0.0 0
M  V30 10 C 3.8500 0.2064 0.0 0
M  V30 11 C 3.8500 2.8736 0.0 0
M  V30 12 C 5.3900 0.2064 0.0 0
M  V30 13 C 5.3900 2.8736 0.0 0
M  V30 14 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(Z)]-N-[1-[4-(Trifluoromethyl)phenyl]ethylidene]methanamine
C10H10F3N
1810713-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 2.6673 0.0 0
M  V30 2 F 6.9300 1.1273 0.0 0
M  V30 3 F 8.4700 2.6673 0.0 0
M  V30 4 F 6.9300 4.2073 0.0 0
M  V30 5 C 0.7700 2.6673 0.0 0
M  V30 6 N 0.0000 1.3336 0.0 0
M  V30 7 C 0.0000 4.0011 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 5.3900 2.6673 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 4.6200 1.3336 0.0 0
M  V30 12 C 3.0800 4.0011 0.0 0
M  V30 13 C 3.0800 1.3336 0.0 0
M  V30 14 C 2.3100 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 709-63-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1810713-33-7
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 1810713-44-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-12841000
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, sealed flask used, molecular sieves used (4 A)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Disulfonimide-Catalyzed Asymmetric Reduction of N-Alkyl Imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wakchaure, Vijay N.; Kaib, Philip S. J.; Leutzsch, Markus; List, Benjamin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2015), 54(40), 11852-11856

$RFMT $RIREG SCHEME61 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pseudolaric acid B
C23H28O8
82508-31-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 12.0013 7.9811 0.0 0
M  V30 2 C 12.3577 9.4792 0.0 0
M  V30 3 C 13.8333 9.9197 0.0 0
M  V30 4 O 11.2384 10.5371 0.0 0
M  V30 5 O 9.0085 3.1110 0.0 0
M  V30 6 C 6.1600 8.8909 0.0 0
M  V30 7 C 4.6200 8.8909 0.0 0
M  V30 8 C 3.8500 10.2248 0.0 0
M  V30 9 C 2.3100 10.2248 0.0 0
M  V30 10 C 1.5400 11.5584 0.0 0
M  V30 11 C 1.5400 8.8909 0.0 0
M  V30 12 O 0.0000 11.5584 0.0 0
M  V30 13 O 2.3100 12.8921 0.0 0
M  V30 14 C 5.4589 7.1018 0.0 0
M  V30 15 C 5.7352 2.6259 0.0 0
M  V30 16 O 6.2591 1.1778 0.0 0
M  V30 17 O 4.2190 2.8963 0.0 0
M  V30 18 C 5.2668 0.0000 0.0 0
M  V30 19 C 8.3121 6.8798 0.0 0 CFG=1
M  V30 20 C 9.4899 5.8878 0.0 0 CFG=2
M  V30 21 C 7.9312 8.4844 0.0 0 CFG=1
M  V30 22 C 6.8019 6.5777 0.0 0
M  V30 23 C 8.1862 5.2698 0.0 0
M  V30 24 C 10.0979 7.0395 0.0 0
M  V30 25 C 9.4484 4.3482 0.0 0
M  V30 26 C 6.9301 7.5573 0.0 0 CFG=1
M  V30 27 C 9.2784 8.3362 0.0 0
M  V30 28 C 6.0968 5.2086 0.0 0
M  V30 29 O 7.0479 6.0279 0.0 0
M  V30 30 C 8.2190 3.4208 0.0 0
M  V30 31 C 6.7274 3.8037 0.0 0
M  V30 32 H 7.4487 9.9468 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 19 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 23
M  V30 6 2 6 7
M  V30 7 1 26 6 CFG=3
M  V30 8 1 7 8
M  V30 9 2 8 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 26 14 CFG=1
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 31
M  V30 18 1 16 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 22 1 20 23 CFG=3
M  V30 23 1 20 24
M  V30 24 1 20 25
M  V30 25 1 21 26
M  V30 26 1 21 27 CFG=3
M  V30 27 1 21 32 CFG=1
M  V30 28 1 22 28
M  V30 29 1 23 29
M  V30 30 1 24 27
M  V30 31 1 25 30
M  V30 32 1 26 29
M  V30 33 1 28 31
M  V30 34 2 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 19 20 21 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2E,4E)-5-[(3R,4R,4aS,9aR)-3,4,4a,5,6,9-Hexahydro-4a-hydroxy-3-methyl-7-[(met...
C21H27NO6
500736-41-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.8011 10.2794 0.0 0
M  V30 2 O 9.7812 9.0086 0.0 0
M  V30 3 C 4.0012 6.1601 0.0 0
M  V30 4 C 4.0012 4.6201 0.0 0
M  V30 5 C 2.6673 3.8501 0.0 0
M  V30 6 C 2.6673 2.3101 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 5.7904 5.4591 0.0 0
M  V30 12 C 10.2663 5.7354 0.0 0
M  V30 13 N 11.7144 6.2592 0.0 0
M  V30 14 O 9.9959 4.2192 0.0 0
M  V30 15 C 12.8922 5.2671 0.0 0
M  V30 16 C 7.0044 9.4900 0.0 0 CFG=2
M  V30 17 C 6.0123 8.3122 0.0 0 CFG=1
M  V30 18 C 7.6224 8.1864 0.0 0
M  V30 19 C 5.8526 10.0982 0.0 0
M  V30 20 C 8.5440 9.4486 0.0 0
M  V30 21 C 4.4077 7.9315 0.0 0 CFG=2
M  V30 22 C 6.3144 6.8022 0.0 0
M  V30 23 O 6.8642 7.0481 0.0 0
M  V30 24 C 4.5559 9.2787 0.0 0
M  V30 25 C 9.4714 8.2192 0.0 0
M  V30 26 C 5.3348 6.9302 0.0 0 CFG=1
M  V30 27 C 7.6835 6.0968 0.0 0
M  V30 28 C 9.0885 6.7275 0.0 0
M  V30 29 H 2.9453 7.4490 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 17 1 CFG=1
M  V30 2 2 2 18
M  V30 3 2 3 4
M  V30 4 1 26 3 CFG=3
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 26 11 CFG=1
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 28
M  V30 15 1 13 15
M  V30 16 1 16 17
M  V30 17 1 16 18 CFG=3
M  V30 18 1 16 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 17 22
M  V30 22 1 18 23
M  V30 23 1 19 24
M  V30 24 1 20 25
M  V30 25 1 21 24 CFG=3
M  V30 26 1 21 26
M  V30 27 1 21 29 CFG=1
M  V30 28 1 22 27
M  V30 29 1 23 26
M  V30 30 2 25 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 17 21 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2E,4E)-5-[(3R,4S,4aS,9aR)-4a-(Acetyloxy)-3,4,4a,5,6,9-hexahydro-3-methyl-7-[...
C23H29NO7
500736-43-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6662 8.4947 0.0 0
M  V30 2 C 1.3113 7.7627 0.0 0
M  V30 3 C 0.0000 8.5700 0.0 0
M  V30 4 O 1.2679 6.2233 0.0 0
M  V30 5 O 4.5928 3.1110 0.0 0
M  V30 6 C 7.4410 8.8909 0.0 0
M  V30 7 C 8.9810 8.8909 0.0 0
M  V30 8 C 9.7510 10.2248 0.0 0
M  V30 9 C 11.2911 10.2248 0.0 0
M  V30 10 C 12.0611 11.5584 0.0 0
M  V30 11 C 12.0611 8.8909 0.0 0
M  V30 12 O 13.6011 11.5584 0.0 0
M  V30 13 O 11.2911 12.8921 0.0 0
M  V30 14 C 8.1422 7.1018 0.0 0
M  V30 15 C 7.8659 2.6259 0.0 0
M  V30 16 N 7.3420 1.1778 0.0 0
M  V30 17 O 9.3821 2.8963 0.0 0
M  V30 18 C 8.3342 0.0000 0.0 0
M  V30 19 C 5.2890 6.8798 0.0 0 CFG=1
M  V30 20 C 4.1112 5.8878 0.0 0 CFG=2
M  V30 21 C 5.6699 8.4844 0.0 0 CFG=1
M  V30 22 C 6.7992 6.5777 0.0 0
M  V30 23 C 5.4148 5.2698 0.0 0
M  V30 24 C 3.5032 7.0395 0.0 0
M  V30 25 C 4.1526 4.3482 0.0 0
M  V30 26 C 6.6710 7.5573 0.0 0 CFG=1
M  V30 27 C 4.3227 8.3362 0.0 0
M  V30 28 C 7.5043 5.2086 0.0 0
M  V30 29 O 6.5532 6.0279 0.0 0
M  V30 30 C 5.3820 3.4208 0.0 0
M  V30 31 C 6.8737 3.8037 0.0 0
M  V30 32 H 6.1523 9.9468 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 19 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 23
M  V30 6 2 6 7
M  V30 7 1 26 6 CFG=1
M  V30 8 1 7 8
M  V30 9 2 8 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 26 14 CFG=3
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 31
M  V30 18 1 16 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 22 1 20 23 CFG=1
M  V30 23 1 20 24
M  V30 24 1 20 25
M  V30 25 1 21 26
M  V30 26 1 21 27 CFG=1
M  V30 27 1 21 32 CFG=3
M  V30 28 1 22 28
M  V30 29 1 23 29
M  V30 30 1 24 27
M  V30 31 1 25 30
M  V30 32 1 26 29
M  V30 33 1 28 31
M  V30 34 2 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 19 20 21 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 82508-31-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 500736-41-4
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 500736-43-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-7838239
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 6
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Antifungal diterpenoids of Pseudolarix kaempferi, and their
structure-activity relationship study
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Sheng-Ping; Dong, Lei; Wang, Ying; Wu, Yan; Yue, Jian-Min
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2003), 11(21), 4577-4584

$RFMT $RIREG SCHEME62 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Bromoacetophenone
C8H7BrO
99-90-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Br 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[1-(4-Bromophenyl)ethylidene]methanamine
C9H10BrN
1810713-32-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 C 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Br 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 6.1601 0.0000 0.0 0
M  V30 10 C 6.1601 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(Z)]-N-[1-(4-Bromophenyl)ethylidene]methanamine
C9H10BrN
1810713-43-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 N 0.0000 1.3337 0.0 0
M  V30 3 C 0.0000 4.0010 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 3.0801 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 4.6201 1.3337 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-90-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1810713-32-6
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 1810713-43-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-10709881
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, sealed flask used, molecular sieves used (4 A)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Disulfonimide-Catalyzed Asymmetric Reduction of N-Alkyl Imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wakchaure, Vijay N.; Kaib, Philip S. J.; Leutzsch, Markus; List, Benjamin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2015), 54(40), 11852-11856

$RFMT $RIREG SCHEME63 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Chloroacetophenone
C8H7ClO
99-91-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, N-[1-(4-chlorophenyl)ethylidene]-, (E)-
C9H10ClN
53441-82-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 C 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Cl 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, N-[1-(4-chlorophenyl)ethylidene]-, (Z)-
C9H10ClN
53441-96-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 N 0.0000 1.3337 0.0 0
M  V30 3 C 0.0000 4.0010 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 3.0801 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 4.6201 1.3337 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-91-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53441-82-0
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 53441-96-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-8580418
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, sealed flask used, molecular sieves used (4 A)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Disulfonimide-Catalyzed Asymmetric Reduction of N-Alkyl Imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wakchaure, Vijay N.; Kaib, Philip S. J.; Leutzsch, Markus; List, Benjamin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2015), 54(40), 11852-11856

$RFMT $RIREG SCHEME64 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Thienyl)-2-propen-1-one
C7H6OS
13191-29-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1049 2.3100 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4385 1.5400 0.0 0
M  V30 5 C 2.4374 2.3100 0.0 0
M  V30 6 C 2.2765 3.8416 0.0 0
M  V30 7 S 1.0306 1.6836 0.0 0
M  V30 8 C 0.7700 4.1618 0.0 0
M  V30 9 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 2 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-α-[2-(Methylamino)ethyl]-2-thiophenemethanol
C8H13NOS
116539-55-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0 CFG=1
M  V30 2 C 5.1048 2.3101 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4386 1.5400 0.0 0
M  V30 5 N 7.7722 2.3101 0.0 0
M  V30 6 C 9.1059 1.5400 0.0 0
M  V30 7 C 2.4374 2.3101 0.0 0
M  V30 8 C 1.0304 1.6836 0.0 0
M  V30 9 S 2.2763 3.8416 0.0 0
M  V30 10 C 0.0000 2.8281 0.0 0
M  V30 11 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αR)-α-[2-(Methylamino)ethyl]-2-thiophenemethanol
C8H13NOS
116539-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0 CFG=2
M  V30 2 C 5.1048 2.3101 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4386 1.5400 0.0 0
M  V30 5 N 7.7722 2.3101 0.0 0
M  V30 6 C 9.1059 1.5400 0.0 0
M  V30 7 C 2.4374 2.3101 0.0 0
M  V30 8 C 1.0304 1.6836 0.0 0
M  V30 9 S 2.2763 3.8416 0.0 0
M  V30 10 C 0.0000 2.8281 0.0 0
M  V30 11 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13191-29-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 116539-55-0
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 116539-57-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-513-CAS-17241074
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 141-53-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 58341-54-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 174813-81-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, regioselective, stereoselective, aza Michael addition
reaction, %ee = 99, alternate reaction conditions also shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Michael Addition-Asymmetric Transfer Hydrogenation One-Pot
Enantioselective Tandem Process for Syntheses of Chiral γ-Secondary Amino
Alcohols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wu, Liang; Jin, Ronghua; Li, Liang; Hu, Xiaoying; Cheng, Tanyu; Liu,
Guohua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(12), 3047-3050

$RFMT $RIREG SCHEME65 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E,6E)-1,8-Bis(4-methoxyphenyl)-2,6-octadiene-1,8-dione
C22H22O4
1633021-03-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 2.3101 0.0 0
M  V30 2 C 8.0022 3.0801 0.0 0
M  V30 3 O 6.6685 0.7700 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 C 10.6697 3.0801 0.0 0
M  V30 6 C 12.0033 2.3101 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 C 14.6708 2.3101 0.0 0
M  V30 9 C 16.0045 3.0801 0.0 0
M  V30 10 O 16.0045 4.6201 0.0 0
M  V30 11 O 1.3337 5.3901 0.0 0
M  V30 12 C 0.0000 4.6201 0.0 0
M  V30 13 O 21.3393 0.0000 0.0 0
M  V30 14 C 22.6730 0.7700 0.0 0
M  V30 15 C 5.3348 3.0801 0.0 0
M  V30 16 C 5.3348 4.6201 0.0 0
M  V30 17 C 4.0012 2.3101 0.0 0
M  V30 18 C 4.0012 5.3901 0.0 0
M  V30 19 C 2.6673 3.0801 0.0 0
M  V30 20 C 2.6673 4.6201 0.0 0
M  V30 21 C 17.3382 2.3101 0.0 0
M  V30 22 C 18.6718 3.0801 0.0 0
M  V30 23 C 17.3382 0.7700 0.0 0
M  V30 24 C 20.0057 2.3101 0.0 0
M  V30 25 C 18.6718 0.0000 0.0 0
M  V30 26 C 20.0057 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 2 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 7 8
M  V30 9 1 8 9
M  V30 10 2 9 10
M  V30 11 1 9 21
M  V30 12 1 11 12
M  V30 13 1 11 20
M  V30 14 1 13 14
M  V30 15 1 13 26
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-2,2′-[(2R,5S)-1-Methyl-2,5-pyrrolidinediyl]bis[1-(4-methoxyphenyl)ethanone]
C23H27NO4
1633021-18-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 2.3101 0.0 0
M  V30 2 C 6.6685 3.0801 0.0 0
M  V30 3 O 6.6685 4.6201 0.0 0
M  V30 4 C 11.0630 0.9473 0.0 0
M  V30 5 C 13.3050 3.4372 0.0 0
M  V30 6 C 14.2100 4.6831 0.0 0
M  V30 7 O 13.5837 6.0899 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 10 O 20.3365 4.0392 0.0 0
M  V30 11 C 21.2417 5.2851 0.0 0
M  V30 12 C 9.3360 3.0801 0.0 0 CFG=1
M  V30 13 N 10.7428 2.4536 0.0 0
M  V30 14 C 9.4969 4.6116 0.0 0
M  V30 15 C 11.7732 3.5981 0.0 0 CFG=2
M  V30 16 C 11.0032 4.9318 0.0 0
M  V30 17 C 5.3348 2.3101 0.0 0
M  V30 18 C 5.3348 0.7700 0.0 0
M  V30 19 C 4.0012 3.0801 0.0 0
M  V30 20 C 4.0012 0.0000 0.0 0
M  V30 21 C 2.6673 2.3101 0.0 0
M  V30 22 C 2.6673 0.7700 0.0 0
M  V30 23 C 15.7418 4.5220 0.0 0
M  V30 24 C 16.6470 5.7680 0.0 0
M  V30 25 C 16.3681 3.1152 0.0 0
M  V30 26 C 18.1786 5.6070 0.0 0
M  V30 27 C 17.8997 2.9542 0.0 0
M  V30 28 C 18.8049 4.2001 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 2 17
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 15 5 CFG=1
M  V30 8 2 6 7
M  V30 9 1 6 23
M  V30 10 1 8 9
M  V30 11 1 8 22
M  V30 12 1 10 11
M  V30 13 1 10 28
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-2,2′-[(2R,5R)-1-Methyl-2,5-pyrrolidinediyl]bis[1-(4-methoxyphenyl)ethanone]
C23H27NO4
1633021-19-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 2.3101 0.0 0
M  V30 2 C 6.6685 3.0801 0.0 0
M  V30 3 O 6.6685 4.6201 0.0 0
M  V30 4 C 11.0630 0.9473 0.0 0
M  V30 5 C 13.3050 3.4372 0.0 0
M  V30 6 C 14.2100 4.6831 0.0 0
M  V30 7 O 13.5837 6.0899 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 10 O 20.3365 4.0392 0.0 0
M  V30 11 C 21.2417 5.2851 0.0 0
M  V30 12 C 9.3360 3.0801 0.0 0 CFG=1
M  V30 13 N 10.7428 2.4536 0.0 0
M  V30 14 C 9.4969 4.6116 0.0 0
M  V30 15 C 11.7732 3.5981 0.0 0 CFG=1
M  V30 16 C 11.0032 4.9318 0.0 0
M  V30 17 C 5.3348 2.3101 0.0 0
M  V30 18 C 5.3348 0.7700 0.0 0
M  V30 19 C 4.0012 3.0801 0.0 0
M  V30 20 C 4.0012 0.0000 0.0 0
M  V30 21 C 2.6673 2.3101 0.0 0
M  V30 22 C 2.6673 0.7700 0.0 0
M  V30 23 C 15.7418 4.5220 0.0 0
M  V30 24 C 16.6470 5.7680 0.0 0
M  V30 25 C 16.3681 3.1152 0.0 0
M  V30 26 C 18.1786 5.6070 0.0 0
M  V30 27 C 17.8997 2.9542 0.0 0
M  V30 28 C 18.8049 4.2001 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 2 17
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 15 5 CFG=3
M  V30 8 2 6 7
M  V30 9 1 6 23
M  V30 10 1 8 9
M  V30 11 1 8 22
M  V30 12 1 10 11
M  V30 13 1 10 28
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1633021-03-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1633021-18-7
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 1633021-19-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-14750906
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, Aza-Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thermodynamic epimeric equilibration and crystallisation-induced dynamic
resolution of lobelanine, norlobelanine and related analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Amara, Z.; Bernadat, G.; Venot, P.-E.; Retailleau, P.; Troufflard, C.;
Drege, E.; Le Bideau, F.; Joseph, D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2014), 12(48), 9797-9810

$RFMT $RIREG SCHEME66 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-[[[3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazol-5-yl]carbonyl]...
C23H12BrCl5N4O3
3036410-21-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.6398 6.9300 0.0 0
M  V30 2 N 6.9735 6.1600 0.0 0
M  V30 3 O 4.3062 6.1600 0.0 0
M  V30 4 Cl 2.1050 11.4361 0.0 0
M  V30 5 Br 7.3150 12.0857 0.0 0
M  V30 6 C 9.6409 4.6200 0.0 0
M  V30 7 O 10.9746 3.8500 0.0 0
M  V30 8 O 9.6409 6.1600 0.0 0
M  V30 9 C 4.3062 4.6200 0.0 0
M  V30 10 Cl 6.9735 0.0000 0.0 0
M  V30 11 Cl 10.9746 6.9300 0.0 0
M  V30 12 Cl 13.6419 2.3100 0.0 0
M  V30 13 Cl 16.3093 6.9300 0.0 0
M  V30 14 N 4.3940 9.3753 0.0 0
M  V30 15 C 5.6398 8.4700 0.0 0
M  V30 16 N 4.8698 10.8398 0.0 0
M  V30 17 C 6.8857 9.3753 0.0 0
M  V30 18 C 6.4098 10.8398 0.0 0
M  V30 19 C 2.9292 8.8992 0.0 0
M  V30 20 C 1.7849 9.9298 0.0 0
M  V30 21 N 2.6091 7.3930 0.0 0
M  V30 22 C 0.3202 9.4540 0.0 0
M  V30 23 C 1.1445 6.9171 0.0 0
M  V30 24 C 0.0000 7.9475 0.0 0
M  V30 25 C 6.9735 4.6200 0.0 0
M  V30 26 C 8.3071 3.8500 0.0 0
M  V30 27 C 5.6398 3.8500 0.0 0
M  V30 28 C 8.3071 2.3100 0.0 0
M  V30 29 C 5.6398 2.3100 0.0 0
M  V30 30 C 6.9735 1.5400 0.0 0
M  V30 31 C 12.3082 4.6200 0.0 0
M  V30 32 C 12.3082 6.1600 0.0 0
M  V30 33 C 13.6419 3.8500 0.0 0
M  V30 34 C 13.6419 6.9300 0.0 0
M  V30 35 C 14.9757 4.6200 0.0 0
M  V30 36 C 14.9757 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 25
M  V30 5 1 4 20
M  V30 6 1 5 18
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 26
M  V30 10 1 7 31
M  V30 11 1 9 27
M  V30 12 1 10 30
M  V30 13 1 11 32
M  V30 14 1 12 33
M  V30 15 1 13 36
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 19
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4,6-Trichlorophenol
C6H3Cl3O
88-06-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 2.6674 0.0 0
M  V30 2 Cl 1.5400 0.0000 0.0 0
M  V30 3 Cl 1.5400 5.3349 0.0 0
M  V30 4 Cl 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 7
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chlorantraniliprole
C18H14BrCl2N5O2
500008-45-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8690 5.3027 0.0 0
M  V30 2 N 7.4090 5.3027 0.0 0
M  V30 3 O 5.0990 6.6364 0.0 0
M  V30 4 Cl 0.5546 3.1677 0.0 0
M  V30 5 Br 4.7419 0.0000 0.0 0
M  V30 6 C 10.4891 5.3027 0.0 0
M  V30 7 N 12.0291 5.3027 0.0 0
M  V30 8 O 9.7190 3.9689 0.0 0
M  V30 9 C 12.7991 3.9689 0.0 0
M  V30 10 C 5.8690 7.9701 0.0 0
M  V30 11 Cl 10.4891 10.6375 0.0 0
M  V30 12 N 3.5673 3.8080 0.0 0
M  V30 13 C 5.0990 3.9689 0.0 0
M  V30 14 N 3.2471 2.3017 0.0 0
M  V30 15 C 5.7253 2.5621 0.0 0
M  V30 16 C 4.5809 1.5317 0.0 0
M  V30 17 C 2.5369 4.9525 0.0 0
M  V30 18 C 1.0306 4.6322 0.0 0
M  V30 19 N 3.0127 6.4171 0.0 0
M  V30 20 C 0.0000 5.7768 0.0 0
M  V30 21 C 1.9823 7.5616 0.0 0
M  V30 22 C 0.4760 7.2413 0.0 0
M  V30 23 C 8.1790 6.6364 0.0 0
M  V30 24 C 9.7190 6.6364 0.0 0
M  V30 25 C 7.4090 7.9701 0.0 0
M  V30 26 C 10.4891 7.9701 0.0 0
M  V30 27 C 8.1790 9.3037 0.0 0
M  V30 28 C 9.7190 9.3037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 23
M  V30 5 1 4 18
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 24
M  V30 10 1 7 9
M  V30 11 1 10 25
M  V30 12 1 11 28
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 17
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3036410-21-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 88-06-2
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 500008-45-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40141623
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A novel process for preparation of chlorantraniliprole and intermediates
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shinde, Ravindra; Gujral, Ajit Singh; Kumar, Vimal; Ailawadhi, Raajan
Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN202111031718 A 2023-03-03

$RFMT $RIREG SCHEME67 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dimethyl 1-[[(4-nitrobenzoyl)amino]methyl]-7-oxabicyclo[2.2.1]hepta-2,5-d...
C18H16N2O8
1370617-24-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9951 3.8438 0.0 0
M  V30 2 N 9.3287 4.6138 0.0 0
M  V30 3 C 10.6623 3.8438 0.0 0
M  V30 4 O 10.6623 2.3038 0.0 0
M  V30 5 C 5.3338 2.3097 0.0 0
M  V30 6 O 6.6676 1.5400 0.0 0
M  V30 7 O 4.0003 1.5395 0.0 0
M  V30 8 C 6.6679 0.0000 0.0 0
M  V30 9 C 2.6674 3.8434 0.0 0
M  V30 10 O 1.3313 4.6091 0.0 0
M  V30 11 O 2.6724 2.3034 0.0 0
M  V30 12 C 0.0000 3.8349 0.0 0
M  V30 13 N 15.9971 6.9238 0.0 0 VAL=5
M  V30 14 O 17.3309 6.1538 0.0 0
M  V30 15 O 15.9971 8.4638 0.0 0
M  V30 16 C 6.6614 4.6138 0.0 0
M  V30 17 C 5.3336 3.8497 0.0 0
M  V30 18 O 5.5619 5.7910 0.0 0
M  V30 19 C 6.6593 6.1546 0.0 0
M  V30 20 C 3.9986 4.6175 0.0 0
M  V30 21 C 3.9915 6.1495 0.0 0
M  V30 22 C 5.3242 6.9225 0.0 0
M  V30 23 C 11.9961 4.6138 0.0 0
M  V30 24 C 13.3298 3.8438 0.0 0
M  V30 25 C 11.9961 6.1538 0.0 0
M  V30 26 C 14.6634 4.6138 0.0 0
M  V30 27 C 13.3298 6.9238 0.0 0
M  V30 28 C 14.6634 6.1538 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 23
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 17
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 20
M  V30 13 1 10 12
M  V30 14 2 13 14
M  V30 15 2 13 15
M  V30 16 1 13 28
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 2 19 22
M  V30 23 1 20 21
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-2,3-Dimethyl (1R,2R,3R,4S)-3-(methylamino)-1-[[(4-nitrobenzoyl)amino]meth...
C19H21N3O8
1370617-61-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.5637 3.8439 0.0 0
M  V30 2 N 8.8974 4.6139 0.0 0
M  V30 3 C 10.2312 3.8439 0.0 0
M  V30 4 O 10.2312 2.3039 0.0 0
M  V30 5 C 4.9024 2.3097 0.0 0
M  V30 6 O 6.2362 1.5400 0.0 0
M  V30 7 O 3.5689 1.5396 0.0 0
M  V30 8 C 6.2365 0.0000 0.0 0
M  V30 9 C 2.0496 4.8794 0.0 0
M  V30 10 O 1.5175 6.3246 0.0 0
M  V30 11 O 1.0640 3.6961 0.0 0
M  V30 12 C 0.0000 6.5865 0.0 0
M  V30 13 N 3.0443 3.1691 0.0 0
M  V30 14 C 1.5285 2.8976 0.0 0
M  V30 15 N 15.5660 6.9240 0.0 0 VAL=5
M  V30 16 O 15.5660 8.4640 0.0 0
M  V30 17 O 16.8996 6.1539 0.0 0
M  V30 18 C 6.2300 4.6139 0.0 0 CFG=1
M  V30 19 C 4.9022 3.8498 0.0 0 CFG=1
M  V30 20 O 5.1304 5.7911 0.0 0
M  V30 21 C 6.2279 6.1547 0.0 0
M  V30 22 C 3.5673 4.6176 0.0 0 CFG=1
M  V30 23 C 3.5601 6.1496 0.0 0 CFG=2
M  V30 24 C 4.8930 6.9226 0.0 0
M  V30 25 C 11.5648 4.6139 0.0 0
M  V30 26 C 11.5648 6.1539 0.0 0
M  V30 27 C 12.8985 3.8439 0.0 0
M  V30 28 C 12.8985 6.9240 0.0 0
M  V30 29 C 14.2322 4.6139 0.0 0
M  V30 30 C 14.2322 6.1539 0.0 0
M  V30 31 H 2.2238 6.9152 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 25
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 19 5 CFG=1
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 22 9 CFG=1
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 22 13 CFG=3
M  V30 16 2 15 16
M  V30 17 2 15 17
M  V30 18 1 15 30
M  V30 19 1 18 19
M  V30 20 1 18 20 CFG=3
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 1 23 20 CFG=3
M  V30 24 2 21 24
M  V30 25 1 22 23
M  V30 26 1 23 24
M  V30 27 1 23 31
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-2,3-Dimethyl (1R,2S,3R,4S)-3-(methylamino)-1-[[(4-nitrobenzoyl)amino]meth...
C19H21N3O8
1370617-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.5637 3.8439 0.0 0
M  V30 2 N 8.8974 4.6139 0.0 0
M  V30 3 C 10.2312 3.8439 0.0 0
M  V30 4 O 10.2312 2.3039 0.0 0
M  V30 5 C 4.9024 2.3097 0.0 0
M  V30 6 O 6.2362 1.5400 0.0 0
M  V30 7 O 3.5689 1.5396 0.0 0
M  V30 8 C 6.2365 0.0000 0.0 0
M  V30 9 C 2.0496 4.8794 0.0 0
M  V30 10 O 1.5175 6.3246 0.0 0
M  V30 11 O 1.0640 3.6961 0.0 0
M  V30 12 C 0.0000 6.5865 0.0 0
M  V30 13 N 3.0443 3.1691 0.0 0
M  V30 14 C 1.5285 2.8976 0.0 0
M  V30 15 N 15.5660 6.9240 0.0 0 VAL=5
M  V30 16 O 15.5660 8.4640 0.0 0
M  V30 17 O 16.8996 6.1539 0.0 0
M  V30 18 C 6.2300 4.6139 0.0 0 CFG=1
M  V30 19 C 4.9022 3.8498 0.0 0 CFG=2
M  V30 20 O 5.1304 5.7911 0.0 0
M  V30 21 C 6.2279 6.1547 0.0 0
M  V30 22 C 3.5673 4.6176 0.0 0 CFG=1
M  V30 23 C 3.5601 6.1496 0.0 0 CFG=2
M  V30 24 C 4.8930 6.9226 0.0 0
M  V30 25 C 11.5648 4.6139 0.0 0
M  V30 26 C 11.5648 6.1539 0.0 0
M  V30 27 C 12.8985 3.8439 0.0 0
M  V30 28 C 12.8985 6.9240 0.0 0
M  V30 29 C 14.2322 4.6139 0.0 0
M  V30 30 C 14.2322 6.1539 0.0 0
M  V30 31 H 2.2238 6.9152 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 25
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 19 5 CFG=3
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 22 9 CFG=1
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 22 13 CFG=3
M  V30 16 2 15 16
M  V30 17 2 15 17
M  V30 18 1 15 30
M  V30 19 1 18 19
M  V30 20 1 18 20 CFG=3
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 1 23 20 CFG=3
M  V30 24 2 21 24
M  V30 25 1 22 23
M  V30 26 1 23 24
M  V30 27 1 23 31
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1370617-24-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1370617-61-0
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 1370617-62-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-6765704
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 2206-26-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Dimethyl
1-((4-nitrobenzamido)methyl)-3-methylamino-7-oxanorborn-5-ene-2,3-dicarboxylate
(8). 1H NMR (500 MHz, CDCl3) δ 8.28 (d, J = 8.8 Hz, 2H), 7.93 (d, J = 8.8
Hz, 2H), 6.68 (t, J = 5.6 Hz, 1H), 6.62 (d, J = 5.7 Hz, 1H), 6.52 (dd, J
= 5.7, 1.8 Hz, 1H), 4.94 (d, J = 1.7 Hz, 1H), 4.16 (dd, J = 14.7, 6.4 Hz,
1H), 3.89 (dd, J = 14.4, 5.2 Hz, 1H), 3.78-3.70 (m, 5H), 3.67 (s, 3H),
3.19 (s, 1H), 3.02 (ddd, J = 6.4, 5.3, 4.0 Hz, 1H), 2.23 (br s, 1H). 13C
NMR (126 MHz, CDCl3) δ 169.96, 169.63, 165.84, 149.86, 139.64, 137.61,
136.29, 128.44, 123.99, 91.64, 84.64, 65.00, 60.96, 58.88, 52.85, 52.69,
40.52, 34.64. ESI-MS: [C19H21N3O8 + H]+ 420.1.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, product further converted into (TFA) salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Degradable Conjugates from Oxanorbornadiene Reagents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kislukhin, Alexander A.; Higginson, Cody J.; Hong, Vu P.; Finn, M. G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2012), 134(14), 6491-6497

$RFMT $RIREG SCHEME68 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Galactonic acid, 5-azido-5-deoxy-3,6-bis-O-(phenylmethyl)-, γ-lactone, 2-me...
C21H23N3O7S
1395068-92-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.3159 4.3816 0.0 0
M  V30 2 C 2.7843 4.2207 0.0 0
M  V30 3 C 7.9886 6.1086 0.0 0 CFG=1
M  V30 4 C 8.7586 4.7749 0.0 0
M  V30 5 N 8.7586 7.4424 0.0 0
M  V30 6 O 10.2986 4.7749 0.0 0
M  V30 7 N 10.2986 7.4424 0.0 0 CHG=1 VAL=4
M  V30 8 C 11.0687 3.4413 0.0 0
M  V30 9 N 11.8387 7.4424 0.0 0 CHG=-1
M  V30 10 O 2.6407 7.2832 0.0 0
M  V30 11 S 2.0143 8.6900 0.0 0 VAL=6
M  V30 12 C 3.4211 9.3164 0.0 0
M  V30 13 O 1.3880 10.0969 0.0 0
M  V30 14 O 0.6074 8.0636 0.0 0
M  V30 15 O 4.8826 9.7730 0.0 0
M  V30 16 C 4.9423 5.7884 0.0 0 CFG=1
M  V30 17 C 6.4486 6.1086 0.0 0 CFG=1
M  V30 18 C 4.1723 7.1222 0.0 0 CFG=2
M  V30 19 O 6.6096 7.6403 0.0 0
M  V30 20 C 5.2028 8.2666 0.0 0
M  V30 21 C 2.1580 2.8137 0.0 0
M  V30 22 C 3.0631 1.5679 0.0 0
M  V30 23 C 0.6263 2.6528 0.0 0
M  V30 24 C 2.4368 0.1611 0.0 0
M  V30 25 C 0.0000 1.2459 0.0 0
M  V30 26 C 0.9052 0.0000 0.0 0
M  V30 27 C 12.6087 3.4413 0.0 0
M  V30 28 C 13.3787 4.7749 0.0 0
M  V30 29 C 13.3787 2.1077 0.0 0
M  V30 30 C 14.9187 4.7749 0.0 0
M  V30 31 C 14.9187 2.1077 0.0 0
M  V30 32 C 15.6887 3.4413 0.0 0
M  V30 33 H 6.6096 4.5771 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=1
M  V30 3 1 2 21
M  V30 4 1 3 4 CFG=1
M  V30 5 1 3 5
M  V30 6 1 3 17
M  V30 7 1 4 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 1 8 27
M  V30 12 1 10 11
M  V30 13 1 18 10 CFG=3
M  V30 14 1 11 12
M  V30 15 2 11 13
M  V30 16 2 11 14
M  V30 17 2 15 20
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 17 33 CFG=1
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 3 16 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Talonamide, 5-azido-5-deoxy-N-methyl-3,6-bis-O-(phenylmethyl)-, 2-methanesu...
C22H28N4O7S
1591782-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 6.9302 0.0 0 CFG=2
M  V30 2 C 4.0012 7.7002 0.0 0 CFG=2
M  V30 3 C 6.6687 7.7002 0.0 0 CFG=2
M  V30 4 O 5.3348 5.3901 0.0 0
M  V30 5 O 2.6675 6.9302 0.0 0
M  V30 6 C 4.0012 9.2402 0.0 0
M  V30 7 C 8.0023 6.9302 0.0 0 CFG=1
M  V30 8 O 6.6687 9.2402 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 S 1.3338 7.7002 0.0 0 VAL=6
M  V30 11 N 2.6675 10.0102 0.0 0
M  V30 12 O 5.3348 10.0102 0.0 0
M  V30 13 C 9.3360 7.7002 0.0 0
M  V30 14 N 8.0023 5.3901 0.0 0
M  V30 15 C 2.1038 9.0338 0.0 0
M  V30 16 O 0.0000 8.4702 0.0 0
M  V30 17 O 0.5638 6.3665 0.0 0
M  V30 18 C 2.6675 11.5503 0.0 0
M  V30 19 O 10.6698 6.9302 0.0 0
M  V30 20 N 9.3360 4.6201 0.0 0 CHG=1 VAL=4
M  V30 21 C 12.0035 7.7002 0.0 0
M  V30 22 N 10.6698 3.8501 0.0 0 CHG=-1
M  V30 23 C 4.0012 3.0801 0.0 0
M  V30 24 C 2.6675 2.3101 0.0 0
M  V30 25 C 5.3348 2.3101 0.0 0
M  V30 26 C 2.6675 0.7700 0.0 0
M  V30 27 C 5.3348 0.7700 0.0 0
M  V30 28 C 4.0012 0.0000 0.0 0
M  V30 29 C 13.3372 6.9302 0.0 0
M  V30 30 C 13.3372 5.3901 0.0 0
M  V30 31 C 14.6708 7.7002 0.0 0
M  V30 32 C 14.6708 4.6201 0.0 0
M  V30 33 C 16.0046 6.9302 0.0 0
M  V30 34 C 16.0046 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5 CFG=1
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8 CFG=3
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 2 6 12
M  V30 12 1 7 13 CFG=3
M  V30 13 1 7 14
M  V30 14 1 9 23
M  V30 15 1 10 15
M  V30 16 2 10 16
M  V30 17 2 10 17
M  V30 18 1 11 18
M  V30 19 1 13 19
M  V30 20 2 14 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 1 21 29
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 30 2 29 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 2 31 33
M  V30 34 2 32 34
M  V30 35 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 2 3 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Galactonamide, 5-azido-5-deoxy-N-methyl-3,6-bis-O-(phenylmethyl)-, 2-methan...
C22H28N4O7S
1591782-94-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 6.9302 0.0 0 CFG=2
M  V30 2 C 4.0012 7.7002 0.0 0 CFG=1
M  V30 3 C 6.6687 7.7002 0.0 0 CFG=2
M  V30 4 O 5.3348 5.3901 0.0 0
M  V30 5 O 2.6675 6.9302 0.0 0
M  V30 6 C 4.0012 9.2402 0.0 0
M  V30 7 C 8.0023 6.9302 0.0 0 CFG=1
M  V30 8 O 6.6687 9.2402 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 S 1.3338 7.7002 0.0 0 VAL=6
M  V30 11 N 2.6675 10.0102 0.0 0
M  V30 12 O 5.3348 10.0102 0.0 0
M  V30 13 C 9.3360 7.7002 0.0 0
M  V30 14 N 8.0023 5.3901 0.0 0
M  V30 15 C 2.1038 9.0338 0.0 0
M  V30 16 O 0.0000 8.4702 0.0 0
M  V30 17 O 0.5638 6.3665 0.0 0
M  V30 18 C 2.6675 11.5503 0.0 0
M  V30 19 O 10.6698 6.9302 0.0 0
M  V30 20 N 9.3360 4.6201 0.0 0 CHG=1 VAL=4
M  V30 21 C 12.0035 7.7002 0.0 0
M  V30 22 N 10.6698 3.8501 0.0 0 CHG=-1
M  V30 23 C 4.0012 3.0801 0.0 0
M  V30 24 C 2.6675 2.3101 0.0 0
M  V30 25 C 5.3348 2.3101 0.0 0
M  V30 26 C 2.6675 0.7700 0.0 0
M  V30 27 C 5.3348 0.7700 0.0 0
M  V30 28 C 4.0012 0.0000 0.0 0
M  V30 29 C 13.3372 6.9302 0.0 0
M  V30 30 C 13.3372 5.3901 0.0 0
M  V30 31 C 14.6708 7.7002 0.0 0
M  V30 32 C 14.6708 4.6201 0.0 0
M  V30 33 C 16.0046 6.9302 0.0 0
M  V30 34 C 16.0046 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5 CFG=3
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8 CFG=3
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 2 6 12
M  V30 12 1 7 13 CFG=3
M  V30 13 1 7 14
M  V30 14 1 9 23
M  V30 15 1 10 15
M  V30 16 2 10 16
M  V30 17 2 10 17
M  V30 18 1 11 18
M  V30 19 1 13 19
M  V30 20 2 14 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 1 21 29
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 30 2 29 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 2 31 33
M  V30 34 2 32 34
M  V30 35 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 2 3 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1395068-92-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1591782-93-2
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 1591782-94-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20725
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 5
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM From lactone 33L: Methylamine (33% in EtOH, 0.11 mL, 0.89 mmol) was added
to a solution of the lactone 33L (137 mg, 0.297 mmol) in 1,4-dioxane (2.5
mL) under argon. The reaction mixture was stirred for 16 h, after which
TLC analysis (3:7, cyclohexane-ethyl acetate) indicated the complete
consumption of the starting material and the formation of a major and a
minor product. The reaction was concentrated in vacuo and the crude
residue was purified by flash chromatography (7:3 to 11:9,
cyclohexane-ethyl acetate) to afford the products. L-talo amide 34L
(Yield: 7 mg, 5%) as a clear oil and the L-galacto amide 35L (Yield: 133
mg, 91%) as a white crystalline solid. L-talo amide 34L: (Rf 0.35).
[α]25D +66.6 (c 2.01 in CHCl3). νmax (thin film): 3418 (br s, OH), 2105
(s, N3), 1666 (s, CO), 1560 (s, CO), 1455 (s, SO2), 1179 (s, SO2). δH
(400 MHz, CDCl3): 2.65 (1 H, d, 4-OH, JOH,4 8.8), 2.83 (3 H, d, N-Me,
JH,NH 5.1), 3.05 (3 H, s, SO2-Me), 3.76 (1 H, dd, H-6, J6,5 5.1, J6,6'
9.9), 3.78 (1 H, dd, H-6', J6',5 6.6, J6',6 9.9), 3.82 (1 H, ddd, H-4,
J4,5 1.3, J4,OH 8.8, J4,3 9.3), 3.85 (1 H, ddd, H-5, J5,4 1.3, J5,6 5.1,
J5,6' 6.6), 4.24 (1 H, dd, H-3, J3,2 1.4, J3,4 9.3), 4.55 (1 H, d,
OCH2Ph, Jgem 11.9), 4.57 (1 H, d, OCH2Ph, Jgem 10.9), 4.59 (1 H, d,
OCH2Ph, Jgem 11.9), 4.77 (1 H, d, OCH2Ph, Jgem 10.9), 5.46 (1 H, d, H-2,
J2,3 1.4), 6.46 (1 H, q, N-H, JNH,H 5.1), 7.30-7.40 (10 H, m, Ar-H). δC
(100 MHz, CDCl3): 26.4 (N-Me), 39.1 (SO2-Me), 60.7 (C-5), 70.3 (C-4),
71.3 (C-6), 73.4, 73.8 (OCH2Ph), 79.0 (C-3), 79.4 (C-2), 127.9, 128.1,
128.6, 128.8 (ArCH), 136.5, 137.4 (ArCC), 167.4 (C-1). m/z (ESI +ve): 515
(M + Na+, 100). (ESI -ve): 491 ([M - H]-, 64), 527 (M + 35Cl-, 52), 529
(M + 37Cl-, 18), 983 ([2M - H]-, 100). HRMS m/z (ESI +ve): found 515.1568
[M + Na+], C22H28N4NaO7S requires 515.1571. L-galacto amide 35L: (Rf
0.64). mp 114-116 °C. [α]25D +33.9 (c 1.08 in CHCl3). νmax (thin film):
3407 (br s, OH), 2105 (s, N3), 1668 (s, CO), 1555 (s, CO), 1455 (s, SO2),
1178 (s, SO2). δH (400 MHz, CDCl3): 2.86 (3 H, d, N-Me, JH,NH 4.5), 3.11
(3 H, s, SO2-Me), 3.15 (1 H, d, 4-OH, JOH,4 8.2), 3.70 (1 H, ddd, H-4,
J4,5 1.3, J4,OH 8.2, J4,3 9.3), 3.75 (1 H, ddd, H-5, J5,4 1.3, J5,6 4.3,
J5,6' 6.6), 3.84 (1 H, dd, H-6, J6,5 4.3, J6,6' 10.4), 3.87 (1 H, dd,
H-6', J6',5 6.6, J6',6 10.4), 4.30 (1 H, dd, H-3, J3,2 1.7, J3,4 9.3),
4.52 (1 H, d, OCH2Ph, Jgem 11.1), 4.58 (3 H, a-d, 3 × OCH2Ph, J11.4),
5.32 (1 H, d, H-2, J2,3 1.7), 6.63 (1 H, q, N-H, JNH,H 4.5), 7.24-7.37
(10 H, m, Ar-H). δC (100 MHz, CDCl3): 26.6 (N-Me), 38.3 (SO2-Me), 59.9
(C-5), 70.4 (C-4), 71.5 (C-6), 73.8, 75.2 (OCH2Ph), 78.7 (C-3), 79.2
(C-2), 127.9, 128.1, 128.2, 128.4, 128.7, 128.7 (ArCH), 137.1, 137.3
(ArCC), 168.4 (C-1). m/z (ESI +ve): 515 (M + Na+, 100). HRMS m/z (ESI
+ve): found 515.1575 [M + Na+], C22H28N4NaO7S requires 515.1571.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nine of 16 Stereoisomeric Polyhydroxylated Proline Amides Are Potent
β-N-Acetylhexosaminidase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ayers, Benjamin J.; Glawar, Andreas F. G.; Martinez, R. Fernando; Ngo,
Nigel; Liu, Zilei; Fleet, George W. J.; Butters, Terry D.; Nash, Robert
J.; Yu, Chu-Yi; Wormald, Mark R.; Nakagawa, Shinpei; Adachi, Isao; Kato,
Atsushi; Jenkinson, Sarah F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2014), 79(8), 3398-3409

$RFMT $RIREG SCHEME69 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E,6E)-1,8-Bis(4-fluorophenyl)-2,6-octadiene-1,8-dione
C20H16F2O2
1432438-19-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 6.6685 0.0 0
M  V30 2 C 6.9300 5.3347 0.0 0
M  V30 3 O 6.9300 8.0021 0.0 0
M  V30 4 C 8.4700 5.3347 0.0 0
M  V30 5 C 9.2400 4.0011 0.0 0
M  V30 6 C 10.7800 4.0011 0.0 0
M  V30 7 C 11.5500 2.6674 0.0 0
M  V30 8 C 13.0900 2.6674 0.0 0
M  V30 9 C 13.8600 1.3336 0.0 0
M  V30 10 O 13.0900 0.0000 0.0 0
M  V30 11 F 0.0000 6.6685 0.0 0
M  V30 12 F 20.0200 1.3336 0.0 0
M  V30 13 C 4.6200 6.6685 0.0 0
M  V30 14 C 3.8500 5.3347 0.0 0
M  V30 15 C 3.8500 8.0021 0.0 0
M  V30 16 C 2.3100 5.3347 0.0 0
M  V30 17 C 2.3100 8.0021 0.0 0
M  V30 18 C 1.5400 6.6685 0.0 0
M  V30 19 C 15.4000 1.3336 0.0 0
M  V30 20 C 16.1700 2.6674 0.0 0
M  V30 21 C 16.1700 0.0000 0.0 0
M  V30 22 C 17.7100 2.6674 0.0 0
M  V30 23 C 17.7100 0.0000 0.0 0
M  V30 24 C 18.4800 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 2 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 7 8
M  V30 9 1 8 9
M  V30 10 2 9 10
M  V30 11 1 9 19
M  V30 12 1 11 18
M  V30 13 1 12 24
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-2,2′-[(2R,5S)-1-Methyl-2,5-pyrrolidinediyl]bis[1-(4-fluorophenyl)ethanone]
C21H21F2NO2
1633021-12-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 2.3100 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 O 5.3348 4.6201 0.0 0
M  V30 4 C 9.7293 0.9473 0.0 0
M  V30 5 C 11.9711 3.4372 0.0 0
M  V30 6 C 12.8763 4.6831 0.0 0
M  V30 7 O 12.2500 6.0899 0.0 0
M  V30 8 F 0.0000 0.0000 0.0 0
M  V30 9 F 19.0027 4.0392 0.0 0
M  V30 10 C 8.0021 3.0801 0.0 0 CFG=1
M  V30 11 N 9.4091 2.4536 0.0 0
M  V30 12 C 8.1632 4.6116 0.0 0
M  V30 13 C 10.4395 3.5981 0.0 0 CFG=2
M  V30 14 C 9.6695 4.9318 0.0 0
M  V30 15 C 4.0011 2.3100 0.0 0
M  V30 16 C 2.6673 3.0801 0.0 0
M  V30 17 C 4.0011 0.7700 0.0 0
M  V30 18 C 1.3337 2.3100 0.0 0
M  V30 19 C 2.6673 0.0000 0.0 0
M  V30 20 C 1.3337 0.7700 0.0 0
M  V30 21 C 14.4079 4.5220 0.0 0
M  V30 22 C 15.3131 5.7680 0.0 0
M  V30 23 C 15.0344 3.1152 0.0 0
M  V30 24 C 16.8448 5.6069 0.0 0
M  V30 25 C 16.5659 2.9542 0.0 0
M  V30 26 C 17.4712 4.2001 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 10 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 2 15
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 13 5 CFG=1
M  V30 8 2 6 7
M  V30 9 1 6 21
M  V30 10 1 8 20
M  V30 11 1 9 26
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 10 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-2,2′-[(2R,5R)-1-Methyl-2,5-pyrrolidinediyl]bis[1-(4-fluorophenyl)ethanone]
C21H21F2NO2
1633021-13-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 2.3100 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 O 5.3348 4.6201 0.0 0
M  V30 4 C 9.7293 0.9473 0.0 0
M  V30 5 C 11.9711 3.4372 0.0 0
M  V30 6 C 12.8763 4.6831 0.0 0
M  V30 7 O 12.2500 6.0899 0.0 0
M  V30 8 F 0.0000 0.0000 0.0 0
M  V30 9 F 19.0027 4.0392 0.0 0
M  V30 10 C 8.0021 3.0801 0.0 0 CFG=1
M  V30 11 N 9.4091 2.4536 0.0 0
M  V30 12 C 8.1632 4.6116 0.0 0
M  V30 13 C 10.4395 3.5981 0.0 0 CFG=1
M  V30 14 C 9.6695 4.9318 0.0 0
M  V30 15 C 4.0011 2.3100 0.0 0
M  V30 16 C 2.6673 3.0801 0.0 0
M  V30 17 C 4.0011 0.7700 0.0 0
M  V30 18 C 1.3337 2.3100 0.0 0
M  V30 19 C 2.6673 0.0000 0.0 0
M  V30 20 C 1.3337 0.7700 0.0 0
M  V30 21 C 14.4079 4.5220 0.0 0
M  V30 22 C 15.3131 5.7680 0.0 0
M  V30 23 C 15.0344 3.1152 0.0 0
M  V30 24 C 16.8448 5.6069 0.0 0
M  V30 25 C 16.5659 2.9542 0.0 0
M  V30 26 C 17.4712 4.2001 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 10 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 2 15
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 13 5 CFG=3
M  V30 8 2 6 7
M  V30 9 1 6 21
M  V30 10 1 8 20
M  V30 11 1 9 26
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 10 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1432438-19-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1633021-12-1
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 1633021-13-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-11109157
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, Aza-Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thermodynamic epimeric equilibration and crystallisation-induced dynamic
resolution of lobelanine, norlobelanine and related analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Amara, Z.; Bernadat, G.; Venot, P.-E.; Retailleau, P.; Troufflard, C.;
Drege, E.; Le Bideau, F.; Joseph, D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2014), 12(48), 9797-9810

$RFMT $RIREG SCHEME70 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chlorobenzaldehyde
C7H5ClO
89-98-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 Cl 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methylbenzenemethanamine
C8H10ClN
94-64-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 Cl 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C16H18Cl2N2
2669007-69-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 4.0012 0.0 0
M  V30 2 C 5.3901 2.6675 0.0 0
M  V30 3 N 5.3901 5.3348 0.0 0
M  V30 4 N 4.6201 1.3338 0.0 0
M  V30 5 C 4.6201 6.6687 0.0 0
M  V30 6 C 5.3901 0.0000 0.0 0
M  V30 7 Cl 3.0801 6.6687 0.0 0
M  V30 8 Cl 6.9302 0.0000 0.0 0
M  V30 9 C 3.0801 4.0012 0.0 0
M  V30 10 C 2.3101 5.3348 0.0 0
M  V30 11 C 2.3101 2.6675 0.0 0
M  V30 12 C 0.7700 5.3348 0.0 0
M  V30 13 C 0.7700 2.6675 0.0 0
M  V30 14 C 0.0000 4.0012 0.0 0
M  V30 15 C 6.9302 2.6675 0.0 0
M  V30 16 C 7.7002 1.3338 0.0 0
M  V30 17 C 7.7002 4.0012 0.0 0
M  V30 18 C 9.2402 1.3338 0.0 0
M  V30 19 C 9.2402 4.0012 0.0 0
M  V30 20 C 10.0102 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 2 15
M  V30 6 1 3 5
M  V30 7 1 4 6
M  V30 8 1 7 10
M  V30 9 1 8 16
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 89-98-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 94-64-4
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 2669007-69-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24618582
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 91
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 6
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM imino-pinacol coupling reaction, autoclave used, sealed tube used,
palladium-ruthenium catalyst prepared and used (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reductive imino-pinacol coupling reaction of halogenated aromatic imines
and iminium ions catalyzed by precious metal catalysts using hydrogen
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dumoleijn, K. N. R.; Van Den Broeck, E.; Stavinoha, J.; Van Speybroeck,
V.; Moonen, K.; Stevens, C. V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Catalysis (2021), 400103-113

$RFMT $RIREG SCHEME71 STEP1
$RXN



  3  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Benzimidazole, 6-bromo-2-chloro-1-(4-chloro-6-methyl-1,3,5-triazin-2-yl)-
C11H6BrCl2N5
1239981-09-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 7.4177 7.0618 0.0 0
M  V30 2 Br 0.0000 3.9107 0.0 0
M  V30 3 C 9.9050 2.6674 0.0 0
M  V30 4 Cl 5.2850 0.0000 0.0 0
M  V30 5 C 3.7534 5.4956 0.0 0
M  V30 6 N 5.2850 5.3347 0.0 0
M  V30 7 C 3.4333 7.0021 0.0 0
M  V30 8 C 2.6091 4.4652 0.0 0
M  V30 9 C 5.9114 6.7417 0.0 0
M  V30 10 N 4.7669 7.7721 0.0 0
M  V30 11 C 1.9686 7.4779 0.0 0
M  V30 12 C 1.1444 4.9411 0.0 0
M  V30 13 C 0.8242 6.4475 0.0 0
M  V30 14 C 6.0550 4.0011 0.0 0
M  V30 15 N 7.5950 4.0011 0.0 0
M  V30 16 N 5.2850 2.6674 0.0 0
M  V30 17 C 8.3650 2.6674 0.0 0
M  V30 18 C 6.0550 1.3336 0.0 0
M  V30 19 N 7.5950 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 12
M  V30 3 1 3 17
M  V30 4 1 4 18
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 6 14
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 2 9 10
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Benzimidazole, 5-bromo-2-chloro-1-(4-chloro-6-methyl-1,3,5-triazin-2-yl)-
C11H6BrCl2N5
1239981-10-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.3512 7.1821 0.0 0
M  V30 2 Br 11.2607 3.0331 0.0 0
M  V30 3 C 0.0000 4.6201 0.0 0
M  V30 4 Cl 2.6673 0.0000 0.0 0
M  V30 5 C 6.7417 3.9936 0.0 0
M  V30 6 N 5.3348 4.6201 0.0 0
M  V30 7 C 7.7721 5.1382 0.0 0
M  V30 8 C 7.2175 2.5290 0.0 0
M  V30 9 C 5.4958 6.1517 0.0 0
M  V30 10 N 7.0021 6.4718 0.0 0
M  V30 11 C 9.2785 4.8180 0.0 0
M  V30 12 C 8.7240 2.2089 0.0 0
M  V30 13 C 9.7544 3.3533 0.0 0
M  V30 14 C 4.0010 3.8501 0.0 0
M  V30 15 N 2.6673 4.6201 0.0 0
M  V30 16 N 4.0010 2.3101 0.0 0
M  V30 17 C 1.3337 3.8501 0.0 0
M  V30 18 C 2.6673 1.5400 0.0 0
M  V30 19 N 1.3337 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 13
M  V30 3 1 3 17
M  V30 4 1 4 18
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 6 14
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 2 9 10
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(6-Bromo-2-chloro-1H-benzimidazol-1-yl)-N,6-dimethyl-1,3,5-triazin-2-amine
C12H10BrClN6
1239981-11-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 5.4031 7.1820 0.0 0
M  V30 2 Br 0.5546 0.7441 0.0 0
M  V30 3 N 9.7544 4.6200 0.0 0
M  V30 4 C 11.0881 3.8500 0.0 0
M  V30 5 C 7.0870 0.0000 0.0 0
M  V30 6 N 4.4197 4.6200 0.0 0
M  V30 7 C 3.0127 3.9936 0.0 0
M  V30 8 C 4.2586 6.1516 0.0 0
M  V30 9 C 1.9823 5.1381 0.0 0
M  V30 10 C 2.5369 2.5290 0.0 0
M  V30 11 N 2.7523 6.4717 0.0 0
M  V30 12 C 0.4759 4.8179 0.0 0
M  V30 13 C 1.0304 2.2088 0.0 0
M  V30 14 C 0.0000 3.3532 0.0 0
M  V30 15 C 5.7533 3.8500 0.0 0
M  V30 16 N 7.0870 4.6200 0.0 0
M  V30 17 N 5.7533 2.3100 0.0 0
M  V30 18 C 8.4206 3.8500 0.0 0
M  V30 19 C 7.0870 1.5400 0.0 0
M  V30 20 N 8.4206 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 13
M  V30 3 1 3 4
M  V30 4 1 3 18
M  V30 5 1 5 19
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(5-Bromo-2-chloro-1H-benzimidazol-1-yl)-N,6-dimethyl-1,3,5-triazin-2-amine
C12H10BrClN6
1239981-12-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 6.9095 7.1821 0.0 0
M  V30 2 N 11.2608 4.6201 0.0 0
M  V30 3 C 12.5947 3.8501 0.0 0
M  V30 4 C 8.5935 0.0000 0.0 0
M  V30 5 Br 0.0000 3.0331 0.0 0
M  V30 6 N 5.9260 4.6201 0.0 0
M  V30 7 C 4.5192 3.9936 0.0 0
M  V30 8 C 5.7651 6.1516 0.0 0
M  V30 9 C 3.4888 5.1382 0.0 0
M  V30 10 C 4.0433 2.5290 0.0 0
M  V30 11 N 4.2588 6.4718 0.0 0
M  V30 12 C 1.9823 4.8180 0.0 0
M  V30 13 C 2.5369 2.2089 0.0 0
M  V30 14 C 1.5065 3.3533 0.0 0
M  V30 15 C 7.2599 3.8501 0.0 0
M  V30 16 N 8.5935 4.6201 0.0 0
M  V30 17 N 7.2599 2.3100 0.0 0
M  V30 18 C 9.9272 3.8501 0.0 0
M  V30 19 C 8.5935 1.5400 0.0 0
M  V30 20 N 9.9272 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 4 19
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1239981-09-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1239981-10-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1239981-11-3
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 1239981-12-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-650021
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2 To a solution of 6-bromo-2-chloro-
1-(4-chloro-6-methyl-1,3,5-triazin-2-yl)-1H-benzo[d]imidazole and
5-bromo-2-chloro-1-(4-chloro-6-methyl-1,3,5-triazin-2-yl)-1H-benzo[d]imidazole
as a 1:1 mixture of regioisomers (2.86 g, 8 mmol) in 1,4-dioxane (40 mL)
was added methylamine, 2.0 M solution in THF (8 mL, 1.59 mmol) at room
temperature and the resulting mixture was stirred overnight. The reaction
mixture was concentrated to yield
4-(6-bromo-2-chloro-1H-benzo[d]imidazol-1-yl)-N,6-dimethyl-1,3,5-triazin-2-amine
and
4-(5-bromo-2-chloro-1H-benzo[d]imidazol-1-yl)-N,6-dimethyl-1,3,5-triazin-2-amine
(2.542 g, 90% yield).
4-(6-bromo-2-chloro-1H-benzo[d]imidazol-1-yl)-N,6-dimethyl-1,3,5-triazin-2-amine
and
4-(5-bromo-2-chloro-1H-benzo[d]imidazol-1-yl)-N,6-dimethyl-1,3,5-triazin-2-amine,
yield (2.542 g, 90%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of indole and benzimidazole compounds as mTOR kinase
inhibitors for the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boezio, Alessandro; Cheng, Alan C.; Coats, James R.; Copeland, Katrina
W.; Graceffa, Russell; Harmange, Jean-Christophe; Huang, Hongbing; La,
Daniel; Olivieri, Philip R.; Peterson, Emily A.; Schenkel, Laurie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010096314 A1 2010-08-26

$RFMT $RIREG SCHEME72 STEP1
$RXN



  3  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Purine-6-methanol, 9-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)-β-D-erythro-pent...
C28H28N4O8S
865434-80-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6896 14.8649 0.0 0
M  V30 2 O 3.0633 16.2717 0.0 0
M  V30 3 S 1.5317 16.4326 0.0 0 VAL=6
M  V30 4 C 1.3706 14.9011 0.0 0
M  V30 5 O 0.0000 16.5937 0.0 0
M  V30 6 O 1.6926 17.9644 0.0 0
M  V30 7 O 13.0908 11.0631 0.0 0
M  V30 8 C 13.5667 12.5276 0.0 0
M  V30 9 O 12.5362 13.6722 0.0 0
M  V30 10 C 11.7280 8.0023 0.0 0
M  V30 11 O 10.9580 6.6686 0.0 0
M  V30 12 C 11.7280 5.3348 0.0 0
M  V30 13 O 13.2681 5.3348 0.0 0
M  V30 14 C 19.5922 13.8085 0.0 0
M  V30 15 C 8.6480 0.0000 0.0 0
M  V30 16 C 7.3792 13.1361 0.0 0
M  V30 17 N 7.6993 11.6296 0.0 0
M  V30 18 C 5.8476 13.2970 0.0 0
M  V30 19 N 8.2844 14.3820 0.0 0
M  V30 20 C 6.3657 10.8596 0.0 0
M  V30 21 C 5.2211 14.7038 0.0 0
M  V30 22 N 5.2211 11.8902 0.0 0
M  V30 23 C 7.6579 15.7888 0.0 0
M  V30 24 N 6.1264 15.9499 0.0 0
M  V30 25 C 9.1061 11.0033 0.0 0 CFG=2
M  V30 26 C 10.4400 11.7733 0.0 0
M  V30 27 O 9.4265 9.4969 0.0 0
M  V30 28 C 11.5844 10.7429 0.0 0 CFG=2
M  V30 29 C 10.9580 9.3359 0.0 0 CFG=2
M  V30 30 C 15.0730 12.8478 0.0 0
M  V30 31 C 15.5488 14.3125 0.0 0
M  V30 32 C 16.1035 11.7034 0.0 0
M  V30 33 C 17.0553 14.6327 0.0 0
M  V30 34 C 17.6098 12.0236 0.0 0
M  V30 35 C 18.0857 13.4883 0.0 0
M  V30 36 C 10.9580 4.0011 0.0 0
M  V30 37 C 9.4180 4.0011 0.0 0
M  V30 38 C 11.7280 2.6675 0.0 0
M  V30 39 C 8.6480 2.6675 0.0 0
M  V30 40 C 10.9580 1.3338 0.0 0
M  V30 41 C 9.4180 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 7 8
M  V30 8 1 28 7 CFG=3
M  V30 9 2 8 9
M  V30 10 1 8 30
M  V30 11 1 10 11
M  V30 12 1 29 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 12 36
M  V30 16 1 14 35
M  V30 17 1 15 41
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 1 25 17 CFG=1
M  V30 23 2 18 21
M  V30 24 1 18 22
M  V30 25 1 19 23
M  V30 26 2 20 22
M  V30 27 1 21 24
M  V30 28 2 23 24
M  V30 29 1 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 25 28 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Acetyl chloride
C2H3ClO
75-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 Cl 2.6673 2.3101 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[9-[2-Deoxy-3,5-bis-O-(4-methylbenzoyl)-β-D-erythro-pentofuranosyl]-9H-pur...
C30H31N5O6
1025503-99-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 15.3523 13.2436 0.0 0
M  V30 2 N 16.8839 13.0827 0.0 0
M  V30 3 C 17.7891 14.3285 0.0 0
M  V30 4 C 17.5102 11.6759 0.0 0
M  V30 5 C 19.3206 14.1676 0.0 0
M  V30 6 O 17.1628 15.7355 0.0 0
M  V30 7 O 7.3592 7.0030 0.0 0
M  V30 8 C 8.3898 5.8585 0.0 0
M  V30 9 O 9.8961 6.1788 0.0 0
M  V30 10 C 5.3900 9.7136 0.0 0
M  V30 11 O 4.6200 11.0472 0.0 0
M  V30 12 C 3.0800 11.0472 0.0 0
M  V30 13 O 2.3100 9.7136 0.0 0
M  V30 14 C 6.4862 0.0000 0.0 0
M  V30 15 C 0.0000 16.3820 0.0 0
M  V30 16 C 12.0104 10.9128 0.0 0
M  V30 17 N 10.5457 11.3887 0.0 0
M  V30 18 C 12.9156 12.1587 0.0 0
M  V30 19 N 12.6367 9.5060 0.0 0
M  V30 20 C 10.5457 12.9287 0.0 0
M  V30 21 C 14.4471 11.9977 0.0 0
M  V30 22 N 12.0104 13.4047 0.0 0
M  V30 23 C 14.1684 9.3451 0.0 0
M  V30 24 N 15.0734 10.5909 0.0 0
M  V30 25 C 9.2998 10.4836 0.0 0 CFG=2
M  V30 26 C 9.2998 8.9436 0.0 0
M  V30 27 O 7.8353 10.9595 0.0 0
M  V30 28 C 7.8353 8.4676 0.0 0 CFG=2
M  V30 29 C 6.9300 9.7136 0.0 0 CFG=2
M  V30 30 C 7.9139 4.3940 0.0 0
M  V30 31 C 8.9444 3.2494 0.0 0
M  V30 32 C 6.4075 4.0738 0.0 0
M  V30 33 C 8.4685 1.7849 0.0 0
M  V30 34 C 5.9316 2.6091 0.0 0
M  V30 35 C 6.9621 1.4647 0.0 0
M  V30 36 C 2.3100 12.3809 0.0 0
M  V30 37 C 0.7700 12.3809 0.0 0
M  V30 38 C 3.0800 13.7145 0.0 0
M  V30 39 C 0.0000 13.7145 0.0 0
M  V30 40 C 2.3100 15.0483 0.0 0
M  V30 41 C 0.7700 15.0483 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 7 8
M  V30 8 1 28 7 CFG=3
M  V30 9 2 8 9
M  V30 10 1 8 30
M  V30 11 1 10 11
M  V30 12 1 29 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 12 36
M  V30 16 1 14 35
M  V30 17 1 15 41
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 1 25 17 CFG=1
M  V30 23 2 18 21
M  V30 24 1 18 22
M  V30 25 1 19 23
M  V30 26 2 20 22
M  V30 27 1 21 24
M  V30 28 2 23 24
M  V30 29 1 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 25 28 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
9-[2-Deoxy-3,5-bis-O-(4-methylbenzoyl)-β-D-erythro-pentofuranosyl]-N-[[9-[2-d...
C55H53N9O10
1025504-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  74 83 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 17.9064 14.2649 0.0 0
M  V30 2 N 17.1364 15.5987 0.0 0
M  V30 3 C 15.5964 15.5987 0.0 0
M  V30 4 C 17.9064 16.9324 0.0 0
M  V30 5 O 27.6533 11.4667 0.0 0
M  V30 6 C 27.9735 12.9730 0.0 0
M  V30 7 O 26.8291 14.0034 0.0 0
M  V30 8 C 26.6180 8.2803 0.0 0
M  V30 9 O 25.9916 6.8734 0.0 0
M  V30 10 C 26.8969 5.6275 0.0 0
M  V30 11 O 28.4284 5.7884 0.0 0
M  V30 12 C 33.8321 14.8766 0.0 0
M  V30 13 C 24.3913 0.0000 0.0 0
M  V30 14 O 8.2994 22.6406 0.0 0
M  V30 15 C 9.4439 23.6712 0.0 0
M  V30 16 O 10.9085 23.1953 0.0 0
M  V30 17 C 6.0576 20.1508 0.0 0
M  V30 18 O 5.1524 18.9050 0.0 0
M  V30 19 C 3.6209 19.0659 0.0 0
M  V30 20 O 2.9944 20.4727 0.0 0
M  V30 21 C 8.1631 29.6966 0.0 0
M  V30 22 C 0.0000 14.0823 0.0 0
M  V30 23 C 21.7565 12.9313 0.0 0
M  V30 24 N 22.2323 11.4667 0.0 0
M  V30 25 C 20.2165 12.9313 0.0 0
M  V30 26 N 22.5265 14.2649 0.0 0
M  V30 27 C 20.9865 10.5615 0.0 0
M  V30 28 C 19.4464 14.2649 0.0 0
M  V30 29 N 19.7404 11.4667 0.0 0
M  V30 30 C 21.7565 15.5987 0.0 0
M  V30 31 N 20.2165 15.5987 0.0 0
M  V30 32 C 23.6969 10.9907 0.0 0 CFG=2
M  V30 33 C 24.9427 11.8959 0.0 0
M  V30 34 O 24.1727 9.5262 0.0 0
M  V30 35 C 26.1888 10.9907 0.0 0 CFG=2
M  V30 36 C 25.7127 9.5262 0.0 0 CFG=2
M  V30 37 C 14.8264 16.9324 0.0 0
M  V30 38 C 13.2864 16.9324 0.0 0
M  V30 39 N 15.5964 18.2660 0.0 0
M  V30 40 C 12.5164 18.2660 0.0 0
M  V30 41 N 12.2558 15.7880 0.0 0
M  V30 42 C 14.8264 19.5997 0.0 0
M  V30 43 N 11.0100 17.9459 0.0 0
M  V30 44 N 13.2864 19.5997 0.0 0
M  V30 45 C 10.8490 16.4143 0.0 0
M  V30 46 C 29.4382 13.4489 0.0 0
M  V30 47 C 30.5826 12.4185 0.0 0
M  V30 48 C 29.7583 14.9553 0.0 0
M  V30 49 C 32.0473 12.8943 0.0 0
M  V30 50 C 31.2230 15.4312 0.0 0
M  V30 51 C 32.3674 14.4008 0.0 0
M  V30 52 C 26.2704 4.2207 0.0 0
M  V30 53 C 27.1756 2.9747 0.0 0
M  V30 54 C 24.7388 4.0596 0.0 0
M  V30 55 C 26.5493 1.5679 0.0 0
M  V30 56 C 24.1125 2.6528 0.0 0
M  V30 57 C 25.0177 1.4070 0.0 0
M  V30 58 C 9.8656 18.9763 0.0 0 CFG=2
M  V30 59 C 10.0265 20.5080 0.0 0
M  V30 60 O 8.3592 18.6561 0.0 0
M  V30 61 C 8.6196 21.1343 0.0 0 CFG=2
M  V30 62 C 7.5892 19.9899 0.0 0 CFG=2
M  V30 63 C 9.1238 25.1774 0.0 0
M  V30 64 C 7.6591 25.6533 0.0 0
M  V30 65 C 10.2682 26.2080 0.0 0
M  V30 66 C 7.3389 27.1597 0.0 0
M  V30 67 C 9.9480 27.7143 0.0 0
M  V30 68 C 8.4833 28.1901 0.0 0
M  V30 69 C 2.7156 17.8200 0.0 0
M  V30 70 C 1.1841 17.9810 0.0 0
M  V30 71 C 3.3420 16.4131 0.0 0
M  V30 72 C 0.2789 16.7351 0.0 0
M  V30 73 C 2.4368 15.1672 0.0 0
M  V30 74 C 0.9052 15.3282 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 28
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 37
M  V30 6 1 5 6
M  V30 7 1 35 5 CFG=3
M  V30 8 2 6 7
M  V30 9 1 6 46
M  V30 10 1 8 9
M  V30 11 1 36 8 CFG=1
M  V30 12 1 9 10
M  V30 13 2 10 11
M  V30 14 1 10 52
M  V30 15 1 12 51
M  V30 16 1 13 57
M  V30 17 1 14 15
M  V30 18 1 61 14 CFG=1
M  V30 19 2 15 16
M  V30 20 1 15 63
M  V30 21 1 17 18
M  V30 22 1 62 17 CFG=3
M  V30 23 1 18 19
M  V30 24 2 19 20
M  V30 25 1 19 69
M  V30 26 1 21 68
M  V30 27 1 22 74
M  V30 28 1 23 24
M  V30 29 1 23 25
M  V30 30 2 23 26
M  V30 31 1 24 27
M  V30 32 1 32 24 CFG=1
M  V30 33 2 25 28
M  V30 34 1 25 29
M  V30 35 1 26 30
M  V30 36 2 27 29
M  V30 37 1 28 31
M  V30 38 2 30 31
M  V30 39 1 32 33
M  V30 40 1 32 34
M  V30 41 1 33 35
M  V30 42 1 34 36
M  V30 43 1 35 36
M  V30 44 2 37 38
M  V30 45 1 37 39
M  V30 46 1 38 40
M  V30 47 1 38 41
M  V30 48 2 39 42
M  V30 49 1 40 43
M  V30 50 2 40 44
M  V30 51 2 41 45
M  V30 52 1 42 44
M  V30 53 1 43 45
M  V30 54 1 58 43 CFG=3
M  V30 55 2 46 47
M  V30 56 1 46 48
M  V30 57 1 47 49
M  V30 58 2 48 50
M  V30 59 2 49 51
M  V30 60 1 50 51
M  V30 61 2 52 53
M  V30 62 1 52 54
M  V30 63 1 53 55
M  V30 64 2 54 56
M  V30 65 2 55 57
M  V30 66 1 56 57
M  V30 67 1 58 59
M  V30 68 1 58 60
M  V30 69 1 59 61
M  V30 70 1 60 62
M  V30 71 1 61 62
M  V30 72 2 63 64
M  V30 73 1 63 65
M  V30 74 1 64 66
M  V30 75 2 65 67
M  V30 76 2 66 68
M  V30 77 1 67 68
M  V30 78 2 69 70
M  V30 79 1 69 71
M  V30 80 1 70 72
M  V30 81 2 71 73
M  V30 82 2 72 74
M  V30 83 1 73 74
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 32 35 36 58 61 62)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 865434-80-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-36-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1025503-99-4
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 1025504-00-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15203542
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 5
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7558-80-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, cytostatic, and anti-HCV activity of 6-(N-substituted
aminomethyl)-, 6-(O-substituted hydroxymethyl)- and 6-(S-substituted
sulfanylmethyl)purine nucleosides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Silhar, Peter; Hocek, Michal; Pohl, Radek; Votruba, Ivan; Shih, I.-hung;
Mabery, Eric; Mackman, Richard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2008), 16(5), 2329-2366

$RFMT $RIREG SCHEME73 STEP1
$RXN



  2  2
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[4-Chloro-6-[4-(methylsulfonyl)phenyl]-2-(trifluoromethyl)-5-pyrimidinyl]be...
C18H11Cl2F3N2O4S2
944245-28-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 7.7000 10.6694 0.0 0
M  V30 2 C 12.3200 8.0021 0.0 0
M  V30 3 F 12.3200 6.4621 0.0 0
M  V30 4 F 13.8600 8.0021 0.0 0
M  V30 5 F 12.3200 9.5421 0.0 0
M  V30 6 S 5.3900 1.3336 0.0 0 VAL=6
M  V30 7 C 4.6200 0.0000 0.0 0
M  V30 8 O 4.0564 2.1036 0.0 0
M  V30 9 O 6.7236 0.5636 0.0 0
M  V30 10 S 1.5400 8.0021 0.0 0 VAL=6
M  V30 11 Cl 0.0000 8.0021 0.0 0
M  V30 12 O 1.5400 9.5421 0.0 0
M  V30 13 O 1.5400 6.4621 0.0 0
M  V30 14 C 8.4700 6.6684 0.0 0
M  V30 15 C 7.7000 8.0021 0.0 0
M  V30 16 N 10.0100 6.6684 0.0 0
M  V30 17 C 8.4700 9.3358 0.0 0
M  V30 18 C 10.7800 8.0021 0.0 0
M  V30 19 N 10.0100 9.3358 0.0 0
M  V30 20 C 7.7000 5.3347 0.0 0
M  V30 21 C 6.1600 5.3347 0.0 0
M  V30 22 C 8.4700 4.0011 0.0 0
M  V30 23 C 5.3900 4.0011 0.0 0
M  V30 24 C 7.7000 2.6673 0.0 0
M  V30 25 C 6.1600 2.6673 0.0 0
M  V30 26 C 6.1600 8.0021 0.0 0
M  V30 27 C 5.3900 6.6684 0.0 0
M  V30 28 C 5.3900 9.3358 0.0 0
M  V30 29 C 3.8500 6.6684 0.0 0
M  V30 30 C 3.8500 9.3358 0.0 0
M  V30 31 C 3.0800 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 18
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 6 9
M  V30 9 1 6 25
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 10 13
M  V30 13 1 10 31
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 20
M  V30 17 2 15 17
M  V30 18 1 15 26
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[4-Chloro-6-[4-(methylsulfonyl)phenyl]-2-(trifluoromethyl)-5-pyrimidinyl]-N...
C19H15ClF3N3O4S2
944245-29-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 8.4700 10.6694 0.0 0
M  V30 2 C 13.0900 8.0021 0.0 0
M  V30 3 F 13.0900 6.4621 0.0 0
M  V30 4 F 14.6300 8.0021 0.0 0
M  V30 5 F 13.0900 9.5421 0.0 0
M  V30 6 S 2.3100 8.0021 0.0 0 VAL=6
M  V30 7 N 0.7700 8.0021 0.0 0
M  V30 8 O 2.3100 9.5421 0.0 0
M  V30 9 O 2.3100 6.4621 0.0 0
M  V30 10 C 0.0000 9.3358 0.0 0
M  V30 11 S 6.1600 1.3336 0.0 0 VAL=6
M  V30 12 C 5.3900 0.0000 0.0 0
M  V30 13 O 7.4936 0.5636 0.0 0
M  V30 14 O 4.8264 2.1036 0.0 0
M  V30 15 C 8.4700 8.0021 0.0 0
M  V30 16 C 9.2400 6.6684 0.0 0
M  V30 17 C 9.2400 9.3358 0.0 0
M  V30 18 N 10.7800 6.6684 0.0 0
M  V30 19 N 10.7800 9.3358 0.0 0
M  V30 20 C 11.5500 8.0021 0.0 0
M  V30 21 C 6.9300 8.0021 0.0 0
M  V30 22 C 6.1600 6.6684 0.0 0
M  V30 23 C 6.1600 9.3358 0.0 0
M  V30 24 C 4.6200 6.6684 0.0 0
M  V30 25 C 4.6200 9.3358 0.0 0
M  V30 26 C 3.8500 8.0021 0.0 0
M  V30 27 C 8.4700 5.3347 0.0 0
M  V30 28 C 6.9300 5.3347 0.0 0
M  V30 29 C 9.2400 4.0011 0.0 0
M  V30 30 C 6.1600 4.0011 0.0 0
M  V30 31 C 8.4700 2.6674 0.0 0
M  V30 32 C 6.9300 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 20
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 6 9
M  V30 9 1 6 26
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 2 11 14
M  V30 14 1 11 32
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 21
M  V30 18 2 16 18
M  V30 19 1 16 27
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-[4-(methylamino)-6-[4-(methylsulfonyl)phenyl]-2-(trifluoromethyl)-...
C20H19F3N4O4S2
944245-30-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 10.6694 0.0 0
M  V30 2 C 5.3900 12.0031 0.0 0
M  V30 3 C 1.5400 8.0020 0.0 0
M  V30 4 F 1.5400 6.4620 0.0 0
M  V30 5 F 0.0000 8.0020 0.0 0
M  V30 6 F 1.5400 9.5420 0.0 0
M  V30 7 S 12.3200 8.0020 0.0 0 VAL=6
M  V30 8 N 13.8600 8.0020 0.0 0
M  V30 9 O 12.3200 9.5420 0.0 0
M  V30 10 O 12.3200 6.4620 0.0 0
M  V30 11 C 14.6300 9.3358 0.0 0
M  V30 12 S 8.4700 1.3336 0.0 0 VAL=6
M  V30 13 C 9.2400 0.0000 0.0 0
M  V30 14 O 7.1364 0.5636 0.0 0
M  V30 15 O 9.8036 2.1036 0.0 0
M  V30 16 C 6.1600 8.0020 0.0 0
M  V30 17 C 5.3900 6.6684 0.0 0
M  V30 18 C 5.3900 9.3358 0.0 0
M  V30 19 N 3.8500 6.6684 0.0 0
M  V30 20 N 3.8500 9.3358 0.0 0
M  V30 21 C 3.0800 8.0020 0.0 0
M  V30 22 C 7.7000 8.0020 0.0 0
M  V30 23 C 8.4700 9.3358 0.0 0
M  V30 24 C 8.4700 6.6684 0.0 0
M  V30 25 C 10.0100 9.3358 0.0 0
M  V30 26 C 10.0100 6.6684 0.0 0
M  V30 27 C 10.7800 8.0020 0.0 0
M  V30 28 C 6.1600 5.3347 0.0 0
M  V30 29 C 5.3900 4.0011 0.0 0
M  V30 30 C 7.7000 5.3347 0.0 0
M  V30 31 C 6.1600 2.6673 0.0 0
M  V30 32 C 8.4700 4.0011 0.0 0
M  V30 33 C 7.7000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 21
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 7 10
M  V30 10 1 7 27
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 2 12 15
M  V30 15 1 12 33
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 22
M  V30 19 2 17 19
M  V30 20 1 17 28
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 944245-28-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 944245-29-8
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 944245-30-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19203834
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel heterocycles as PDE4 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srinivas, Akella Satya Surya Visweswara; Tadiparthi, Ravikumar; Sharma,
Ganapavarapu Veera Raghava; Bhakiaraj, Durairaj Peter; Narsimhan,
Kilambi; Rajagopal, Sriram; Parameswaran, Venkatesan; Janarthanam,
Venkatesan; Narayanam, Maruthikumar; Gadde, Sathyanarayana; Ramachandran,
Uma; Narayanan, Sukunath; Thirunavukkarasu, Sappanimuthu; Kachhadia,
Virendra; Thara, Sathya Narayana; Reddy, Gaddam Om
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN261399 B 2014-06-27

$RFMT $RIREG SCHEME74 STEP1
$RXN



  2  3
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-N-(5-Bromo-3-methoxy-2-pyridinyl)-1,3-dihydro-1,3-dioxo-α-(phenylmethyl)...
C23H18BrN3O4
1428264-28-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6200 0.0 0 CFG=2
M  V30 2 C 6.6684 3.0800 0.0 0
M  V30 3 C 5.3347 5.3900 0.0 0
M  V30 4 N 5.3347 6.9300 0.0 0
M  V30 5 O 4.0011 4.6200 0.0 0
M  V30 6 O 9.7291 3.2573 0.0 0
M  V30 7 O 7.0186 7.9521 0.0 0
M  V30 8 O 5.3347 10.0100 0.0 0
M  V30 9 C 5.3347 11.5500 0.0 0
M  V30 10 Br 0.0000 10.0100 0.0 0
M  V30 11 N 8.0020 5.3900 0.0 0
M  V30 12 C 9.4089 4.7637 0.0 0
M  V30 13 C 8.1631 6.9215 0.0 0
M  V30 14 C 10.4394 5.9081 0.0 0
M  V30 15 C 9.6694 7.2417 0.0 0
M  V30 16 C 11.9794 5.9081 0.0 0
M  V30 17 C 10.4394 8.5755 0.0 0
M  V30 18 C 12.7494 7.2417 0.0 0
M  V30 19 C 11.9794 8.5755 0.0 0
M  V30 20 C 5.3347 2.3100 0.0 0
M  V30 21 C 5.3347 0.7700 0.0 0
M  V30 22 C 4.0011 3.0800 0.0 0
M  V30 23 C 4.0011 0.0000 0.0 0
M  V30 24 C 2.6673 2.3100 0.0 0
M  V30 25 C 2.6673 0.7700 0.0 0
M  V30 26 C 4.0011 7.7000 0.0 0
M  V30 27 C 4.0011 9.2400 0.0 0
M  V30 28 N 2.6673 6.9300 0.0 0
M  V30 29 C 2.6673 10.0100 0.0 0
M  V30 30 C 1.3336 7.7000 0.0 0
M  V30 31 C 1.3336 9.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 20
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 26
M  V30 8 2 6 12
M  V30 9 2 7 13
M  V30 10 1 8 9
M  V30 11 1 8 27
M  V30 12 1 10 31
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N1,N2-Dimethyl-1,2-benzenedicarboxamide
C10H12N2O2
19532-98-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 4.0011 0.0 0
M  V30 2 N 0.7700 4.0011 0.0 0
M  V30 3 O 3.0800 5.3349 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 5.3900 4.0011 0.0 0
M  V30 6 N 6.9300 4.0011 0.0 0
M  V30 7 O 4.6200 5.3349 0.0 0
M  V30 8 C 7.7000 5.3349 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 5.3900 1.3338 0.0 0
M  V30 13 C 3.0800 0.0000 0.0 0
M  V30 14 C 4.6200 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-α-Amino-N-methylbenzenepropanamide
C10H14N2O
35373-92-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0 CFG=2
M  V30 3 C 6.6684 1.5400 0.0 0
M  V30 4 N 5.3347 3.8500 0.0 0
M  V30 5 N 8.0021 2.3100 0.0 0
M  V30 6 O 6.6684 0.0000 0.0 0
M  V30 7 C 9.3358 1.5400 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5-Bromo-3-methoxy-2-pyridinamine
C6H7BrN2O
42409-58-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 1.3338 0.0 0
M  V30 2 C 2.3100 0.0000 0.0 0
M  V30 3 N 0.0000 4.0011 0.0 0
M  V30 4 Br 6.1600 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 1.5400 4.0011 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 N 2.3100 5.3349 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1428264-28-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 19532-98-0
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 35373-92-3
$DTYPE RXN:PRO(3):CAS_RN
$DATUM 42409-58-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-545429
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(3):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure, exemplified by
2-amine-3-methoxy 5-bromopyridine (2a) The compound 1a (480 mg, 1 mmol)
was dissolved in 5 ml ethanol, then 1 ml 30 % methylamine was added. The
mixture was stirred at room temperature for 20 min. Removal of the
solvent under reduced pressure gave the crude product, which was purified
by column chromatography on silica gel. 2-amine-3-methoxy 5-bromopyridine
(2a) (Yield: 90%), Compound 4, Compound 5. IR (KBr): 3, 460, 1,605,
1,452, 1,287 cm-1. 1H NMR (300 MHz, CDCl3): δ (ppm) 7.73 (d, J 2.1 Hz,
1H), 7.02 (d, J 2.1 Hz, 1H), 4.69 (s, 2H), 3.86 (s, 3H). 13C NMR (300
MHz, CDCl3) δ (ppm) 152.0, 130.1, 124.5, 122.7, 120.2, 66.2. Anal. calcd.
(%) for C6H7BrN2O: C 35.49, H 3.48, N 13.80; found: C 35.62, H 3.71, N
13.69. MS m/z (ESI): 203, 205 [M+1].
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown, optimization study, optimized on base and
solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ortho-substituent effect promoted rapid cleavage of amide C-N bond under
mild conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Peng; Cai, Jin; Hu, Huayou; Li, Lushen; Sun, Chunlong; Ji, Min
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research on Chemical Intermediates (2014), 40(8), 2935-2943

$RFMT $RIREG SCHEME75 STEP1
$RXN



  2  3
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-[[5-Nitro-2-(phenylmethyl)-2H-indazol-3-yl]oxy]ethyl]-1H-isoindole-1,3(2...
C24H18N4O5
2231757-73-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.2708 7.9521 0.0 0
M  V30 2 C 8.7353 7.4762 0.0 0
M  V30 3 C 9.8799 8.5067 0.0 0
M  V30 4 C 7.6210 4.6200 0.0 0
M  V30 5 N 1.5400 9.9091 0.0 0 VAL=5
M  V30 6 O 2.3100 11.2429 0.0 0
M  V30 7 O 0.0000 9.9091 0.0 0
M  V30 8 O 10.9152 5.3202 0.0 0
M  V30 9 O 12.5903 10.4760 0.0 0
M  V30 10 C 4.6200 7.2418 0.0 0
M  V30 11 C 6.1263 6.9217 0.0 0
M  V30 12 C 3.8500 5.9082 0.0 0
M  V30 13 C 3.8500 8.5755 0.0 0
M  V30 14 N 6.2872 5.3900 0.0 0
M  V30 15 N 4.8804 4.7637 0.0 0
M  V30 16 C 2.3100 5.9082 0.0 0
M  V30 17 C 2.3100 8.5755 0.0 0
M  V30 18 C 1.5400 7.2418 0.0 0
M  V30 19 C 7.6210 3.0800 0.0 0
M  V30 20 C 8.9546 2.3100 0.0 0
M  V30 21 C 6.2872 2.3100 0.0 0
M  V30 22 C 8.9546 0.7700 0.0 0
M  V30 23 C 6.2872 0.7700 0.0 0
M  V30 24 C 7.6210 0.0000 0.0 0
M  V30 25 N 11.3444 8.0308 0.0 0
M  V30 26 C 11.8203 6.5661 0.0 0
M  V30 27 C 12.5903 8.9360 0.0 0
M  V30 28 C 13.3603 6.5661 0.0 0
M  V30 29 C 13.8363 8.0308 0.0 0
M  V30 30 C 14.3908 5.4217 0.0 0
M  V30 31 C 15.3426 8.3510 0.0 0
M  V30 32 C 15.8971 5.7419 0.0 0
M  V30 33 C 16.3730 7.2066 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 25
M  V30 5 1 4 14
M  V30 6 1 4 19
M  V30 7 2 5 6
M  V30 8 2 5 7
M  V30 9 1 5 17
M  V30 10 2 8 26
M  V30 11 2 9 27
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 15
M  V30 17 1 12 16
M  V30 18 2 13 17
M  V30 19 1 14 15
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[5-Nitro-2-(phenylmethyl)-2H-indazol-3-yl]amino]ethanol
C16H16N4O3
2231757-25-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.0618 3.5673 0.0 0
M  V30 2 C 5.9173 2.5368 0.0 0
M  V30 3 C 6.2375 1.0306 0.0 0
M  V30 4 O 5.0931 0.0000 0.0 0
M  V30 5 C 4.0011 4.9300 0.0 0
M  V30 6 N 11.6221 7.5519 0.0 0 VAL=5
M  V30 7 O 12.3921 6.2181 0.0 0
M  V30 8 O 12.3921 8.8855 0.0 0
M  V30 9 C 7.7721 6.2181 0.0 0
M  V30 10 C 6.7417 5.0737 0.0 0
M  V30 11 C 7.0021 7.5519 0.0 0
M  V30 12 C 9.3121 6.2181 0.0 0
M  V30 13 N 5.3347 5.7000 0.0 0
M  V30 14 N 5.4956 7.2315 0.0 0
M  V30 15 C 7.7721 8.8855 0.0 0
M  V30 16 C 10.0821 7.5519 0.0 0
M  V30 17 C 9.3121 8.8855 0.0 0
M  V30 18 C 2.6674 5.7000 0.0 0
M  V30 19 C 1.3336 4.9300 0.0 0
M  V30 20 C 2.6674 7.2400 0.0 0
M  V30 21 C 0.0000 5.7000 0.0 0
M  V30 22 C 1.3336 8.0100 0.0 0
M  V30 23 C 0.0000 7.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 13
M  V30 6 1 5 18
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 16
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 14
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-5-nitro-2-(phenylmethyl)-2H-indazol-3-amine
C15H14N4O2
2231757-72-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3302 0.4759 0.0 0
M  V30 2 C 3.8657 0.0000 0.0 0
M  V30 3 C 8.3910 1.8386 0.0 0
M  V30 4 N 0.7700 4.4605 0.0 0 VAL=5
M  V30 5 O 0.0000 5.7941 0.0 0
M  V30 6 O 0.0000 3.1267 0.0 0
M  V30 7 C 4.6200 3.1267 0.0 0
M  V30 8 C 5.6504 1.9823 0.0 0
M  V30 9 C 5.3900 4.4605 0.0 0
M  V30 10 C 3.0800 3.1267 0.0 0
M  V30 11 N 7.0574 2.6086 0.0 0
M  V30 12 N 6.8964 4.1401 0.0 0
M  V30 13 C 4.6200 5.7941 0.0 0
M  V30 14 C 2.3100 4.4605 0.0 0
M  V30 15 C 3.0800 5.7941 0.0 0
M  V30 16 C 9.7246 2.6086 0.0 0
M  V30 17 C 11.0584 1.8386 0.0 0
M  V30 18 C 9.7246 4.1486 0.0 0
M  V30 19 C 12.3921 2.6086 0.0 0
M  V30 20 C 11.0584 4.9186 0.0 0
M  V30 21 C 12.3921 4.1486 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 11
M  V30 4 1 3 16
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 14
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 12
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[5-Nitro-2-(phenylmethyl)-2H-indazol-3-yl]oxy]ethanamine
C16H16N4O3
2231757-90-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.0618 3.5673 0.0 0
M  V30 2 C 5.9173 2.5368 0.0 0
M  V30 3 C 6.2375 1.0306 0.0 0
M  V30 4 N 5.0931 0.0000 0.0 0
M  V30 5 C 4.0011 4.9300 0.0 0
M  V30 6 N 11.6221 7.5519 0.0 0 VAL=5
M  V30 7 O 12.3921 6.2181 0.0 0
M  V30 8 O 12.3921 8.8855 0.0 0
M  V30 9 C 7.7721 6.2181 0.0 0
M  V30 10 C 6.7417 5.0737 0.0 0
M  V30 11 C 7.0021 7.5519 0.0 0
M  V30 12 C 9.3121 6.2181 0.0 0
M  V30 13 N 5.3347 5.7000 0.0 0
M  V30 14 N 5.4956 7.2315 0.0 0
M  V30 15 C 7.7721 8.8855 0.0 0
M  V30 16 C 10.0821 7.5519 0.0 0
M  V30 17 C 9.3121 8.8855 0.0 0
M  V30 18 C 2.6674 5.7000 0.0 0
M  V30 19 C 1.3336 4.9300 0.0 0
M  V30 20 C 2.6674 7.2400 0.0 0
M  V30 21 C 0.0000 5.7000 0.0 0
M  V30 22 C 1.3336 8.0100 0.0 0
M  V30 23 C 0.0000 7.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 13
M  V30 6 1 5 18
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 16
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 14
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2231757-73-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2231757-25-6
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 2231757-72-3
$DTYPE RXN:PRO(3):CAS_RN
$DATUM 2231757-90-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19285553
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Antichagasic, Leishmanicidal, and Trichomonacidal Activity of
2-Benzyl-5-nitroindazole-Derived Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fonseca-Berzal, Cristina; Ibanez-Escribano, Alexandra; Vela, Nerea;
Cumella, Jose; Nogal-Ruiz, Juan Jose; Escario, Jose Antonio; Bernardino
da Silva, Patricia; Batista, Marcos Meuser; Soeiro, Maria de Nazare C.;
Sifontes-Rodriguez, Sergio; Meneses-Marcel, Alfredo; Gomez-Barrio,
Alicia; Aran, Vicente J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2018), 13(12), 1246-1259

